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Abstract 
The prevalent business model in the pharmaceutical industry requires rapid and robust process 
development and flexible manufacturing processes. This work reports the attempts to develop 
structured procedures for membrane process development to meet these requirements. 
The Donnan Steric Pore Model, in conjunction with a computational molecular dynamics 
programme, was evaluated as tool for membrane performance predictions to circumvent the need 
for tedious membrane screening experiments. However, the computational effort required was too 
onerous, making experimentation more efficient than computational method at this stage. 
Process chemistry manipulation enabled the use of otherwise incompatible membranes for 
separation and reduced the time needed for membrane scoping. Firstly, through pH manipulation to 
selectively increase electrostatic sieving, the permeation selectivity of a membrane to 2 different 
solutes was changed. Secondly, a structured procedure for polyalkylation of an ‘anchor’ molecule to 
increase the steric hindrance of an organocatalyst was used to enable the total retention of the 
catalyst so that a single stage membrane recycling strategy for the catalyst could be enacted.  
Published membrane processes were analysed and found to lack robustness and to be too sensitive 
to slight deviations in membrane performance. Hence new membrane processes were devised to 
address these challenges. Firstly, a membrane cascade process was used to enhance the rejection of 
an active pharmaceutical ingredient (API) over the single pass membrane rejection. This cascade 
process was then used for concurrent API concentration and solvent recovery. Secondly, a 
permeable stripping cascade configuration was used for the removal of an excess reagent from an 
API to enable the excess loading of the reagent to increase the yield of the API. The membrane 
cascades benefited from enhanced reliability, increased productivity and improved robustness.    
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Nomenclature 
Symbol Description Unit 
  Membrane area m2 
   
Coefficient for description of concentration profile in retentate of 
stage j 
g  L-1 min-1 
   Initial concentration of retentate in stage j  g L
-1 
   
Concentration of solute i in the membrane pore or membrane 
interface 
mol m-3 
   Concentration of solute i in the bulk solution mol m
-3 
    Bulk concentration of solute i in the permeate  mol m
-3 
     Bulk concentration of solute i in the retentate mol m
-3 
    Species i diffusivity in across membrane m
2 s-1 
     Species i diffusivity in bulk solution m
2 s-1 
    Species i diffusivity across membrane pore m
2 s-1 
   Permeate flux of stage j L m
-2 h-1 
  Feed flow L min-1 
   Faraday’s constant 96 485.3365 C mol-1 C mol-1 
   Solute i flux across membrane mol m
-2 s-1 
   Solvent flux across membrane m s
-1 
  Boltzmann constant 1.38065 x 10-23 J K-1 J K-1 
   Mass transfer coefficient of solute i m s
-1 
   
Partition coefficient of species i across between bulk solution and 
membrane 
- 
     Solute i hindrance factor for convection - 
    Solute i hindrance factor for diffusion - 
  Position across pore length M 
   Molecular weight of solute i kg mol
-1 
   
  Modified Peclet number - 
    Pressure at location i along the x-axis bar 
   Effective transmembrane pressure in stage j bar 
   Permeate flow leaving stage j ml min
-1 
  Distance away from membrane wall m 
   Membrane pore radius m 
  Recycle ratio,  
  
  
 - 
   Universal gas constant 8.314 4621 J mol-1 K-1 J mol-1 K-1 
     Rejection of solute i in stage j, where         
    
    
 - 
     Rejection of solute i over the whole cascade,  where        
   
    
 - 
  Filtration time  min 
  Temperature  K 
   Pump flow feeding into stage j L min
-1 
  Solvent velocity in membrane pore m s-1 
   Partial molar volume of species i m
3 mol-1 
  Solute velocity in membrane pore m s-1 
     Volume of retentate in stage j at filtration time t  L 
      Volume of permeate from stage j at filtration time t L 
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   Retentate flow leaving stage j ml min
-1 
  Position in x-axis of membrane pore or membrane m 
     Concentration of species i in retentate leaving stage j   g L
-1 
       Concentration of species i in retentate leaving stage j at time t  g L
-1 
          Concentration of species i in retentate stream leaving cascade g L
-1 
      Purity of solute i in the retentate at time t - 
    Friction coefficient between solute and membrane N s m
-1 mol-1 
    Proportionality constant between solvent i and membrane 
J s m-2 g-1 
mol-1 
    Proportionality constant between solute j and membrane 
J s m-2 g-1 
mol-1 
  Position in y-axis of membrane pore M 
     Concentration of species i in permeate leaving stage j   g L
-1 
      Purity of solute i in the permeate at time t - 
          
Concentration of species i in permeate collected from stage j at 
filtration time t 
g L-1 
          Concentration of species i in permeate stream leaving cascade g L
-1 
   Charge on solute i - 
     Concentration of species i in the feed g L
-1 
  Membrane porosity - 
  Solution viscosity Pa s 
   Membrane thickness m 
    Effective transmembrane pressure difference bar 
    Born solvation energy of solute i J 
    Donnan potential V 
   Chemical potential of solute i J mol
-1 
   Superficial velocity of solvent across membrane m s
-1  
   Steric partitioning coefficient factor of solute i - 
   Ratio of solute i radius to membrane pore radius - 
   Force exerted by solute i molecule on pore wall J g
-1 mol-1 
   Activity coefficient of solute i in the membrane pore  - 
  
  Activity coefficient of solute i in the bulk solution - 
  Shear stress N m-2 
   Stage cut of membrane stage j - 
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1. Introduction 
The international pharmaceutical market is huge, with a worldwide turnover of $800 billion in 2009 
(am Ende, 2011). However, the industry now faces increasing cost pressures due to decreasing profit 
margins and shrinking product pipelines.  Improving the efficiency of manufacturing is imperative in 
maintaining the competitiveness of the industry since production accounts for an estimated 30% of 
the overall cost of a drug (Filtration+Separation, 2006). Furthermore, the increasing complexities of 
syntheses for the active pharmaceutical ingredients (API’s) of upcoming drugs will disproportionately 
contribute to increases in production costs. Therefore there is an industry trend to minimise the cost 
of API manufacturing, while doing so in a safe and environmentally benign way (Federsel, 2006).  
Meanwhile, separation processes account for somewhere between 40-70% of the capital and 
operating costs of the chemical industry (Spear, 2006), hence optimisation of separation processes 
in API manufacturing will likely play an important part in driving efficiency gains in the 
pharmaceutical industry. 
Nanofiltration (NF) has gained attention in recent years for its potential to streamline separation 
processes.  NF involves the separation of solutes, based on their size and charge, through the use of 
a pressure difference across a membrane. NF membranes tend to retain solutes that are larger than 
the nanometre range, while smaller solutes and solvents can permeate easily through them. NF and 
organic solvent nanofiltration (OSN), which sprung up with the development of NF membranes 
stable in organic solvents in the last 2 decades (See Toh et al., 2007a; See Toh et al., 2007b; See Toh, 
2008; Vandezande et al., 2008; White & Nitsch, 2000), have the potential to be used in a myriad of 
industrial processes and lab scale syntheses in the pharmaceutical industry. Thermal degradation 
and side reactions can be minimized due to their lower operational temperatures relative to 
distillation, while their energy consumptions are lower than distillation and crystallization. Solvent 
exchange from a high-boiling point to a low-boiling point solvent can also be performed more easily 
than distillation. Moreover the modular nature of the membrane setup makes continuous 
processing simple (Vandezande et al., 2008). 
UCB Pharma SA (henceforth called UCB Pharma in the rest of this thesis), like many other companies 
dealing with chemical synthesis of API’s, faces a significant challenge in applying OSN to its 
processes. While OSN membranes typically show molecular weight cutoffs (MWCO) of 200-1000Da 
(Vandezande et al, 2008), the typical compounds dealt with at UCB Pharma have molecular weights 
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in the low hundreds of Daltons. In many cases, the solutes are similar in sizes, posing a greater 
purification challenge. 
1.1 Process Development in Pharma 
Patents applied after 1995 are typically valid for 20 years from the earliest application date, giving 
pharmaceutical companies limited market exclusivity for any of their drugs. While further 
innovations such as improved indications or formulations can extend the exclusivity for 3-5 years 
(FDA, 2011), this is short compared to the 10-15 years of research required to bring a new 
compound to market. Hence securing the availability of a drug as quickly as possible remains one of 
the highest priorities of pharmaceutical companies and process development has to cater to this 
need (am Ende, 2011). Furthermore, the productivity and cost pressures faced by the 
pharmaceutical industry make identification of optimum production processes as early as clinical 
studies in phase II a necessity (Federsel, 2006). Due to this time constraint in developing processes 
that have to be robust and quantifiably ‘optimum’, tools and methods for process development in 
the pharmaceutical industry have to be predictable and quick to scale up.   
Process development is also driven by the demands of API manufacturers. Plants used in API 
production are primarily batch-operated multipurpose plants which allow flexibility in response to 
product demand (am Ende, 2011), with the trend of pharmaceutical companies outsourcing their 
manufacturing to contract manufacturing organisations (CMO) (Morvan, 2012) likely to cement the 
prevalence of such plants. Therefore compatibility with the multipurpose batch plant model is 
necessary for any process to gain widespread adoption in API production. On the other hand, new 
processes should also be forward compatible with continuous operations as the industry gradually 
switches to continuous processing (LaPorte et al., 2011). This switch will likely occur as ICH (2000) 
has cleared the regulatory hurdle to batch tracking in continuous processing by allowing a batch to 
correspond to a defined fraction in a continuous process. 
OSN can potentially meet the process development needs of the pharmaceutical industry. The 
modular design of OSN equipment makes OSN flexible and easily scalable between batch and 
continuous operation, while the dominance of membrane processes in the desalination/water 
treatment industry (Zarkadas & Sirkar, 2011) should be a testament of the predictability of OSN 
performance.  
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1.2 Overview of OSN Applications  
The proliferation of publications which purport to apply OSN technology on API production masks 
the low adoption rate of OSN in the pharmaceutical industry. Most works published are largely 
academic with few examples of industrial use. This is despite the seemingly good fit of OSN with the 
requirements of the pharmaceutical industry. In this section, notable OSN applications are 
summarised in an attempt to identify the resistance to adopting this technology in the industry. In 
general, these applications can be grouped into solvent exchange, solvent recovery and solute 
fractionation. The retention/rejection of a solute is often used to quantify membrane performance 
and is expressed according to Equation 1.1 (See Toh et al., 2007b). Do note this differs from the 
definition by Mulder (1996) as the common apparatus used for the characterisation of membrane 
performance in OSN (See Toh et al., 2007a; See Toh et al., 2007b; Sereewatthanawut et al., 2008) 
measures the concentration in the retentate and not the feed. The terms for the equation are 
illustrated in Figure 1.1. 
        
    
    
 Equation 1.1 
 
Figure 1.1: Schematic for NF membrane stage j and the terms for concentrations for the streams 
into and out of the NF unit. 
1.2.1 Solvent recovery 
The success and increasing prevalence of membrane filtration in water treatment (Fritzmann et al., 
2007) have raised interest in the use of OSN for solvent recovery. The efficiency of organic solvent 
usage in the pharmaceutical industry is abysmal though solvents are widely used in the industry 
Retentate 
concentration =      
Permeate 
concentration =      
Feed  
concentration =      
Stage j 
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(Hellweg et al., 2004). In fact, while solvent use accounts for an estimated 80-90% of the mass 
utilization in a typical pharmaceutical batch chemical operation, recovery rates of organic solvents 
are low with GlaxoSmithKline (GSK) quoting solvent recycle rate of less than 50% (Constable et al., 
2006). Improving organic solvent recycling rates can be part of the strategy to reduce solvent 
wastage and OSN might help realise it. However, the success in water treatment might not be 
directly translational in many cases because the solute in solution is often a desirable product and 
needs to be recovered. Water treatment on the other hand tends to employ destructive processes 
for solute removal in pre-membrane water treatment.  
It has been aptly pointed out that significant energy savings can be realised if a single-stage OSN 
process is used as an alternative to distillation for every solvent recovery step (Darvishmanesh et al., 
2011; Geens et al., 2007; Rundquist et al., 2012a; Rundquist et al., 2012b). The success of OSN in 
solvent recovery relied on the use of a membrane with a high retention of the solute, with only 
membranes having rejections of >0.95 considered. However, such high rejections are not always 
possible even with the extensive membrane screening (Darvishmanesh et al., 2011; Geens et al., 
2007; Rundquist et al., 2012a ; Rundquist et al., 2012b).  
The use of multiple membrane passes in batch diafiltration has been demonstrated in response to 
inadequate membrane performance (Katraro et al., 1997; Rundquist et al., 2012b), with concurrent 
progress also being made in the development of continuously operated membrane cascade for 
solvent recovery (Abejon et al., 2012; Caus et al., 2009).  
1.2.2 Solvent exchange 
Solvent exchange is a common unit process in the pharmaceutical industry, usually performed using 
batch distillation with intensive use of energy and solvent (Zarkadas & Sirkar, 2011). Sheth et al. 
(2003) demonstrated how OSN can enable an easy solvent switch at ambient temperature, even 
switching to a solvent that has a lower boiling point. An ethyl acetate solution of erythromycin was 
switched to methanol using a batch diafiltration process, employing hydrophobic SelRO® 
membranes that gave high single pass rejection of erythromycin of 0.8-0.95. Yields of 84-96% of 
erythromycin were achieved. Rundquist et al. (2012a) also managed a solvent exchange with low API 
losses of 2.3%, using StarmemTM 240 membrane which had >0.99 retention of the API. 
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A solvent exchange can also be performed continuously using OSN. Lin & Livingston (2007) 
demonstrated the use of a membrane cascade in switching a toluene solution of 
tetraoctylammonium bromide to a more volatile methanol solution by employing STARMEMTM 122 
membranes which had retentions of between 0.74 and 0.99 for the ammonium salt. Salt losses were 
minimised when the rejection of the salt approached unity for every stage.  
1.2.3 Solute fractionation 
Emulating the success in aqueous ultrafiltration (Cheang & Zydney, 2003; Zydney, 1998), OSN 
membranes have already been used in a number of solute fractionating processes, such as 
homogeneous catalyst recycling (Anyanwu & Venkataraman, 2005; Ferreira et al., 2007; Dijkstra et 
al., 2002; Nair et al., 2002; Tsoukala et al., 2012), intermediate purification (Ghazali, 2006; So et al., 
2010) and API purification (Pink et al., 2008; Sereewatthanawut et al., 2010, Székely et al., 2011; 
Székely et al., 2012). These examples mostly employed diafiltration, with a partiality towards 
constant volume diafiltration. The authors for these works relied on membrane screening for the 
highest possible retention for the most retained solute to develop a successful separation 
procedure. 
Continuous operation of OSN units for solute fractionation is absent in literature, though the 
concept has been demonstrated for protein fractionation in water (Mayani et al., 2010) using 
ultrafiltration membranes.  
1.3 Scope of Study and Objectives 
The relatively low volumes and short life-times of most products in the pharmaceutical industry 
(Roberge et al., 2005) necessitate rapid process development and the use of flexible processes. A 
review of the OSN examples listed in Section 1.2 showed that speedy development of OSN process 
for use in the industry is not easy. A high membrane rejection of the target solute was critical for the 
success of these processes, with complete rejection of the target compound the optimum condition 
sought after. Membranes were screened laboriously, searching for the membrane with the highest 
rejection and not all screenings culminated in a suitable membrane. While membranes can be 
custom-made for a particular solute-solvent system to achieve complete rejection, membrane 
development is often tedious and not in the scope of API producers. Furthermore the membranes 
were often dedicated to a particular process and rarely interchangeable due to the sensitivity of the 
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process to membrane rejection, making membrane screening necessary for each and every 
application. 
Process development can be sped up, with the use of appropriate tools for membrane performance 
predictions, by reducing the effort required for membrane screening. Modifying the process 
parameters such as process solvent to suit the capabilities of the membrane available can also 
eliminate the need for extensive membrane screening. Despite single stage diafiltration being the 
state-of-the-art for the application of OSN, forays into developing staged membrane cascade 
systems have attempted to achieve superior separation performance over the single stage process. 
Therefore, it is evident that manipulation of process configuration is another tool available to API 
producers to circumvent membrane limitations and avoid membrane screenings. 
The first objective of this work is to determine tools for the prediction of membrane performance to 
hasten membrane process development. The next objective is to showcase how both process 
modifications and manipulation of process configuration can be used to make OSN applications work 
in spite of the performance limitations of commercially available membranes. Hopefully, this work 
can help minimise the need for membrane screening, which is so ubiquitous in published OSN works.    
In order to meet the objectives stated above, the following deliverables are planned as part of this 
thesis: 
1. Review of various membrane transport models (Chapter 2). 
2. Case study on the use of process modifications on solutes to improve OSN separation, 
including their relevance in improving solute rejection and their use for membrane 
performance predictions (Chapter 3). 
3. Review of common OSN processes and their inherent limitations (Chapter 4). 
4. Case study for the use of process engineering to address the limitation of the state of the art 
OSN processes (Chapter 5). 
5. Conclusion for this thesis, recommendation for future work and review of what was 
achieved against the stated objectives of this thesis (Chapter 6). 
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2. Membrane Transport Modelling  
Henceforth, a distinction is made between a membrane process model, which describes variables in 
a membrane process, and a membrane transport model, which describes transport across the 
membrane itself.  
An accurate membrane transport model, especially one that can provide an a priori prediction of 
membrane performance, can contribute to a better adoption rate of OSN technology in the 
pharmaceutical industry by enabling the selection of suitable membranes with greater certainty.  
A number of transport models have been proposed to explain the transport of solvent and solutes 
across membranes. While all of them are semi-empirical at best, they do offer users a tool to 
understand membrane transport. Broadly speaking, these models can be classified as either a 
solution-diffusion model or a pore flow model. 
2.1 Solution-diffusion Model 
In the mathematical description of solution-diffusion models (Wijmans & Baker, 1995), the fluxes of 
solvents and solutes through the membrane are scaled by the membrane permeability constants of 
the solvents and solutes respectively. Firstly, the transport of solvent i through a membrane can be 
described by  
    
           
     
      Equation 2.1 
Where the partitioning between the bulk solution and membrane, due to the difference in activity 
coefficients in both phases, is accounted for with the partitioning coefficient, shown in the equation 
below. 
    
  
 
  
 Equation 2.2 
Secondly, the flux of solute j can be expressed as  
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           Equation 2.3 
Hence one can see that the permeabilities of solvents and solutes are proportional to both the 
diffusivity of the species through the membrane, and the sorption of the species onto the 
membrane. Solute-solvent separation, as described by this mechanism, occurs when the solute 
diffuses and/or sorbs into the membrane at a different rate than the solvent. 
The species diffusivities (   ) and sorption coefficients (  ), which the permeability constants are 
dependent upon, are often concentration dependent (Wijman & Baker, 1995) and are hard to 
determine independently without direct testing on the specific solvent-solute-membrane system. 
This makes experimentation necessary whenever a new solvent-solute-membrane system is 
employed. Without a correlation of the solute diffusivity and solute sorption on the membrane with 
measureable membrane variables, an a priori prediction tool using the solution-diffusion model is 
impossible. 
2.2 Pore-flow Model 
The pore-flow models on the other hand tend to relate membrane transport to the pressure 
gradient through the membrane. Solvent flow is often described in continuum with a hydrodynamic 
equation such as the Hagen-Poiseuille equation or a modification of it. Solute transport on the other 
hand is described in two parts. Firstly the “partitioning” equation gives a measure of the affinity of 
the solute to the membrane, mathematically relating the concentration of solute in the bulk solution 
to the concentration of solute in the pore. Secondly, the transport equation relates the rate of solute 
transport through the membrane pore. Solute-solvent separation occurs due to the difference in the 
rate of transport of solute and solvent through the membrane pore and also due to the higher or 
lower affinity for solute sorption into the membrane pore than solvent sorption.  
The surface force pore flow (SFPF) model proposed by Matsuura & Sourirajan (1981) implies that 
“partitioning” of solutes occurs due to a potential resulting from the interaction between the pore 
on the membrane surface and the solute j in bulk solution according to   
           
   
  
  Equation 2.4 
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A result of the partitioning is a reduction or increase of solute concentration in the pore compared 
to the immediate bulk solution when the potential is repulsive or attractive respectively. The solutes 
are then co-transported with the solvent, hindered by friction forces, between the solute and 
solvent and between the solute and pore wall. The flux of solute j through a pore can be 
mathematically expressed as 
    
    
       
 
   
  
     
   
       
 Equation 2.5 
Where the proportionality constant between solute and membrane is 
     
      
  
 Equation 2.6 
And the proportionality constant between solute and membrane is 
     
    
   
 Equation 2.7 
Solvent transport is not described in this model as the model relies on fitting with experimental flux 
data. While the friction force in this model can be determined easily from the diffusivity of the solute 
in solvent, the potential has to be obtained empirically through fitting with experimental data. 
Therefore this model is not designed for the a priori prediction of membrane transport. 
The finely porous model developed by Jonsson & Boeson (1975) and explored by Niemi & Palosaari 
(1993) describes partitioning as a result of an equilibrium distribution between the pore fluid and 
bulk solution. For the finely porous model, assuming a porosity of unity, the permeate flux of a 
solution containing solute i can be expressed as 
    
   
 
  
 
   
  
    
  
  
  Equation 2.8 
While the solute i flux can be expressed with  
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 Equation 2.9 
Hence one can see that solvent transport follows a modified Hagen-Poiseuille equation, with the 
velocity slowed down by friction between solute and membrane, while solute transport is described 
as a combination of diffusive and viscous flows (co-transport with solvent). Therefore solvent and 
solute transports are dependent on the friction forces between solute-membrane, solute-solvent 
and solvent-solute. While the friction coefficient between solute and solvent can be determined 
from the diffusivity of solute in solvent, the determination of friction coefficient between solute and 
membrane using the diffusivity of solute in membrane is harder and will require fitting with 
experimental data. Hence this model is not suited for the a priori prediction of membrane transport 
either. 
The Donnan Steric Pore Model (DSPM), employed by Bowen & co-workers (Bowen et al., 1997; 
Bowen & Mohammad, 1998; Bowen & Welfoot, 2002) and Déon et al. (2007), stands out amongst 
the pore flow models. Partitioning of uncharged solutes in this model is solely dependent on a size 
factor that can potentially be determined through independent measurements of the solute and the 
membrane, without the need to fit with experimental data. As such, a priori predictions of 
membrane performance are possible with this model. Similar to the finely porous model, solute 
transport occurs as a result of pressure driven solvent flow and diffusive flow of solute in solution in 
the pore. Solvent transport in this model follows the Hagen-Poiseuille equation.  
It should be noted that for solvent volume to be conserved on both sides of a membrane, solvent 
velocity through the pores has to be higher than the actual permeate flux, if the porosity of the 
membrane is less than unity. This mathematical condition runs contrary to the solution diffusion 
models. However, this was not been taken into account by a number of pore flow modellers 
(Matsuura & Sourirajan, 1981; Bowen & Welfoot, 2002; Deon et al., 2007), hence they might have 
underestimated the significance of viscous transport of solute in their analysis. 
2.2.1 Donnan-steric pore model 
The DSPM, proposed by Bowen et al. (1997), where ion transport is described by the extended 
Nernst-Planck equation and equations added to account for hindered transport of ions and solutes 
due to steric and electrostatic hindrance, was successfully used in the prediction of aqueous NF 
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performance in dye-salt diafiltration (Bowen & Mohammad, 1998) and the prediction of various 
solutes and inorganic salts rejection in continuous NF (Bowen and Welfoot, 2002; Déon et al., 2007). 
This model assumes the following: 
1. A porous membrane structure with uniform pore sizes and pores with tortuosity of unity 
2.  Negligible concentration polarisation 
3. Pores that can be charged, depending on pH and ionic strength of the solution the 
membrane is in 
4. Pores have hard walls while the solutes in the model are represented by hard spheres 
that obey the Stokes-Einstein equation  
5. Solvent behaves as a continuum 
The DSPM uses 3 main equations to describe solute rejection. Unhindered solvent transport is 
modelled using a Hagen-Poiseuille type equation. Both the sieving effect of the membrane, which is 
accounted for by the partitioning equation, and the solute transport in the membrane pore, 
described using a hydrodynamic model, are used to describe hindered solute transport across a 
membrane. 
2.2.1.1 Solvent transport equation 
Solvent transport in the DSPM is expressed in the form of Equation 2.10, with the assumption that 
the membrane contains only straight pores of identical sizes.  
    
   
    
   
  
  
     
Equation 
2.10 
Do note that this equation differs slightly from the equation used by Bowen & Welfoot (2002) and 
Déon et al. (2007) because they neglected to consider the direction of pressure drop despite 
expressing the pressure drop from the retentate to the permeate side. The porosity of the 
membrane, which these two groups neglected, is also represented in this equation. Implicitly, their 
membranes were modelled as having a porosity of unity, contradicting observations of a dense 
separation layer on the membrane under microscopy (Tung et al., 2009). A more detailed derivation 
of this equation is presented in Appendix 8.1. 
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The magnitude of water flux has been shown to fit well with this Hagen-Poiseuille equation variant 
(Bowen & Mohammad, 1998; Bowen & Welfoot, 2002), hence the equation should be a good model 
of solvent flow behaviour through the membrane pore. However there are questions on the 
quantification of solution viscosity increase, relative to the viscosity in the bulk solution, due to the 
confinement of solvent molecules in the membrane pore (Bowen & Welfoot, 2002; Silva et al, 2005). 
2.2.1.2 Partitioning equation 
The partitioning equation describes the probability of finding a solute particle in a pore, which is in 
contact with the bulk solution of a certain solute concentration. The most commonly used 
partitioning coefficient is (Bowen & Welfoot, 2002)  
 
    
  
   
       
     
   
     Equation 2.11 
 
Figure 2.1. Schematic illustrating solute partitioning between the bulk solution and the membrane 
pore. The solute must overcome steric hindrance, through chance, and charge hindrance, by 
having sufficient energy, before it can enter a membrane pore for transport across the membrane. 
The equation implies that for a solute to enter a pore, it has to both be able to orientate itself into 
the pore and overcome the energy barrier due to electrostatic interactions between it and the 
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membrane.  A schematic representation is shown in Figure 2.1. The i ( 1,)1(
2  iii  ) term 
represents the steric hindrance to a solute i entering a pore. The larger the solute size is relative to 
the pore size, the lower the concentration of the solute in the pore compared with the bulk solution 
concentration. When the solute is larger than the pore it will not be possible for solute to enter the 
pore and the concentration of solute in the pore will always be zero. The exponential term 
represents the electrostatic energy barrier to the solute entering the pore and accounts for the 
increasing ease at which a solute can enter a pore if it has attractive interactions with the membrane 
and the difficulty when there are repulsive interactions.  
On the other hand Bowen & Welfoot (2002) proposed the addition of an extra exponential term to 
account for the theoretical increase in difficulty for the solvation of ions in the pore, modifying 
Equation 2.11 to 
 
    
  
   
       
    
   
        
    
  
  Equation 2.12 
This additional term will always be smaller than unity if the orientation of solvent molecules at the 
pore wall leads to a reduction of dielectric constant, and therefore increases the energy barrier to 
ion salvation in the pore (Bowen & Welfoot, 2002). This additional term calculated from the Born 
model becomes more significant when an ion is larger, representing the relative difficulty for a larger 
ion to be solvated into the pore. This is similar to the steric hindrance factor, but is only in effect 
when the solute is charged. The equation suggests that the hindrance to an ion will be larger than an 
uncharged solute of equivalent size.  
An important feature of the DSPM is that the ions of an electrolyte are partitioned individually hence 
the constituent ions of a salt can be split. While the studies on application of the DSPM by Bowen & 
co-workers (Bowen & Mohammad, 1998; Bowen & Welfoot, 2002) and Déon et al. (2007) have been 
limited to strong neutral inorganic salts that can be considered fully ionized in solution, Antonucci et 
al. (2002) demonstrated the displacement of benzenesulfonate ions with chloride ions through the 
diafiltration of the benzenesulfonate salt of an API with a LiCl solution, giving strong evidence that 
the ions in an organic salt can be split. Furthermore, the work of Antonucci et al. (2012) showed that 
even if one of the ions is non-permeating, the permeating counterion can still be transported 
through the membrane, possibly with the counter or co-transport of a more mobile and permeable 
H+ ion (Nghiem et al., 2005) across the membrane to maintain charge neutrality. 
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2.2.1.3 Solute transport equation 
The equation used to describe solute transport across the pore is the hydrodynamic model, modified 
to include hindered convection and diffusion within the pores as shown below. Equation 2.13, 
derived and proposed by Anderson and Quinn (1974) and Deen (1987), assumes that the solute 
molecules are hard spheres in dilute solution. The equation was derived from the balance of the 
chemical potential of a solute, as it moved along the pore, and the drag force on the solute. 
    
      
   
   
  
          Equation 2.13 
The solute diffuses at a slower rate through the membrane pore than through the bulk solvent. The 
bulk diffusivity of the solute is modified by the hindrance factor for diffusion to obtain this lowered 
pore diffusivity (Equation 2.14). 
             Equation 2.14 
The hindrance factor for diffusion, for a range of solute radius to pore radius ratios, has been 
determined using finite element techniques with a centre-line approach for a spherical solute 
moving inside a cylindrical pore of infinite length and fitted to an empirical model (Bowen & 
Mohammad, 1998) as shown below. 
                        
         
   Equation 2.15 
Solute transport via viscous flow with the solvent is also hindered. The hindrance factor for 
convection of solute i in the pore, determined using the same method as the hindrance factor for 
diffusion, is shown in Equation 2.16.  
                                 
         
   Equation 2.16 
The change in potential across the pore is a result of the change in activity (due to the concentration 
gradient across the pore), pressure (due to the application of a higher pressure on the retentate 
side) and electrical potential (due to the interaction of charged particles, if any, with the membrane) 
across it. Hence Equation 2.13 can be expanded to Equation 2.17. 
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          Equation 2.17 
It can be deduced from the model that a lower potential gradient across the pore will result in 
slower transport across the membrane. Also, according to the Wilke-Chang correlation, diffusivity is 
inversely proportional to the power of 0.6 of the partial molar volume of the solute and proportional 
to the square root of the product of the molecular weight of the solvent and the association factor 
between the solvent and the solute (See Toh et al., 2007b). Hence through the use of a larger solute 
or the use of a solvent which has low affinity for the solute, diffusivity can be decreased to lower the 
potential gradient across the pore. 
Additionally, if the solute concentration in the pore was low to begin with, solute transport across 
the pore would be low due to the unfavourable convective transport (denoted by the last term in 
Equation 2.17) and slow diffusion caused by a low chemical potential gradient across the pore 
(denoted by the other terms in the equations). This can be achieved through increasing the sieving 
of the solute by increasing its size or its repulsive interaction with the membrane pore. 
Analytically Equation 2.17 can be solved when there is no change in the activity coefficient and if the 
solute in question was uncharged. Rejection of solute i in this single stage can be expressed as 
        
   
    
   
 
       
    
      
       
             
  
 Equation 2.18 
Where 
    
   
   
  
  
  
  Equation 2.19 
And 
    
  
  
   
  
       
 
 Equation 2.20 
This conclusion differs from that of Bowen & Welfoot (2002) because of the difference in sign 
convention for the solvent transport equation used. In most cases encountered, where the partial 
42 
 
molar volume of solutes are low, the difference in both equations would not make too much of a 
difference. 
Comparison between the use of different variants of DSPM 
As an example, glycerol transport through a membrane of thickness of 1000nm, with a uniform pore 
size of 0.5nm, was determined using both the model proposed by Bowen & Welfoot (2002) and the 
DSPM proposed in this work. The transmembrane pressure was arbitrarily set at 10bar and a dilute 
aqueous solution of glycerol was assumed. The hydrodynamic radius of glycerol were obtained from 
the work of Bowen & Welfoot (2002). 
 
Figure 2.2. Comparison between the glycerol rejections determined by the DSPM model in this 
work and the DSPM model proposed by Bowen & Welfoot (2002). Note that the predictions by 
these 2 models converged when the partial molar volume of the solute was low and diverged 
when it was high. 
The rejections of glycerol determined by both models were very similar when the partial molar 
volume of glycerol (7.08E-5 m3 mol-1) was used. In fact, the rejection determined using these 2 
models converged as the partial molar volume decreased. Only in cases where the partial molar 
volume was high will the rejection values predicted by both models diverge (see Figure 2.2).   
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2.2.1.4 DSPM use for OSN 
While the DSPM has only been utilised in the aqueous systems (Bowen & Mohammad, 1998; Bowen 
& Welfoot, 2002; Déon et al., 2007), it is equally capable of correlating experimental data in organic 
systems. As an example, the model was fitted with experimental data from the work of Peeva et al. 
(2004) in the filtration of a high concentration docosane-toluene solution across polyimide 
STARMEM® 122 membranes  (See Figure 2.3). Concentration polarisation is known to increase solute 
concentration on the membrane surface (Peeva et al., 2004) according to  
                  
 
  
      Equation 2.21 
This in turn leads to an observation of a rejection that is lower than the true rejection. Hence for 
high solute concentrations, concentration polarisation should be accounted for. 
Using Microsoft Excel on a laptop computer, Equation 2.18 to Equation 2.20 were simultaneously  
solved with an iterative method from the initial values of membrane pore radius, membrane 
thickness and membrane porosity typical in an OSN membrane (Stawikowska & Livingston, 2012). 
The solute rejections obtained from the equations were compared with the experimental solute 
rejection and the sum of squares computed. The 3 parameters were modified one by one to obtain 
the least sum of squares, at which point the iteration was stopped. 
The model was largely in agreement with the experimental data though numerous parameters had 
to be fitted. Due to the number of parameters being fitted, there is also uncertainty in the relative 
values of each parameter. Accounting for concentration polarisation in the model worsened the fit 
of the model with experimental data, hence it was not included in the fit. This was probably because 
the Van’t Hoff equation was unable to accurately account for osmotic pressure and the 
corresponding reduction in pressure driving force through the membrane, as exemplified by the 
presence of solvent despite the Van’t Hoff equation predicting otherwise. In any case, the 
parameters for the best fit model was 
1. Membrane pore radius (0.48nm); 
2. Membrane thickness (640nm); 
3. Membrane porosity (1.00). 
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The straight pores assumption and membrane porosity of unity are contradictory to observed 
membrane structures. Independent determination of the 3 mentioned membrane structural 
properties, which is beginning to be possible at high resolution (Stawikowska & Livingston, 2012), 
and using them in the DSPM would be needed to verify the validity of this model.   
 
Figure 2.3: Fitting of the DSPM model to experimental rejection of docosane in toluene across 
STARMEM® 122 membranes. The crossflow velocity seemed to have little influence on the 
rejection of the solute. Concentration polarisation was not accounted for in this example because 
accounting for it decreased the convergence between the model and experimental data. 
The DSPM predicts that the most straightforward method of increasing rejection is to increase the 
size of the solute. An increment of solute radius from 0.43nm (the Stoke-Einstein radius of docosane 
in toluene) to 0.48nm gradually increases the rejection of the solute at all pressures towards unity 
(See Figure 2.4). On the other hand, total rejection through charge exclusion, while not obtainable 
mathematically, may be approached if charge exclusion effects are high enough. Strategies to 
increase solute retention based on these hypotheses were tested and are presented in Chapter 3. 
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Figure 2.4 Calculated increase in solute rejection in a toluene solution as the solute radius 
increases from 0.42nm to 0.48nm, for a membrane containing cylindrical pores of 0.48nm radius. 
When the size of the solute is the same as the pore, total rejection of the solute occurs. 
2.2.2 Application of molecular dynamics to DSPM 
Solvent flux has often been the main variable used in DSPM model fitting (Bowen & Welfoot, 2002; 
Déon et al., 2007). An a priori determination of solvent flux through a membrane can be used in 
conjunction with the DSPM as a predictive tool for membrane performance, provided that the 
structural properties of the membrane (pore size, membrane thickness, tortuosity, porosity) can be 
defined accurately. The simple Hagen-Poiseuille equation (Equation 2.10) has been used to model 
water fluxes through aqueous membranes (Bowen et al., 1997; Bowen & Mohammad, 1998; Bowen 
& Welfoot, 2002; Déon et al., 2007) and may be used for membrane flux prediction. The applicability 
of this equation to OSN was investigated by plotting the fluxes of various solvents through a 
polyimide Starmem® 122 membrane at 30bar and 30˚C (Rundquist, 2011) against the inverse of the 
dynamic viscosities of these solvents. While the equation predicted that the flux of a solvent through 
a membrane was inversely proportion to the solvent’s viscosity, this was not always the case in the 
study (See Figure 2.5). For example, methanol permeated almost 4 times as much as toluene despite 
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having a slightly higher viscosity. Bowen & Welfoot (2002) hypothesised that the solvents 
constrained in a membrane pore have much higher viscosities than the bulk solvent. They proposed 
an arbitrary method to quantify this increase which leads to solvents with larger sizes having higher 
increases in viscosity. However, the use of this method was unable to account for the higher pore 
viscosity of toluene compared to methanol to justify the decreased toluene flux.  
 
Figure 2.5: Fluxes of various solvents through Starmem® 122 at 30bar, with solvent temperature 
maintained at 30˚C. The inverse of the solvent viscosities at 30˚C are plotted for comparison with 
the fluxes. If the Hagen-Poiseuille equation is valid, the values for inverse of viscosity and 
corresponding fluxes should correlate perfectly. (Data source: Peeva et al., 2004) 
A more accurate method for the determination of solvent flux, at least its order of magnitude, using 
easily available solvent physical properties was sought. Molecular dynamic has been used to model 
gas permeation through porous coal beds (Salih, 2010) and has the potential to be used in place of 
the Hagen-Poiseuille for solvent flux prediction through porous OSN membranes. 
2.2.2.1 Simulation method 
Simulations were performed using a Fortran programme written by Avendano Jimenez & Frentrup 
(2010). The membrane was envisioned to be made up of straight slit pores, with each wall of the 
pore being a hexagonally packed closed lattice formed with benzene molecules. The programme was 
used to form the structured walls of the pore and the solvent molecules were inserted into the 
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remaining space of the wall using a Monte Carlo type sequence until the specified solvent density 
was fulfilled. Following which, a force in the x-direction was exerted in a region at the end of the 
pore on the molecules there. As periodic boundary conditions were used, molecules leaving one end 
of the pore return from the other end. The number of molecules traversing the reference line in the 
middle of the pore in the x-direction was counted to determine the solvent flux in the simulations. 
Interactions between the solvent molecules and between the pore wall and solvent molecules were 
determined with the Lennard-Jones potentials, truncated and shifted at 2.5σ to reduce the 
computational effort required for the simulations. The potential well and σ of the Lennard-Jones 
potential were estimated using the critical temperature and critical volume of the molecules 
simulated, respectively. Simulations were performed for up to 3 000 000 time steps until the system 
approached steady state. The simulations took up to 2-14 days each on a laptop computer. 
The permeation of methanol, toluene and acetone through Starmem® 122 were simulated and 
compared with experimental data to determine the relative accuracy of the simulations. 
 
 
 
Figure 2.6: Schematic of slit pore and solvent molecules in the pore. A force was applied in the 
simulation in the force field to push the solvent molecules in the x-direction. The number of 
solvent molecules traversing the reference point, in the x-direction, in the middle of the pore was 
counted at each frame to determine the solvent flux through the pore at each discrete time step. 
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2.2.2.2 Simulation results 
The solvents’ permeations were first simulated at 30bar and 30˚C. The absolute values of the flux 
were 1016 order lower than experimental data. The order of flow was also not in the correct order 
for toluene relative to acetone and methanol (Compare Figure 2.5 with Figure 2.7). Simulations were 
done for an increased pressure of 60bar and membrane permeability was determined via an 
interpolation between solvent fluxes at these 2 pressures. Methanol had a much higher permeability 
than toluene, in agreement with experimental data. However, acetone had little flux at both 
pressures, resulting in almost zero permeability and not in agreement with experimental data. 
 
Figure 2.7: Solvent flux simulated at 30bar and membrane permeability for the solvents for 
pressures between 30-60bar. Solvents simulated were methanol, toluene and acetone. (Data 
source: Rundquist, 2010)  
2.2.2.3 Use in process development 
The programme was unable to give an accurate prediction of solvent flux at the specified pressure. 
While it has been shown to provide a decent estimate for the order of permeability of methanol and 
toluene through a membrane, the amount of time required for simulation was high. Comparatively, 
experimentation for solvent flux determination was faster, with each experiment requiring only a 
few hours, and inspired more confidence since the results were tangible. The use of molecular 
dynamics will likely be attractive, compared to direct experimentation, only when simulation times 
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can be significantly reduced to the order of minutes. As such, further development of this tool was 
not pursued.   
2.3 Conclusion of transport model 
Various transport models have been presented with emphasis on the DSPM as it related membrane 
transport to structural properties of the membrane. The DSPM predicts that increased membrane 
retention can be achieved through increased steric hindrance by increasing the size of the solute, or 
through increased electrostatic sieving by increasing the charge on the solute. These strategies have 
been pursued and are presented in Chapter 3. 
The use of the DSPM and molecular dynamics to produce a predictive tool for membrane transport 
has been presented. The DSPM would require more work with independently determined 
membrane structural characteristics to validate the model. The molecular dynamics approach to 
solvent transport prediction was time consuming compared to conventional experimental 
determination of solvent flux. Furthermore its accuracy was not satisfactory. Unless the 
computational time and accuracy can both be improved, it will unlikely be an option in research 
development in the pharmaceutical industry. 
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3. Process Modification with Process Chemistry 
The DSPM suggest that an increase in solute rejection can be achieved with an increase in solute 
exclusion from the membrane pore. Such an increase would require either a change of solute charge 
or an increase in the size of the solute. Through the use of process chemistry, either of these 
changes is possible. In the first part of this chapter, pH manipulation as a technique to increase 
solute rejection is reviewed. A demonstration of how this technique was used to improve NF of 2 
similarly-sized solutes is also presented. Later in the chapter, methods used to enlarge solutes are 
reviewed and presented. Following which, a variant of such a method, termed polyalkylation, is 
presented to showcase how it can be used to increase the membrane retention of an 
organocatalyst, hence improving its separation from the reaction mixture.  
3.1 Manipulation of Solute Rejection with pH 
It has been observed that NF membranes allow easy permeation of monovalent ions while rejecting 
most multivalent ions through charge exclusion (Bowen & Welfoot, 2002; Déon et al., 2007).  This 
phenomenon has been used in the demineralization of whey (Cuartas-Uribe et al., 2007), dyes 
(Bowen & Mohammad, 1998) and water (Van der Bruggen et al., 1999).  
In the case when the solute is not charged, pH manipulation can be used to induce a charge. This has 
been used to improve the retention of an alkaline API, sulfamethoxazole (SMX), in water through a 
relatively loose polyamide NF-270 membrane (Nghiem et al., 2005). The polyamide membrane 
contained both ionisable carboxylic and amine functional groups, and as a function of pH became 
more positively charged as pH decreased and negatively charged as pH increased (Childress & 
Elimelech, 1996; Childress & Elimelech, 2000). The retention of SMX remained almost constant at 
0.20-0.30 in pH range 3.5-5.0 before rising rapidly to above 0.90 at pH8.0. This coincided with the 
increased anionic speciation of SMX from pH4.0-8.0 (See Figure 3.1) and the increase in negative 
charge character of the membrane at pH above its isoelectric point of about pH3.5 (Nghiem et al., 
2005). The observation was in agreement with the increased “sieving” effect of SMX at pH>5.0 
predicted by the partitioning equation.  
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Figure 3.1 Speciation of the amino acid SMX. Source: Nghiem et al., 2005   
A similar process which was used to improve NF performance in the purification of an acidic API, 
2,3,4,5-tetrahydroxy-6-sulfooxy hexanoic acid (THSH), from a crude product mixture containing an 
amino acid impurity, dimethylglycine (DMG), has been patented (Da Silva et al., 2008). In this 
process, calcium hydroxide was added to the crude product to form the calcium salt of THSH, and to 
increase the pH of the mixture to a range of pH4.5-9.0. The mixture was then diafiltered using a 
polyamide Desal-5 membrane to flush out DMG while retaining the THSH salt. Examples in the 
patent application showed that after about 180 diafiltration volumes, all of the dimethylglycine was 
removed while THSH was enriched. A study of the speciation showed that in the pH range dictated 
by the patent application, DMG exists predominantly in the uncharged zwitterionic form, whereas 
the bivalent anionic form of THSH dominates (Figure 3.2). The Desal-5 membrane used has an 
isoelectric point of pH4.0, hence the membrane was negatively charged in the operating pH range 
(Hagmeyer & Gimbel, 1998). Therefore, while the “sieving” effect of the uncharged DMG was 
neither augmented nor suppressed due to the lack of electrostatic interactions with the membrane 
pores, the negatively charged bivalent THSH anions encountered repulsive electrostatic interactions 
with a negatively charged membrane surface which increased the “sieving” and rejection of THSH. 
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Figure 3.2: Speciation of 2,3,4,5-tetrahydroxy-6-sulfooxy hexanoic acid (THSH) on left and  
dimethylglycine (DMG) on the right as a function of pH in aqueous solution. Note that THSH is 
highly ionised at all pHs and only low levels of unionised THSH exists. 
While this approach might seem a proven method to improve solute separation in NF, the paucity of 
examples for it raises questions on its limits and applicability. Hence to investigate its effectiveness, 
this concept was applied to the NF separation of 2 ionisable and similarly-sized solutes. 
3.1.1 Case study and process development 
The synthesis of an API at UCB Pharma was possible starting from a racemic N-acetylated amino acid 
(AMS(DL)). The L-isomer of this compound was selectively deacetylated to the L-isomer of the amino 
acid, MS(L). Following which, the D-isomer of the compound, AMS(D), and MS(L) were separated 
before further reactions on AMS(D) could be performed to form the API. Recycling of MS(L) was 
desired for reduction of waste and cost, therefore a full separation of AMS(D) and MS(L) to high 
purities was required.  This scheme is illustrated in Scheme 3.1. The high water solubilities for both 
compounds and their similar polarities meant traditional liquid-liquid extraction and crystallisation 
were not effective for their purification. Hence NF was an attractive technique to evaluate for their 
separation. 
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Scheme 3.1: Scheme illustrating production of an API from the racemic mixture of AMS. The 
racemate was asymmetrically hydrolysed to form the L-isomer of MS. The D-isomer of AMS was 
then separated out before it could be used in reactions to form the API. The purified L-isomer of 
MS was reformed back to a racemic mixture of AMS to recycle the MS. 
AMS, a strong acid, was known to deprotonate progressively with increasing pH. On the other hand, 
MS, a zwitterionic amino acid, becomes positively charged at pH’s below its isoelectric point (pI) and 
negatively charged at pH’s above its pI. The degrees of ionisation of the 2 compounds are illustrated 
in Figure 3.3.  
  
   
   
      
   
        
   
   
    
   
      
Figure 3.3: Speciation of AMS, on the left, and MS, on the right, in aqueous solution. In the region 
pH6.0-7.5, AMS- dominates while MS, in its uncharged form, dominates. 
Following the example presented by Da Silva et al. (2008), an operating pH where one solute was 
uncharged and the other charged had to be chosen. From the speciation diagram (See Figure 3.3), 
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one can deduce the possible operating pHs were pH0 and in the range pH6.0-7.5. Given the 
instability of the membrane at extreme pHs, a conscious decision was made to designate the 
operating pH at about 7.   
3.1.2 Results and discussions 
3.1.2.1 Effects of charge manipulation on solute retention 
An initial investigation on how salt formation between AMS and different bases will affect AMS 
retention was performed. A relatively loose DuraMem® 300 membrane was used in the NF 
comparison to elucidate the effect of electrostatic “sieving”. Solutions containing AMS and MS at 
concentrations of 0.025M each were filtered. Bases calcium hydroxide, magnesium hydroxide and 
quinine were later added to the solutions to investigate the effect of different bases. Bases were 
used to adjust the pH of the solution from the initial value of 2.8 to 6.8. This pH was chosen as 
attempts to go above this pH were hard due to the proximity of this pH to the equivalence point.  
A large and consistent increase (0.13-0.32) in AMS rejection was observed when any base was added 
to the solution (Figure 3.4). This was in agreement with the DSPM which predicted that an increase 
in charge character of AMS increased the hindrance to the “partitioning” of AMS into the pore 
(Bowen & Welfoot, 2002). The use of different bases, while shown to influence AMS rejection, did 
not affect the rejection as much as pH effects, with the change in base causing increases of 0.03-0.11 
in rejection. Hence the effect of pH was the overriding factor in determining AMS retention. The 
addition of base was also noted to increase MS rejection (0.06-0.19), but at a smaller extent than for 
AMS (See Figure 3.5). A consequence of this was a change in membrane selectivity for AMS 
retention over MS at pH6.8, as opposed to MS retention at pH2.8. This was akin to chromatography, 
with the membrane acting as a stationary phase that retained solutes at different rates when 
different diafiltering fluid (mobile phase) conditions were used.  
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Figure 3.4: Dependence of the rejection of AMS during filtration of an equimolar solution, 
containing 0.025M AMS and 0.025M MS, on the added bases at various pressures. The bases 
(calcium hydroxide, quinine and magnesium hydroxide) were added to change the pH of each 
solution to 6.8. The equimolar solution of AMS and MS, put in the graph for comparison, had a pH 
of 2.8.  
 
Figure 3.5: Dependence of the rejection of MS during filtration of an equimolar solution, 
containing 0.025M AMS and 0.025M MS, on the added bases at various pressures. The bases 
(calcium hydroxide, quinine and magnesium hydroxide) were added to change the pH of each 
solution to 6.8. The equimolar solution of AMS and MS, put in the graph for comparison, had a pH 
of 2.8. 
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While the addition of a base improved AMS retention, it also decreased membrane flux due to an 
increase in osmotic potential in the retentate which reduced the effective pressure driving 
permeation through the membrane (See Figure 3.6). A weaker base like quinine resulted in a larger 
decrease in flux than the stronger mineral bases due to the larger amount of base that had to be 
added to increase the pH to the same value. About twice the number of moles of quinine had to be 
added to increase the pH compared to the mineral bases. From this observation, it would seem 
advantageous to use a strong base in such a rejection augmentation strategy to minimise the 
amount of base added. 
 
Figure 3.6: Dependence of the solvent flux during filtration of an equimolar solution, containing 
0.025M AMS and 0.025M MS, on the added bases at various pressures. The bases (calcium 
hydroxide, quinine and magnesium hydroxide) were added to change the pH of each solution to 
6.8. The equimolar solution of AMS and MS, added to the graph for comparison, had a pH of 2.8. 
3.1.3 Application to constant volume diafiltration 
A demonstration of how such changes in retention through pH manipulation can be used to improve 
the diafiltration separation of AMS and MS was carried out. Magnesium hydroxide was used as the 
base as it increased the rejection of AMS significantly while not diminishing membrane flux 
excessively. The aim for the separation was to achieve a full separation of AMS and MS using 
diafiltration because both solutes were desired. The parameters represented by equations 3.1 – 3.4 
were used to characterise the performance of the diafiltration process after filtration time, t. 
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The purity of solute h enriched in the retentate was expressed by Equation 3.1 
       
     
           
 Equation 3.1 
The purity of the enriched solute i in the permeate was represented by 
       
         
                   
 Equation 3.2 
The yield of the solute h enriched in the retentate was expressed as  
           
     
     
 Equation 3.3 
The yield of the solute i enriched in the permeate was expressed as 
             
     
     
 Equation 3.4 
An acidic retentate caused an enrichment of MS in the retentate while the addition of base to pH6.8 
effected an enrichment of AMS in the retentate by increasing the rejection of AMS. One such 
example is shown in Figure 3.7, where diafiltration over a Desal 5 membrane was performed first 
without a base and later with a base. In the first case, AMS concentration in the retentate decayed 
at a faster rate than for MS, while the reverse was true for the 2nd case. The rejections of AMS and 
MS (See Table 3.1) were obtained by fitting the decrease in concentrations of the individual solutes 
in the retentate over 15h to Equation 3.5 (Mulder, 1996; Sereewatthanawut et al., 2010), assuming 
constant rejection throughout the whole diafiltration. 
               
             Equation 3.5 
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Figure 3.7: Concentration profile in the retentate for AMS and MS during constant volume 
diafiltration performed for 15h using the Desal 5 membrane; about 15 diafiltration volumes of 
fresh solvent were used over 15h. The figure on the left shows the solute profile for the 
diafiltration of an equimolar solution of AMS and MS at pH2.8, with an enrichment of MS in the 
retentate. The figure on the right represents the diafiltration of an equimolar solution of AMS and 
MS when Mg(OH)2 was added to increase the pH to 6.8, resulting in an enrichment of AMS  
The slow decay in solute concentration meant long separation cycle times and high diafiltration 
volumes for complete separation (Refer to Table 3.1). Hence simulations were made with the 
rejection data of the solutes to predict if full separation of the solutes could be accomplished with a 
single stage constant volume diafiltration. The diafiltrations were designed to enrich the better 
retained solute in the retentate to a purity of 0.95 from an equimolar solution of AMS and MS. While 
simulations show that the purity was achievable, the yields of enriched solutes were low for all 
entries, at between 0.04-0.46. The addition of a base improved the yield of the more retained solute 
by increasing the retention of the better retained solute by up to 31 percentage points. However, a 
complete separation was not possible, with even the best separation in Entry 4 producing a 
permeate stream of 0.65 purity for the more permeable solute (MS in this case). While the yield was 
high, the purity was too low for use. A full retention of one of the solutes is required to guarantee 
complete separation. While the addition of more base to increase the pH to 14 so that the bivalent 
anionic species of AMS dominates might bring the rejection of AMS to unity, this would pose a 
challenge to equipment design with the DuraMem® series membranes and Desal® series membranes 
tested to be unstable and dissolving at high pH. 
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The similar sizes of both solutes, with the MW of AMS being about 40 higher than MS due to the 
additional acetyl group, resulted in low rejection differences between these solutes which led to 
large diafiltration solvent requirements (28-130 diafiltration volumes) in all entries. A change in the 
membrane process used is needed to improve the separation performance and productivity of this 
process. 
Table 3.1: Attempts to separate an equimolar solution of AMS and MS by diafiltration to obtain a 
retentate stream enriched (purity of 0.95) in the better retained solute. The rejection values of the 
individual solutes were obtained through model fitting of the decay curves of the solutes. In 
entries 1-2 where no base was added, MS was enriched in the retentate. For entries 3-5 where  
Mg(OH)2 was added to adjust the initial solution pH to 6.8, AMS was enriched in the retentate.  
 
3.1.4 Summary of results 
The targeted formation of solute charge through pH changes was able to increase the rejection of 
the targeted solute. Such a change caused the selectivity of membrane retention for 2 similarly sized 
solutes to be reversed. However, it proved insufficient for the complete separation of these solutes 
when constant volume diafiltration was used.     
3.2 Covalent Bonding with an Anchor Molecule 
The technique of anchoring a solute to a bulky anchor molecule, to enlarge the solute and increase 
its membrane retention, has been widely used to improve homogeneous catalyst recycling with NF 
(Dijkstra et al., 2001). A common approach to this technique involved the use of a polymer chain to 
anchor a single or multiple catalysts to improve membrane retention of the catalyst (Giffels et al., 
No. Membrane 
Base 
added 
Rejection 
of AMS / 
- 
Rejection 
of MS / - 
Diafiltration 
volumes / - 
Yield of 
enriched 
solute in 
retentate 
/ - 
    / 
- 
Yield of 
enriched 
solute in 
permeate 
/ - 
1 DM200 - 0.888 0.955 44 0.14 0.54 0.99 
2 Desal 5 - 0.926 0.971 65 0.15 0.54 0.99 
3 DM200 Mg(OH)2 0.988 0.962 110 0.26 0.57 0.99 
4 Desal 5 Mg(OH)2 0.994 0.971 130 0.46 0.65 0.98 
5 DM300 Mg(OH)2 0.886 0.780 28 0.04 0.51 1.00 
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1998; Wöltinger et al., 2001). Monodispersed polymer supported catalysts, however, were tedious 
to synthesise, in stark contrast with simple one-step procedures which usually produced 
uncontrollable and polydispersed polymer supported catalysts (Dickerson et al., 2002; Schlenk et al., 
2000; Toy & Janda, 2000).    
Another approach involved the attachment of catalysts to dendrimers. Dendrimers are tree-like 
molecules with very well-defined macrostructures whose dimensions are easily altered to allow 
optimisation of retention of such catalysts while allowing precise catalysts loading to be defined as 
compared to catalysts attached to polymers (Dijkstra, 2001). Dendritic catalysts have been highly 
retained by SelRO-MPF-50 NF membranes (Kleij et al., 2000). However, the synthesis of dendrimers 
that are monodispersed and well-defined also involved expensive and tedious procedures (Schlenk 
et al., 2000).  
In response to the flexibility of dendrimers which prevents the total retention of the attached 
catalysts, rigid aromatic backbones, synthesised using tedious procedures, were used as anchors 
instead by Dijkstra and co-workers (Dijkstra et al., 1999; 2001; 2003). They found that an increase in 
size of a metallic catalyst by anchoring to a rigid backbone led to a proportional increase in 
membrane retention of the catalyst. 
A concern that has not been addressed in all these approaches is the recovery of the original solute 
from the anchor moiety.  Experience in synthesis suggests the addition of reaction steps to anchor a 
solute and eventually recover the solute would decrease total process yield and make the process 
inefficient. As such, this anchoring technique might be more relevant to improving catalyst recycle. 
There is an exception to this statement as the use of PEG as an anchor to a growing peptide chain in 
lieu of a solid phase support has been demonstrated to improve the process efficiency of peptide 
synthesis (So et al., 2010). 
The relative complexity in synthesising viable anchors makes the development of a simple anchoring 
strategy an attractive proposition. The strategy for anchoring has largely been fixated on enlarging 
the anchor as much as possible, with molecular weights often in excess of thousands of Daltons. 
Enlargement of the anchors have been achieved by adding “spacer” molecules to the anchor, which 
bear no functional purpose other than to add bulk to the anchor. The work presented below 
surmises that a more efficient approach to anchoring the target solute exists.      
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3.2.1 Case study and process development 
Despite remarkable advances in the field of asymmetric organocatalysis in the last decade, its 
industrial application is limited (Berkessel & Groger, 2005; Groger, 2008). O-desmethylquinidine is an 
organocatalyst used in the asymmetric synthesis of an advanced intermediate (2) at UCB Pharma 
S.A. for the production of a developmental API (See Scheme 3.2). While the catalyst enabled a 
relatively fast reaction and high enantiomeric selectivity, the catalyst loading required was high 
(2.5mol% of nitrostyrene loading) and no catalyst recycling scheme was in place. Therefore there 
was a need to develop a viable catalyst recycling strategy for the scheme.  
O O
NO
2
OMeMeO
NO
2
O O
OMeMeO
Asymmetric addition
1 
(MW ~ 200)
2
(MW ~ 300)
EWG EWG
Further reactions
API
 
Scheme 3.2: Reaction scheme for the Michael addition of dimethyl malonate to a nitrostyrene, 1, 
for the asymmetric synthesis of an advanced intermediate, 2, at UCB Pharma S.A. 
If heterogeneously supported, the organocatalyst can be easily recycled via solid-liquid separation 
(Han & Janda, 1997b). However, heterogeneous catalysts tend to have reduced catalytic activities 
and selectivities, while costing more than non-supported catalysts. 
O-desmethylquinidine, derived from cinchona alkaloids, has multiple loci where modifications can 
take place (See Figure 3.8). These loci make the catalyst versatile as multiple anchoring strategies 
can be explored. The versatility of this class of organocatalyst extends to its utility. Depending on the 
modifications made, the resulting catalyst can be used for either Michael addition (Chen et al., 2007; 
Dixon & Hynes, 2005; Li et al., 2004; Li et al., 2005), phase transfer catalysis (Park & Jew, 2009; Lee et 
al., 2007; Park et al., 2001; Park et al., 2009) and asymmetric dihydroxylation (Hajamis et al., 1999; 
Han & Janda, 1997a; Han & Janda, 1997b; Zhang et al., 1999). 
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Figure 3.8: Structure of O-desmethylquinidine and potential modification site indicated by dotted 
circles.  
The core business of UCB Pharma SA is not in catalyst development, hence the commercial 
availability and the simplicity of the anchor molecule were key considerations in developing an 
enlargement strategy for O-desmethylquinidine. To this end, 4 commercially available anchor 
candidates were chosen for, in 3 different approaches to enlarge the organocatalyst. These 
approaches were 
1. Olefin metathesis, using either quinidine or 1-dodecene as the anchor; 
2. PEGylation, using polyethylene glycol (PEG) as the anchor; 
3. Polyalkylation, using 1,3,5-tris(bromomethyl)benzene as the anchor. 
3.2.1.1 Olefin metathesis 
Cross metathesis of the double bond (Pariya et al., 1998), first attempted with only quinidine (See 
Scheme 3.3), to ascertain if a coupling of quinidine would result from the catalytic effect of the 
Grubb’s catalyst was unsuccessful with no reaction observed. 
OH
N
N
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Scheme 3.3: Attempted metathesis of quinidine. The yield for this reaction was very low.  
Further cross metathesis was attempted between 1-dodecene and quinidine (See Scheme 3.4). 
However, the yield was low, with only 3% of the original quinidine converted. Therefore this 
approach was aborted. 
O
N
N
OH
O
N N
OH
9
9
1st Generation
Grubbs' catalyst
THF
700C
19h  
Scheme 3.4: Attempted metathesis of quinidine with 1-dodecene. No discernible reaction 
occurred. 
3.2.1.2 PEGylation 
PEGylation of quinidine (Danelli et al., 2003; Ghoshal et al., 1998) was attempted via a commercially 
available alkylating PEGylating agent with an average molecular weight of 2000 (See Scheme 3.5). 
The yield was low, with 24% of the quinidine converted, due to competing side reactions of the 
PEGylating agent with sodium hydride (NaH) to form polyethylene glycol (PEG) and sodium bromide. 
On the other hand, the PEGylating agent was not monodispersed which made control of the size of 
the enlarged catalyst impossible. For these reasons, this approach was not developed further. 
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Scheme 3.5: PEGylation of quinidine with a brominated PEGylating agent. The yield for this 
reaction was very low. 
3.2.1.3 Polyalkylation 
Polyalkylation, which was a modification of the other ‘anchoring’ strategies (Chen et al., 2008; Chen 
et al., 2010; Yan et al., 2009), was attempted to increase the amount of catalyst loaded in each 
enlarged catalyst moiety and reduce the amount of non-functional ‘spacers’ in the enlarged 
molecule. This was achieved by attaching multiple organocatalyst to every ‘anchor’ molecule. The 
commercial availability of the alkylating 1,3,5-tris(bromomethyl)benzene influenced the choice of it 
as an anchor. Additionally, the stiffness of the short bond between the catalyst and the benzene 
backbone would decrease the flexibility of the resulting molecule, maintaining the increased size of 
the catalyst at all orientations. 
Q
Q
Q
R
N
N
OH
Q =
 
Figure 3.9: Concept of polyalkylation. Multiple molecules of the organocatalyst are attached to a 
1,3,5-tris(methyl)benzene anchor by alkylation. In effect the molecular weight of the resulting 
catalyst is a multiple of the number of catalysts attached.  
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The versatility of this approach is aptly illustrated in Scheme 3.6, which shows the various enlarged 
catalysts synthesized. Quinidine, a low cost and commercially available cinchona alkaloid, was easily 
transformed to 4 different enlarged catalysts in 1-2 steps.   
The synthesis of the advanced intermediate (Scheme 3.2) had to be performed in THF. Hence the 
new catalyst had to be soluble in THF for membrane recycling. Only 5 – 7 fulfilled this requirement 
and were tested further for membrane retention and catalytic performance, along with quinidine (3) 
and O-desmethylquinidine (4). The results from these tests are described in sub-Sections 3.2.2 to 
3.2.4. 
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Scheme 3.6: Synthesis routes for the various catalysts from commercially available quinidine. NaH 
= sodium hydride, NaSEt = sodium ethanethiolate. TBMB = 1,3,5-tris(bromomethyl)benzene.  
  
67 
 
3.2.2 Membrane retention of catalyst 
All the compounds listed in Scheme 3.6, less 8, were tested on the loosest membranes available in 
the inventory at the time of catalyst synthesis, DuraMem® 500 and DuraMem® 300. The use of a 
single membrane stage for catalyst recycle necessitated a catalyst rejection approaching unity, with 
high solvent flux through the membrane a secondary quality sought after. 
The newly polyalkylated catalysts (5 – 7) had almost consistently higher rejections than the non-
polyalkylated catalysts (quinidine and O-desmethylquinidine). This proved that polyalkylation was a 
feasible strategy for rejection enhancement. However, polyalkylation alone was not necessarily 
sufficient in enhancing rejection to the required level; only 6 and 7 had membrane rejections 
approaching unity on both membranes. 
O-desmethylquinidine, formed from the demethylation of quinidine, was better retained than 
quinidine by DuraMem® 500 and DuraMem® 300.  The effect of demethylation was also apparent in 
the polyalkylated catalyst. 6 was rejected at a substantially higher level than 5 on both DuraMem® 
500 and DuraMem® 300 membranes. This might be due to the ability of the phenolic hydroxyl group 
in forming hydrogen bonds with THF, giving the catalysts with the phenolic hydroxyl group a larger 
hydrodynamic radius compared to catalysts with the methoxy group. 
Charge formation, which was previously shown in Section 3.1 to increase solute retention, 
unsurprisingly increased catalyst rejection. While the electrically neutral 5 had a lacklustre rejection 
value, the presence of the trivalent charge in 7 caused an elevation of rejection which approached 
unity. 
 
 
  
68 
 
 
Figure 3.10: (a) Rejection and flux data of the various catalysts from recirculation experiments of 
individual catalyst solutions in THF across DuraMem® 500 flatsheet membranes. (b) Rejection and 
flux data of the various catalysts from recirculation experiments of individual catalyst solutions in 
THF across DuraMem® 300 flatsheet membranes. The most desirable membrane-solute 
combination possesses both a high membrane flux and solute rejection that is at unity. 
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Figure 3.11: (a) Resulting membrane flux, obtained from recirculation experiments utilising 
DuraMem® 500 flatsheet membranes, at various applied transmembrane pressures. (b) Resulting 
membrane flux, obtained from recirculation experiments utilising DuraMem® 300 flatsheet 
membranes, at various applied transmembrane pressures. 
3.2.3 Catalytic performance of catalyst 
3.2.3.1 Comparison of polyalkylated catalysts 
While the catalyst had to be rejected highly by the membranes used in the process, it was also 
critical for the catalyst to fulfil its catalytic function in the asymmetrical Michael addition used to 
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form the advanced intermediate (See Scheme 3.2). Therefore the catalyst candidates in Scheme 3.6 
were tested and compared, in particular with the original catalyst, 4. The original catalyst has been 
patented (Deng et al., 2009) and reaction performance data exists for the addition of dimethyl 
malonate to trans-β-nitrostyrene, 9, (See Scheme 3.7). This reaction has been frequently used as a 
benchmark for the performance of new Michael addition catalysts (Chen et al., 2007; Deng et al., 
2009; Li et al., 2004; Ye et al., 2005), therefore it was used to benchmark the performance of the 
polyalkylated catalysts. 
R
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Scheme 3.7: Scheme for the Michael addition of dimethyl malonate (in excess) to various 
nitrostyrenes 
To maintain the consistency in comparison, the polyalkylated catalysts loadings were at 3.3mol%, 
with respect to the amount of nitrostyrene 9 used, compared to 10.0mol% for the non-polyalkylated 
catalysts. This ensured that the same number of catalytic sites were used in each reaction. The 
performances of the catalysts were quantified by the extent of conversion of the 9 after 24h and the 
enantiomeric excess (ee) of the R isomer over the S isomer after full conversion of 9. 
It has been suggested that cinchona-derived organocatalysts serve as bifunctional catalysts and the 
Michael addition requires the hydroxyl and quinuclidine functionalities for the stabilisation and 
organisation of the transition state (Li et al., 2004). The performances of the catalysts were in 
agreement with this hypothesis. Without an electron-rich quinuclidine group, 7 was unable to 
catalyse the Michael addition (Entry 5, Table 3.2). On the other hand, the lack of a phenolic hydroxyl 
group in quinidine (3) resulted in a slower catalysed reaction compared to O-desmethylquinidine (4) 
(Compare Entries 1 and 2, Table 3.2). Polyalkylation of quinidine lowered the catalysis rate even 
further as no hydroxyl group was available (Entry 3, Table 3.2). The importance of the phenolic 
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hydroxyl group over the aliphatic hydroxyl should not be understated; the catalysis with 6 was much 
faster than both 3 and 5 despite the absence of the aliphatic hydroxyl group in 6 (See Entries 3-5, 
Table 3.2).   
Table 3.2: Summary of Michael addition of dimethyl malonate to trans-β-nitrostyrene (9) with the 
various catalysts. 
Entry 
Catalyst  
(loading mol%) 
Conversion 24ha / % 
Timeb /  
day 
Yieldc /  
% 
eed /  
% 
1 3 (10.0mol%) 45 12 52 19 
2 4 (10.0mol%) 99 1 82 86 
3 5 (3.3mol%) 41 18 44 7 
4 6 (3.3mol%) 90 3 62 94 
5 7 (3.3mol%) No reaction N.A. N.A. N.A. 
 
a Determined by HPLC analysis under comparison with a naphthalene internal standard after 24h.  
b Total time taken for the reactions, which were run with 0.4mmol of 9 and 3mol eq. of dimethyl 
malonate at -20°C until all of 9 was consumed as determined by HPLC analysis at λ = 230nm. 
c Isolated yield of product using preparative chromatography  
d Determined by chiral HPLC analysis. 
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Figure 3.12: Mechanistic action of O-desmethylquinidine 
The short methyl chain between the anchor and the catalytic site in 6 prevents easy rotation of the 
catalytic site around the benzene backbone, making 6 conformationally rigid. This is a common 
feature of many efficient chiral catalysts (Li et al., 2004) and was in agreement with the increased 
enantioselectivity of catalyst 6 over catalyst 4 (See Entries 2 and 4, Table 3.2). However, this 
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increased enantioselectivity was achieved at the expense of the slower rate of reaction, possibly 
because the same rigidity prevented easy access of the substrate into the catalytic site.  
3.2.3.2 Increased catalytic loading 
The decreased catalytic activity can be remedied with a higher catalyst loading since the catalyst can 
be easily recovered using OSN. By tripling the catalytic loading, the amount of time required for the 
completion of the Michael addition was cut from 3 days to 1 day (Compare Entries 1 and 2 in Table 
3.3). The potential for increased catalytic loading also opened up new process design possibilities. A 
tripling of catalytic loading enabled the reaction to take place with the use of only 1mol eq. of 
dimethyl malonate, as opposed to the 3mol eq. originally used. Enantiomeric selectivity was largely 
unchanged at ee of 93% compared to 94% when 3mol eq. of dimethyl malonate was used (See 
Entries 1 and 3 in Table 3.3), albeit with a slight increase in time required for completion of the 
reaction to 4 days from the original 3 days. The use of equimolar amounts of reagent can eliminate a 
separation step downstream for the purification of the Michael addition adduct from the excess 
dimethyl malonate. This would simplify the synthesis process and reduce waste incurred from the 
excess dimethyl malonate loading. 
Table 3.3: Comparison of Michael addition reaction at different catalytic loadings and dimethyl 
malonate loading. 
Entry 
Nitrostyrene (catalyst 
loading mol%) 
Conversion 24ha / % Timeb / day Yieldc / % eed / % 
1 9 (3.3%) 90 3 62 94 
2 9 (10%) 100 1 89 94 
3 9 (10%)e 87 4 89 93 
a Determined by HPLC analysis under comparison with a naphthalene internal standard after 24h.  
b Total time taken for the reactions using 6, which were run with 0.4mmol of 9 and 3mol eq. of 
dimethyl malonate at -20°C until all of 9 was consumed as determined by HPLC analysis at λ = 
230nm.  
c Isolated yield of product using preparative chromatography.   
d Determined by chiral HPLC analysis.  
e 1mol eq. of dimethyl malonate 
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3.2.3.3 Catalyst applicability to advanced intermediate synthesis 
Since 6 had the best enantioselectivity amongst the polyalkylated catalysts, it was further tested 
with the nitrostyrene used in the advanced intermediate synthesis (Scheme 3.2). In a bid to 
elucidate the effects of the nitrostyrene substituent on the Michael addition,  the reaction of various 
nitrostyrenes were also examined (Scheme 3.7).   
6 was a versatile catalyst, catalysing the addition reactions asymmetrically with enantiomeric 
excesses above 90% for all nitrostyrenes (See Table 3.4).  
Table 3.4: Michael addition of various nitrostyrenes to dimethyl malonate using 6. 
Entry Nitrostyrene Conversion 24ha / % Timeb / day Yieldc / % eed / % 
1 9 90 3 62 94 
2 10 76 5 62 93 
3 11 93 3 81 94 
4 12 100 1 88 95 
5 13 94 3 92 96 
6 1 98 2 67 92 
a Determined by HPLC analysis under comparison with a naphthalene internal standard after 24h.  
b Total time taken for the reactions using 6, which were run with 0.4mmol of nitrostyrene and 3mol 
eq. of dimethyl malonate at -20°C until all nitrostyrene was consumed as determined by HPLC 
analysis at λ = 230nm.  
c Isolated yield of product using preparative chromatography.  
d Determined by chiral HPLC analysis.  
 
The rate of reaction varied with the degree of activation by the substituent. The more electron-
donating substituents (Entries 1 and 2 in Table 3.4) retarded the reaction while the electron-
withdrawing substituents accelerated the rate of reaction (Entries 3 – 6  in Table 3.4). Note that the 
nitrostyrene used in the advanced intermediate synthesis was known to be electron-withdrawing.  
In any case, the suitability of 6 for the desired Michael addition was established. Hence effort was 
put in to develop a membrane process for the recycling of this catalyst. 
3.2.4 Catalyst recycling with OSN 
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Fortuitously 6, which gave the best catalytic performance amongst the polyalkylated catalysts, was 
also highly retained by the membranes tested. A process was developed to separate the catalyst 
from the product (2), using the membranes tested. In the test case for catalyst recovery it was 
assumed that the reaction was performed, with equimolar quantities of nitrostyrene 1 and dimethyl 
malonate, batch wise until all the nitrostyrene was consumed. This can be done with no loss in 
enantioselectivity as long as a huge excess of catalyst was used, as shown in Table 3.3.  
3.2.4.1 Membrane process development 
Recirculation experiments were performed by filtering a solution containing both 6 and the product 
(2) across DuraMem® 300 and DuraMem® 500 flatsheet membranes. While both membranes 
retained the catalyst at rejection values close to unity, DuraMem® 500 allowed much better 
permeation of the product (See Figure 3.13). Do note that while there seemed to be a slight 
decrease in catalyst rejection over DuraMem 500 at 10bar, this probably due to the HPLC method 
uncertainty in the determination of concentration of the catalyst, as illustrated by the error bars in 
the Figure. In any case this was not important in this work as the aim was to screen for an operating 
pressure where catalyst rejection is close to unity. 
In order to determine the best conditions, out of the pressures tested, to perform constant volume 
diafiltration, the constant volume diafiltration equation (Equation 3.5) was used with the assumption 
of constant solute rejection at all concentrations to determine the change of Michael addition 
product and 6 concentration in the retentate at each tested operating pressure over the diafiltration 
period. While both membranes were capable of selectively retaining the catalyst for recycling, 
DuraMem® 500 was more productive in the separation, requiring significantly lower number of 
diafiltration volumes and filtration times for the separation. The number of diafiltration volumes and 
filtration times, if the same amount of membrane area was used, were 2 orders of magnitude higher 
for DuraMem® 300 than for DuraMem® 500 (See Figure 3.14). Therefore the choice of DuraMem® 
500 for the diafiltration was obvious. The highest operating pressure of 18bar was used for the 
diafiltration as catalyst retention in the retentate at this pressure was predicted to be quantitative, 
while 38% and 52% of the catalyst losses were predicted for operating pressures of 5bar and 10bar.       
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Figure 3.13: (a) Rejection and flux data for organocatalyst 6 (solid lines) and the Michael addition 
product 2 (dotted lines) in THF solution from recirculation experiments using DuraMem® 300 and 
DuraMem® 500. (b) Flux dependence on applied transmembrane pressure obtained from the same 
recirculation experiments. 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
0.95 
0.96 
0.97 
0.98 
0.99 
1 
0 10 20 30 40 50 
P
ro
d
u
ct
 r
ej
ec
ti
o
n
 /
 -
 
C
at
al
ys
t 
re
je
ct
io
n
 /
 -
 
Flux / L m-2 h-1 
DuraMem 300 - catalyst 
DuraMem 500 - catalyst 
DuraMem 300 - product 
DuraMem 500 - product 
(a) 
0 
10 
20 
30 
40 
50 
0 10 20 30 40 
Fl
u
x 
/ 
L 
m
-2
 h
-1
 
Transmembrane pressure / bar 
DuraMem 300 flux 
DuraMem 500 flux 
(b) 
76 
 
 
Figure 3.14: Productivity of diafiltration, expressed in terms of the number of diafiltration volumes 
and total diafiltration time, in the removal of the Michael addition product from catalyst 2. A 
300ml solution containing 10g of the product (2) and 1g of the catalyst (6) was diafiltered in this 
simulation until the retentate contained pure catalyst, at 99% weight purity of the total solute 
mass.  
To make the process more productive, and since DuraMem® 300 was able to retain the product 
effectively (rejection above 0.99) at all the pressures tested, a second membrane stage was 
incorporated in series with the catalyst recycle stage. This stage was used to recycle the solvent from 
the permeate of the first stage so that the solvent can be reused in the diafiltration for the 
separation of the catalyst from the product. At the same time, a concentrate product stream was 
produced which facilitated recovery of the product via evaporation of the solvent. The schematic of 
the membrane separation process is presented in Figure 3.15. 
3.2.4.2 Membrane separation process setup 
The process consisted of two membrane stages connected in series. The first membrane stage, 
termed the catalyst retention stage, employed a looser DuraMem® 500 membrane coupon which 
retained 6 in the retentate tank (RT1). It was necessary to use a crossflow Evonik-MET cell to 
implement this stage. The forced circulation of fluid through a small aperture in the crossflow 
membrane unit (M1) from RT1, driven by a recirculating gear pump (RCP),  provided sufficient 
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turbulence to mitigate fouling of the membrane by “oiling” out of the product and the catalyst. An 
attempt to use a magnetic stirrer in a deadend membrane cell and another attempt to force 
circulation through a wider ¼” aperture both resulted in membrane fouling which elevated losses of 
the catalyst through the permeate. The reaction mixture, on total consumption of the nitrostyrene, 
was charged into RT1 which had a capacity of 500ml. M1 held a flatsheet membrane coupon with an 
active filtration area of 54cm2. Membrane filtration in the first stage was pressure-driven, with 
pressure provided by a stream of nitrogen gas, from a gas cylinder, charged into RT1. The pressure 
was controlled with a proportional relief valve, through which nitrogen gas was able to flow out 
slowly. A resistance temperature probe inserted into RT1 provided temperature reading for the 
retentate in RT1. This probe also provided feedback to the hotplate on which RT1 was placed so that 
the retentate temperature could be regulated. A stream of THF from T1 was fed into RT1 using 
Pump 2, a HPLC pump, to flush out the product in the permeate from M1. This stream was regulated 
by controlling Pump 2 using a PI controller code implemented on LabView, with feedback from the 
weighing scale on which RT1 and the hotplate were placed. This regulation kept the level in RT1 
constant for an automated implementation of constant volume diafiltration in the catalyst retention 
stage. 
The permeate stream was fed into a buffer tank, T2, which fed into the second membrane unit, M2, 
of the solvent recovery stage via Pump 3. The level in T2 was maintained with a PI controller, also 
implemented with LabView, that regulated Pump 3 based on feedback from the weighing scale on 
which T2 was placed. M2 was a modified deadend membrane filtration unit with a holdup volume of 
500ml. It held a flatsheet DuraMem® 300 membrane coupon with an effective membrane filtration 
area of 54cm2. M2 was placed on a hotplate which regulated the temperature of the retentate in it 
based on feedback from the resistance temperature probe inserted into the retentate. The hotplate 
was also a magnetic stirrer that spun the magnetic flea suspended a short distance above the 
membrane coupon. This provided convection to mitigate concentration polarisation on the 
membrane. M2 was pressurised with fluid fed in with Pump 3, and the pressure was controlled with 
a back pressure regulator, PCV2, which allowed a concentrated solution of the product to flow out 
while maintaining the pressure in M2. This resulting pressure drove permeation of a pure recovered 
THF stream from M2. This permeate stream was recycled back into T1 for reuse in the diafiltration in 
the catalyst retention stage. 
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The loss of fluid via the retentate stream in the solvent recovery stage necessitated the input of 
fresh THF into T1 from T0. This input was regulated by controlling Pump 1 with a PI controller, based 
on feedback from the weighing scale T1 was placed on, so that the level in T1 was constant. 
3.2.4.3 Performance of catalyst recycling process 
In an example, the process shown in Figure 3.15 was used to diafilter a 250ml solution containing 1g 
of 2 and 1g of 6 continuously over 72h. The rejection of product 2 was 0.95 during the diafiltration 
while the rejection of the catalyst 6 was 1.00; the catalyst was undetectable in the permeate. These 
rejection values were significantly higher than those obtained from recirculation experiments (see 
Section 3.2.4.1) and were probably due to the inconsistency in the membrane flatsheet performance 
on different parts of the flatsheet where the coupons were cut. 
After diafiltration for 3 days, the retentate streams from RT1 and M2 and the solutions in T1, T2 and 
T3 were collected. These fractions were evaporated to dryness separately and weighed to determine 
the total mass of product and catalyst in each fraction. The dried residues were analysed using HPLC 
to determine the composition of the residues. The mass balance of the analysis is presented in Table 
3.5. 
Table 3.5: Summary of mass balance at the start and the end of the 3-day diafiltration of a 250ml 
THF solution containing 1g of the product 2 and 1g of the catalyst 6 using the equipment shown in 
Figure 3.15   
 
0h 72h 
Product mass 
/ g 
Catalyst mass 
/ g 
Product mass 
/ g 
Catalyst mass 
/ g 
T1 0.00 0.00 0.00 0.00 
RT1 1.00 1.00 0.30 0.52 
T2 0.00 0.00 0.00 0.00 
M2 0.00 0.00 0.35 0.00 
T3 0.00 0.00 0.43 0.00 
Total 1.00 1.00 1.08 0.52 
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Figure 3.15: Schematic of membrane cascade setup used for organocatalyst recycling. T1 and T2 were buffer tanks, M1 and M2 were membrane units 
holding flatsheet membrane coupons (DuraMem® 500 in M1 and DuraMem® 300 in M2) and RT1 was the retentate holding tank for M1. M1 was used to 
retain the catalyst while letting the Michael addition product permeate through. M2, holding a tighter membrane, was used to retain and concentrate 
the product, while producing a pure recovered solvent stream for reuse in M1. The dotted lines denote control loops which controlled the pumps to 
maintain the levels in T1, T2 and RT1. LC = level controller; PCV = pressure control valve; PI = pressure indicator; RCP = recirculating pump; TI = 
temperature indicator. 
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The product permeated selectively through the membrane in M1, resulting in a loss of 0.78g of 
product from RT1 which was collected downstream in M2 and T3. This was confirmed by the 
collection of 0.30g of 2 in RT1. The mass balance of 2 was largely conserved with a small 8% increase 
in mass of 2 collected at the end of the diafiltration over the original mass put into the system. The 
small increase in mass could be attributed to sheared O-ring and seal material that were visible as 
black particulates in the residue from RT1. Analysis of the fractions confirmed that no quantifiable 
amount of catalyst 6 was lost through the membrane in M1. No catalyst was detectable in the 
solutions downstream of RT1 and M1 and the recycled solvent stream had no detectable presence 
of catalyst, hence the yield of catalyst from the retentate in RT1 should be quantitative with a 
theoretical catalyst purity of 0.82. However, only 0.52g of the catalyst was recovered from RT1, 
representing a 48% loss of catalyst though the catalyst purity increased from 0.50 to 0.63. The loss of 
catalyst can be attributed to absorption of the catalyst on the membrane. Absorption tests were 
performed by soaking 4 x 1cm2 membrane coupons each into 1ml of THF solution containing 70mg 
of the catalyst for 3 days. It was estimated from these tests that 0.6g of catalyst were absorbed onto 
each gram of dry mass of membrane. The average weight of 4 randomly cut membrane coupon was 
1.0g, therefore the loss of 0.49g of catalyst to adsorption was within expectations.  A possible way to 
mitigate this issue is to reuse the membrane so that the membrane becomes saturated with the 
catalyst on the initial filtration so that future losses of catalyst will be minimal.  
The diafiltration was ceased prematurely as a separation for the recovery of a 0.99 purity catalyst 
required in excess of 11 days. The long separation time required was a result of the low separation 
productivity in the first stage due to the low difference in separation difference between the product 
and the catalyst. This low productivity necessitated the use of copious amounts of diafiltering 
solvent for the separation in the first stage, but was reduced with the implementation of the second 
solvent recovery stage in M2. 6L of diafiltering solvent permeated through the membrane in M1 
from T1 over the 3-day period but only 225ml of fresh THF was fed into the system from T0, which 
meant 96% of the diafiltering solvent used was recycled.    
Another limitation with this setup is its non-robustness as the separation was dependent on the full 
rejection of the catalyst on the first DuraMem® 500 coupon. In a separate test, 300ml of a THF 
solution containing 10g of product and 1g of catalyst was diafiltered using the rig. A new batch of 
DuraMem® 500 membrane coupons which were used had a lower rejection of 0.97 for the catalyst. 
While there was little change in catalyst rejection (-3%), the loss of catalyst over time was significant. 
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At the end of the 7-day diafiltration most of the catalyst had actually permeated into M2, with no 
enrichment of the catalyst occurring in RT1 (See Table 3.6).  
Table 3.6: Summary of mass balance at the start and the end of the 7-day diafiltration of a 300ml 
THF solution containing 10g of the product 2 and 1g of the catalyst 6 using the equipment shown 
in Figure 3.15 
 
0h 168h 
Product mass 
/ g 
Catalyst mass 
/ g 
Product mass 
/ g 
Catalyst mass 
/ g 
T1 0.00 0.00 0.87 0.01 
RT1 10.00 1.00 1.43 0.08 
T2 0.00 0.00 0.07 0.00 
M2 0.00 0.00 7.92 0.24 
T3* 0.00 0.00 0.00 0.00 
Total 10.00 1.00 10.28 0.33 
* No retentate flux was produced from M2 into T3 in this run 
These limitations are a consequence of the single stage setup for the catalyst retention stage and for 
the solvent recovery stage. These limitations are discussed in detail in Chapter 4 and an alternative 
membrane configuration is proposed in Chapter 5.    
3.2.4.4 Effectiveness of recycled catalyst 
The catalyst recovered from RT1 in the 3-day diafiltration was used in the reaction illustrated by 
Scheme 3.7. The nitrostyrene 1 was used and it was verified that catalyst 6 retained its activity and 
selectivity (See Entries 1 and 2 Table 3.7) despite the long filtration time required for separation. To 
ascertain that contamination of the catalyst by any residual product was not the cause of the 
observed consistency in catalytic activity, the recycled catalyst was also used to catalyse the Michael 
addition of 9 to dimethyl malonate. Again there was little change in the catalytic performance of the 
recycled catalysts (see Entries 3 and 4 in Table 3.7). Therefore 6 is compatible with this membrane 
recycling process. 
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Table 3.7: Comparison of activity and selectivity of fresh and recycled catalyst 6 in the catalysis of 
Michael addition.  
Entry Nitrostyrene Conversion 24ha / % Timeb / day Yieldc / % eed / % 
1 1 98 2 67 92 
2 1 100* 1 75 93 
3 9 90 3 89 94 
4 9 93* 3 99 92 
* Recycled catalyst, 17mg to account for theoretical catalyst purity of 0.82  
a Determined by HPLC analysis under comparison with a naphthalene internal standard after 24h.  
b Total time taken for the reactions using catalyst 6 (14mg), which were run with 0.4mmol of 
nitrostyrene and 3mol eq. of dimethyl malonate at -20°C until all nitrostyrene was consumed as 
determined by HPLC analysis at λ = 230nm.  
c Isolated yield of product using preparative chromatography.  
d Determined by chiral HPLC analysis.  
 
3.2.5 Summary of results 
Three different approaches to attaching an organocatalyst, O-desmethylquinidine, to a bulky anchor 
to increase its membrane retention were attempted, culminating in the successful synthesis of a 
new class of enlarged organocatalyst with polyalkylation. A combination of molecular weight 
increase and charge or hydroxyl group formation was more effective in increasing the retention of 
the catalyst. The enlarged catalyst with the phenolic hydroxyl group and basic quinuclidine nitrogen 
was effective in catalysis and catalysed the Michael addition more selectively than the incumbent 
catalyst. This catalyst was diafiltered in an attempt to separate it from the Michael addition product. 
The catalyst was purified over the 3-day diafiltration, and complete retention of the catalyst by the 
membrane was critical in a successful membrane recycling strategy for the catalyst. The catalyst was 
later reused and shown to be robust it was still catalytically effective after the diafiltration. 
3.3 Materials and methods 
3.3.1 Chemicals 
AMS and MS were available at UCB Pharma SA. The bases Ca(OH)2, Mg(OH)2 and quinine were 
purchased from Sigma Aldrich and used without further purification. 
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The catalysts synthesis procedures and Michael addition reaction procedures are detailed in Section 
8.2 of the Appendices.  
3.3.2 Membranes 
Desal 5 DK membranes were purchased from GE Water & Process Technologies. DuraMem® series 
membranes were purchase from MET (now Evonik-MET).  
3.3.3 Membrane testing with recirculation experiments 
Membrane testing were carried out on a METcell crossflow system (Evonik-MET, UK) illustrated in 
Figure 3.16. The OSN system was operated with a single flatsheet membrane coupon with an active 
filtration area of 54cm2. The test solution was added into the retentate tank after membrane 
washing and RCP turned on to prime the pump. After priming the pump, the hotplate was turned on 
to maintain the temperature of the retentate in RT, with feedback from the resistance thermometer 
inserted into RT. Nitrogen gas from a gas bottle was fed into RT to provide pressure for the filtration. 
A proportional relief valve, PRV, was fitted in the gas line and calibrated such that it opens slightly to 
slowly relief nitrogen gas from the gas feed. This kept the pressure in RT constant at the desired 
pressure. Filtration was performed over different pressures by adjusting the PRV and gas supply into 
RT. The permeate flow from M1 was collected in a buffer tank, RBT. At the bottom of RBT was the 
feed tube for the metering pump. The metering pump was regulated by a PI controller implemented 
using LabView. The controller changed the flow rate of the pump in response to the level in RT. The 
level in RT was monitored with a weighing scale, which RT and the hotplate put on. Each 
recirculation at a different pressure was done for at least 2h or until the permeate metering pump 
flow stabilised. The retentate from RT was sampled from the drain valve, DV. Membrane flux was 
determined by collecting the permeate from M1 over a fixed time interval and verified with the 
metering pump flow. These samples were analysed on HPLC to determine solute concentration. 
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Figure 3.16: Schematic for constant volume diafiltration. 
3.3.4 Constant volume diafiltration 
Constant volume diafiltrations were later performed on binary solutions containing AMS and MS at 
concentrations of 0.025M each. Diafiltrations performed with no base added utilised Desal® 5 DK 
and DuraMem 200® membranes; DuraMem® 300 was not used as the retention of either solute was 
too low. Diafiltrations performed with Mg(OH)2 added to increase the pH utilised Desal 5 DK, 
DuraMem® 200 and DuraMem® 300 membranes. The diafiltrations were performed using the 
procedure outlined by Székely et al. (2011). 
3.3.5 Operation of membrane separation process 
The membrane process was constructed according to the schematic in Figure 3.15. The operating 
procedure  of the process can be classified into 1. startup; 2. operation of diafiltration; 3. shutdown 
of the process. Before startup, the membranes were rinsed with fresh THF by allowing the 
permeation of 300ml of THF through each membrane. This washed out the preservatives from the 
membranes. The Michael addition was performed batch wise in a separate vessel as the reaction 
temperature was low (-20˚C) and the total cycle time long (1 day). 
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Startup 
During startup, the mixture to be separated was charged into RT1 and RCP was switched on to prime 
the gear pump. After the pump was primed, RT1 was pressurised to 18bar with bottled nitrogen gas. 
The pressure was maintained by allowing a slow flow of nitrogen through the pressure relief valve, 
which was calibrated to relief at 18bar. The hotplate which RT1 was on was used to regulate the 
temperature at a setpoint of 30˚C. The permeate from M1 was recycled back into T1 for recirculation 
back into RT1, with control for Pump 2 turned on to maintain a constant retentate level in RT1. This 
recirculation was performed overnight to condition the membrane and achieve steady membrane 
flux. After conditioning, samples of the retentate and permeate of the catalyst retention stage were 
taken to verify total retention of the catalyst by the membrane and permeation of the product 
through it. 
On successful verification, the permeate flow from M1 was fed into T2 with the process set up as 
shown in Figure 3.15. The PI controllers for Pump 1 and Pump 3 were switched on to maintain the 
levels in T1 and T2.  M2 was allowed to be filled with feed from T2 until the level of fluid in M2 
overflowed from a port on top of M2. This port was then plugged with a swage cap to allow 
pressurisation of M2 while avoiding gas entrainment. The back pressure regulator, calibrated to 
relief at 10bar with nitrogen gas, was adjusted so that the pressure in M2 was maintained at 10bar.  
Operation of diafiltration 
The flow rates of Pumps 1, 2 and 3 were monitored along with the levels in (weights of) T1, RT1 and 
T2. Based on these outputs, the corresponding PI controllers were further fine-tuned to maintain the 
weights of these tanks within a range of ±1g and flowrate variations of the pumps within ±2ml min-1.  
Samples of the retentate from RT1 and M2 were taken every 24h to ascertain complete separation 
of the product from the catalyst retained in RT1. These samples were analysed using HPLC and the 
peaks of the product and catalysts were monitored at 230nm. 
Shutdown 
When separation was determined to be complete, Pumps 1, 2 and 3 were turned off. RT1 was 
depressurised by cutting the nitrogen feed and allowing the rest of the nitrogen to relief from RT1 
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until gauge pressure was at 0bar. The retentate from RT1 was drained out and RT1 was further 
rinsed with (3 x 250ml) of THF to flush out most of the residual retentate. This fraction was dried in 
vacuo to determine the amount of catalyst retained. The solution in T2, the retentate from M2 and 
the fluid in the concentrated product solution tank were collected separately and dried in vacuo to 
determine the amount of product removed from the reaction mixture. Finally the solution in T1 was 
evaporated to dryness and analysed to verify the mass balance around the whole system. 
3.4 Conclusion 
The selective addition of charge(s) to a solute, either through pH manipulation or polyalkylation, and 
the increase in molecular size of a solute using polyalklyation have been shown to improve the 
retention of the target solute, in agreement with predictions by the DSPM. However, these 
approaches were not always sufficient on their own to achieve full rejection of the solute to enable a 
complete separation with a single constant volume diafiltration stage due to the limitations of the 
diafiltration process. These limitations are discussed Chapter 4 while alternative membrane process 
configurations  are proposed in Chapter 5.  
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4. Membrane Processes and Their Models 
From the membrane processes reviewed in Chapter 1, it is evident that OSN can be widely applied in 
the pharmaceutical industry. However, their use to facilitate the chemical synthesis of API 
industrially has not been reported.  The limitations of OSN processes, identified by considering 
performance based on their process models, might be able to explain the dearth of industrial 
examples.   
In the first part of this chapter, the simpler solvent recovery membrane process models are covered. 
In these cases, the models only consider a single solute for simplicity. Subsequently, solvent 
exchange and solute fractionation are examined together because their models can be used 
interchangeably. 
4.1 Solvent Recovery 
Solvent recovery in the pharmaceutical industry is often performed in conjunction with solute 
concentration as the solutes are usually desired and need to be recovered (Rundquist et al., 2012a ; 
Rundquist et al., 2012b). The prevalence of distillation for solvent recovery can be attributed to the 
typically high volatility difference between the solute and solvent which allows for easy recovery of 
pure solvent and minimal solute loss. Hence an OSN alternative needs to possess a similar capacity 
for pure solvent recovery and allow only minimal solute loss during concentration to compete with 
distillation. 
4.1.1 Batch concentration 
The simplest setup (Figure 4.1) for solvent recovery involves the filtration of a solution with a 
membrane that can retain the solute(s) in solution until the solute concentration reaches a target 
concentration level, or when the desired amount of solvent has permeated through the membrane 
(Darvishmanesh et al., 2011; Geens et al., 2007; Rundquist et al., 2012b). 
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Figure 4.1: Schematic illustrating batch concentration. For this concentration stage j, the retentate 
volume is reduced from      to      while the concentration of solute i rises from        to        
over the filtration time t. This produces a permeate stream (recovered solvent stream) of volume 
      with a concentration of        at the end of the filtration cycle. The dotted arrows denote 
batch transfer of fluids.  
When the solute rejection across the membrane is lower than unity, the solute concentration in the 
permeate changes over the filtration time. Suppose for a moment that the solution in the retentate 
and the exiting permeate are always well-mixed and that the rejection of the solute remains 
constant throughout the filtration time, t. In this case, the concentration of the solute i (  
      ) in the permeate from diafiltration stage j             follows 
                       Equation 4.1 
Hence the solute concentration in the permeate stream increases over time as the solute 
concentration in the retentate increases. Determination of the exact permeate concentration at the 
end of the batch concentration requires detailed understanding of the process dynamics in the 
retentate. This is challenging as evolution of solute concentration over the filtration time is 
uncertain. The process model can be simplified if the concentration of solute in the retentate is 
assumed to increase linearly over time, as illustrated by Figure 4.2. With the further assumption that 
the system has both a perfect flow controller and a perfect actuator that can maintain constant 
permeate flux and solute rejection over the filtration time, the concentration of solute i in the 
retentate of stage j can be expressed as a first order equation (Equation 4.2) with respect to 
filtration time, t. 
 
            
 
Stage j 
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Figure 4.2: Change in retentate concentration, from    to       , in stage j, assuming a linear 
increase in retentate concentration over filtration time, t 
               Equation 4.2 
The recovered solvent from the permeate stream will have a solute i concentration that is an 
average of the permeate collected over the total filtration time. A mass balance analysis of the loss 
of solute i from the retentate and its relationship with the solute in the permeate is shown in 
Equation 4.3. 
 
                                       
 
 
                    
 
 
 
Equation 4.3 
Equation 4.3 can be further simplified to 
                             
  
 
        Equation 4.4 
By dividing this amount of solute by the total volume of permeate collected over the filtration time, 
the concentration of solute i in the recovered solvent can be expressed by  
                 
  
 
      Equation 4.5 
xi,j 
t 
B
j
 
time 
Ajt + Bj 
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The stage cut, which is defined as the ratio of the solvent volume recovered and the initial solution 
volume being filtered (see Equation 4.6), determines the amount of the recovered solvent. A high 
stage cut would result in a high solvent recovery rate and vice versa.  
   
   
    
 
     
    
 Equation 4.6 
The solute i             balance over the process is 
                                   Equation 4.7 
While the solvent flow balance over the process is  
                 Equation 4.8 
Combining the solute balance (Equation 4.7) and material balance (Equation 4.8) equations and 
rearranging would yield 
 
     
    
 
             
             
 Equation 4.9 
Also by combining the stage cut equation (Equation 4.6) and the flow balance equation (Equation 
4.8) with Equation 4.9 and rearranging, an alternative expression for stage cut can be obtained to 
solve this set of equations.  
   
     
    
  
     
    
 Equation 4.10 
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Figure 4.3: Solute concentration in recovered solvent when using membranes in batch 
concentration mode for solvent recovery from a solution containing 10g L-1 of a solute. The 
rejection values refer to the single pass rejection of these membranes. As more solvent is 
recovered (higher stage cut), the concentration increases, making pure solvent recovery a 
challenge at high recovery rates.  
The limitations of the batch concentration process became apparent when simulations were 
performed, at various stage cuts and membrane rejections, for the batch concentration of a solution 
containing 10g L-1 of solute. The results are illustrated in Figure 4.3. When solvent recovery rates 
were increased, the amount of solute in the recovered permeate increased. While this increase was 
delayed as the single pass rejection approached unity, the recovery of high purity solvents with the 
process was limited to high rejection membranes, making the process inflexible. Do note that 
constraints imposed by elevated osmotic pressure, excessive concentration polarisation and the 
solubility limit of the solute were neglected in these simulations to illustrate the challenges faced 
when trying to achieve high recovery rates for pure solvent. 
4.1.1.1 Batch permeate multipass cascade 
When the single pass rejection of the membrane is too low, the permeate from a batch 
concentration stage can be sent to further concentration stages to produce an increasingly dilute 
permeate (Katraro et al., 1997; Rundquist et al., 2012b). A series of such batch concentration stages 
forms a batch permeate multipass cascade. Schematically, the permeate stream from stage j is sent 
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for further filtration in stage j + 1 until the desired permeate solute concentration,    , from the 
final stage is achieved (see Figure 4.4). 
   
Figure 4.4: Schematic of a batch permeate multipass cascade. For every stage j, the retentate 
volume is reduced from      to      while the concentration rises from        to        over the 
filtration time t. This produces a permeate stream from each stage of volume       with a 
concentration of        at the end of the filtration cycle. In this scenario                 . The 
dotted arrow lines denote batch transfer of fluids. 
As this cascade is an expansion of the batch concentration nanofiltration, Equation 4.2 and Equation 
4.5 can be used to describe the evolution of solute concentration in each stage. Equation 4.9 and 
Equation 4.10 were used to determine the solute balance in each stage. 
If a fixed stage cut was used in each stage, the amount of permeate at the end of the filtration in 
each stage can be expressed, with respect to the initial retentate volume, by  
           
      Equation 4.11 
The concentration of the resulting retentate, where t is the constant filtration time for each stage, 
can be expressed as 
           
                 
                 
      
                       
 Equation 4.12 
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Figure 4.5: Relationship between overall rejection of the batch permeate multipass cascade and 
the number of stages in this cascade. Simulations were performed for a high stage cut of 0.95 to 
maximise solvent recovery. The overall rejection of the cascade increased with the increase in 
number of stages. 
The performance of the cascade was quantified with the overall rejection, which is represented by 
Equation 4.13.  
        
     
         
 Equation 4.13 
Simulations of the cascade for the treatment of a 10g L-1 solution, with a high stage cut of 0.95 to 
maximise solvent recovery and assuming the solute is soluble at all concentrations, showed that the 
addition of stages increased the overall rejection of the cascade (Figure 4.5). At first glance, this 
approach seems feasible as a workaround for insufficient membrane rejection in pure solvent 
recovery as the process scaled well with the increase in the number of stages. 
Further simulations of a 3-stage batch permeate multipass cascade performance at different stage 
cuts showed that the overall rejection of the cascade decreased as the stage cut approaches unity 
(see Figure 4.6), which was a minor impediment to the use of this cascade. The cascade also had a  
low capacity for solute enrichment in the retentate (see Figure 4.7) at stage cuts below 0.6. This 
meant that the operation of the cascade with the dual aims of high overall rejection and high solute 
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enrichment, typically required for maximal solvent recovery (Katraro et al., 1997; Rundquist et al., 
2012b), is not attainable unless the membranes reject the solute highly. 
Furthermore, such a batch system would become unwieldy as the amount of solvent treated and 
number of stages required increase. The sizes of all the buffer tanks required between each stage 
increases proportionally to the volume of solvent treated, while each additional stage adds an 
additional cycle and its associated time to the whole process. 
The complexity of designing such a cascade is also an issue. If every cascade stage is sized identically, 
the first stage will take most time for filtration and will be the rate limiting step if the stage cut for 
every stage is not unity. It should be noted that each additional stage also decreases the amount of 
recovered solvent, with    of the initial solvent volume recovered at the end of n stages, limiting the 
number of stages that can be added if high solvent recovery rate is required. 
 
 
Figure 4.6. Relationship between overall rejection of a 3-stage batch permeate multipass cascade 
and the stage cut for each stage. The overall rejection of the cascade decreased as the stage cut 
for each membrane stage approached unity. Hence a cascade aiming for high overall rejection 
would operate at low to moderate stage cuts. 
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Figure 4.7: Relationship between stage cut of each stage and the concentration of the product 
retentate from the 3-stage batch permeate multipass cascade. A stage cut below 0.6 limits the 
capacity of the cascade for the concentration of solute in the retentate. Therefore the conflicting 
aims of high overall rejection and concentration of solutes cannot be achieved simultaneously 
unless the rejection is high. 
 
Figure 4.8. Schematic of a continuous permeate multipass cascade. In each stage, the proportion 
of feed solution filtered is based on the stage cut; a higher stage cut results in a higher proportion 
of solution filtered. The resulting permeate from each stage is channelled to successive membrane 
stages for further rectifying.            is equivalent to the average concentration of all the 
retentate streams and               . 
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4.1.2 Continuous concentration 
The use of continuous membrane filtration cascade processes has also been explored for solvent 
recovery (Abejon et al., 2012; Caus et al., 2009). In the simplest fashion, the batch permeate 
multipass cascade can also be operated continuously as shown in Figure 4.8, with the permeate from 
stage j sent to stage j + 1 until the desired solute concentration in the permeate product stream 
from stage n (             ) is achieved. The retentate streams from all the stages can be 
collected together to form the concentrate product stream. 
For this continuous permeate multipass cascade, the flow balance over each stage can be 
summarised by 
                              Equation 4.14 
Where    is the stage cut of stage j            .  
    
  
    
        Equation 4.15 
Therefore, the material balance over each stage can be expressed as 
                                      Equation 4.16 
Partitioning of solute across the membrane at each stage is dependent on membrane performance 
and operating conditions. If the retentate in each membrane unit is assumed to be well-mixed, the 
partitioning of the solute can be expressed as 
                   Equation 4.17 
Equation 4.16 and Equation 4.17 can be combined and rearranged to give 
    
      
                 
 Equation 4.18 
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This can be solved to obtain the concentration of solute in the retentate from stage j, while Equation 
4.17 can be solved to obtain solute concentration in the permeate from the same stage. 
 
Figure 4.9: Relationship between overall rejection of the continuous permeate stage system and 
the stage cut in each membrane stage. Note that the overall rejection decreased with increasing 
stage cut, while the concentration of the retentate increased with stage cut.  
Meanwhile the solute concentration in the retentate stream of the cascade can be expressed as 
           
                     
          
 Equation 4.19 
Hence the overall rejection over this cascade can be represented by 
        
   
         
 Equation 4.20 
The main operating parameter for this cascade is the stage cut for each membrane stage. The 
cascade was simulated for the treatment of a 10g L-1 solution, at different stage cuts and with a 
single pass rejection of 0.55, and it was evident from Figure 4.9 that the cascade had limited capacity 
for concentration of the retentate stream though it had a high theoretical limit for overall rejection 
of 0.91 when the stage cut approached zero. The cascade barely concentrated the solution at stage 
0 
5 
10 
15 
20 
25 
0 
0.2 
0.4 
0.6 
0.8 
1 
0 0.2 0.4 0.6 0.8 1 
x i
,0
 /
 g
 L
-1
 
O
ve
ra
ll 
re
je
ct
io
n
 /
 -
 
Stage cut / - 
Overall rejection 
Effective retentate 
concentration 
98 
 
cuts below 0.6. On the other hand, the overall rejection dropped rapidly toward the single pass 
rejection of 0.55 at stage cuts above 0.8. 
A variant of this cascade was proposed firstly by Caus et al. (2009) and then by Abejon et al. (2012), 
where the retentate from stage j + 1 is recycled back into stage j, with the exception of stage n 
where no further stages were available downstream to provide the recycle (see Figure 4.10). This 
new configuration also made it possible for all stages, except the final one, to be sized identically. 
 
Figure 4.10: Schematic of cascade by Caus et al. (2009) and Abejon et al. (2012). Adapted from 
work by Abejon et al. (2012) 
For this cascade, the flow balance over the cascade from stage j can be expressed with 
            Equation 4.21 
The material balance in this cascade follows the general formula 
                         Equation 4.22 
This can be rearranged to 
                 
          
      Stage 1 Stage j Stage n 
W1, xi,1 
W
2
, x
i,2
 
W
j
, x
i,j
 W
n
, x
i,n
 
W
j+1
, x
i,j+1
 
P
0
,  
y
i,0
 
P
1
,  
y
i,1
 
P
j-1 
,  
y
i,j-1
 
P
j
,  
y
i,j
 
P
n-1
,  
y
i,n-1
 
P
n
,  
y
i,n
 
99 
 
 
     
    
  
       
  
  
    Equation 4.23 
The partitioning of solute can be assumed to follow Equation 4.17. 
 
Figure 4.11: Relationship between overall rejection of the cascade system proposed by Caus et al. 
(2009) and Abejon et al. (2012) and the ratio between the recycled retentate and permeate flow. 
While the overall rejection increases with the ratio of flows, the concentration of the retentate 
decreased with the ratio causing little enrichment of the solute at high rejections. 
The recycle ratio in this cascade, defined as the flow ratio between the retentate sent to stage j – 1 
from stage j and the permeate sent from stage j – 1 to to stage j, with the exception of the final 
stage n can be expressed as 
 
  
  
    
       Equation 4.24 
Suppose the permeate flux for all stages, less the final stage, are constant and the solute rejection in 
all stages are identical. Simulations were performed for such a cascade (see Figure 4.11), with the 
single stage membrane rejection set at 0.55, to elucidate the depedence of the cascade’s 
performance on the recycle ratio in this cascade. While total recycle of the permeate was able to 
bring the overall rejection of this cascade to a maximum of 0.91, the concentration of the resulting 
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retentate fell towards the feed concentration of 10g L-1, resulting in very little enrichment of the 
solute in the retentate. To achieve a maximum enrichment of the solute to 22.2g L-1, there should be 
no permeate recycled. However, in this case the rejection in the cascade drops to the single stage 
rejection of 0.55. Hence it is evident that this cascade has a limited solute concentration capacity 
when trying to attain high overall rejections, unless the single pass rejection is at unity. 
4.2 Solvent Exchange and Solute Fractionation 
Solvent exchange is a routine unit operation in the pharmaceutical industry as many sequential 
reactions are carried out in different organic solvents (Lin & Livingston, 2007). The solutes, of lower 
volatility, are retained in the reaction mixture while the solvent, of higher volatility, is removed; 
another solvent is routinely added into the mixture to increase the solvent content of the replacing 
solvent. 
Solute fractionation, on the other hand, can be critical to the success of the synthesis of an active 
pharmaceutical ingredient (API). The processes commonly used for solute fractionation include 
distillation, adsorption-desorption, solvent extraction, membrane-assisted liquid-liquid extraction 
(Eldrige, 1993), fractional crystallisation (Sherwood & Pigford, 1952) and chromatography 
(Sereewatthanawut et al., 2010).  These processes involve the separation of a solute that has a 
higher affinity for a phase from another solute with a lower affinity for that phase. When the affinity 
differences in these processes prove insufficient, nanofiltration might be used as an alternative tool 
to induce an adequate separation driving force. 
The process models for solvent exchange and solute fractionation can be treated similarly as at least 
3 species need to be processed for these equations. Arguably, these processes are harder to model 
than the solvent recovery processes.  
4.2.1 Discontinuous batch diafiltration 
Solvent exchange with discontinuous batch diafiltration is analogous to the “put-and-take” 
distillation commonly used for solvent exchange in the pharmaceutical industry. In both cases, a 
solution containing the reaction mixture is first concentrated by a batch removal of solvent, using 
either a batch concentration membrane process described in Section 4.1.1 or distillation. Secondly, 
the replacing solvent is added to the concentrated solution to dilute it. These 2 steps are repeated 
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until the desired solvent switch is achieved. While the membrane process can potentially realise 
energy savings, distillation is well-established and simpler to use. Solvent switch with distillation can 
be stopped unambiguously when the desired vapour temperature is achieved. Furthermore the 
solutes in the reaction mixture tend to be a lot less volatile than the solvent,  minimising the loss of 
the desired solute during the concentration phase. 
 
Figure 4.12: Solvent exchange procedure performed by Sheth et al. (2003). 
To illustrate a working example of a discontinuous batch diafiltration, a process model for the 
process used by Sheth et al. (2003) (see Figure 4.12) was developed. Firstly an initial batch 
concentration process was used to remove some solvents. The batch concentration equations can 
be used to describe the evolution of solute concentration in the retentate during the batch 
concentration step. Hence Equation 4.1 can be used to describe the partitioning of the solute, 
Equation 4.2 for the concentration change of solute in the retentate, Equation 4.5 the change in 
solute concentration in collected permeate and Equation 4.9 for the description of the relationship 
between the volume ratio of the permeate and retentate after the batch concentration. 
When rediluting the solution for the subsequent concentration, the retentate was replenished to its 
original volume with a replacing solvent. The amount of solvent added after every stage (step) j of 
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the diafiltration was      . By rearranging Equation 4.9, an equation to determine the concentration 
of solute in retentate tank can be obtained  
          
          
      
 Equation 4.25 
 
 
Figure 4.13: Changes in concentration of solute in the retentate during the solvent exchange cycle 
as performed by Sheth et al. (2003). 
The volumes and rejection values from the solvent exchange cycle described by Sheth et al. (2003) 
were used in this equation set for validation. The rejection of the solute was also varied to illustrate 
the influence of solute rejection on the effect of the solvent exchange / solute removal. 
The loss of the solute, using the rejection of 0.9637 as reported by Sheth et al. (2003), was estimated 
at 18.8% compared to the 10.9% reported by them. While not spot on, this was of the same order of 
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magnitude and this model should give a good idea of the performance of discontinuous diafiltration. 
As seen in Figure 4.13 the changes in solute concentration were larger when the rejections of the 
solute were lower. On the other hand, the loss of solute in such a cycle decreases exponentially with 
an increase in the rejection of the solute (see Figure 4.14). In the case of solvent exchange, where 
the rejections of the solvents are often assumed to be zero (Lin & Livingston, 2007; Rundquist et al., 
2012a), it is apparent that a successful solvent switch require the use of a membrane which rejects 
the desired solute very close to unity. 
This process has not been used for solute fractionation purposes in organic solvents yet, though 
conceptually a high yield fractionation should see high rejection of the desired solute by the 
membrane and low rejection of the undesired solute (see Figure 4.14). 
 
Figure 4.14: Solute loss from the retentate, when using the procedure depicted in Figure 4.12, as a 
function of the rejection of the solute. 
The need for a high rejection membrane was further highlighted when the solute concentration in 
the permeate, from simulation of the process, was examined (see Figure 4.15). When rejection was 
below unity, the more retained solute was always present in the permeate. In chromatography 
parlance, co-elution of the more retained solute occurred. Hence full fractionation of the desired 
solute from the rest of the solutes is impossible with such a process unless the desired compound is 
completely retained by the membrane. The requirement for full rejection means the process is not 
robust as even a slight deviation from total rejection can cause co-elution and decrease the 
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efficiency of the separation. The sensitivity of the process to membrane retention of the solute also 
means that it is a rigid process, making implementation in the typical multipurpose pharmaceutical 
manufacturing plant a challenge.  
 
Figure 4.15: Solute concentration in the permeate during the batch concentration steps for the 
solvent switching of a 5g L -1 solution. Only when rejection was unity was there no solute present 
in the permeate. 
4.2.2 Constant Volume Diafiltration 
The elevated osmotic pressures in discontinuous diafiltration at high solute concentrations have led 
to the adoption of constant volume diafiltration (Da Silva et al., 2008). Constant volume diafiltration 
is the state of the art in OSN processes for solute fractionation (Rundquist et al., 2012b; 
Sereewatthanaut et al., 2010; So et al., 2010; Székely et al, 2011; Vanneste et al., 2012). In constant 
volume diafiltration, the membrane is used to retain a compound preferentially while pressure 
driven solvent flow causes the permeation of the less retained solute(s). The fluid level in the 
retentate tank is kept constant by a flow of diafiltering fluid into it. Past work has shown that the 
preferentially retained solute will not always be retained completely (Darvishmanesh et al., 2011; 
Geens et al., 2007; Rundquist et al., 2012b), hence product purification often occurs in the retentate 
tank; co-elution makes product purification in the permeate stream impossible. Constant volume 
diafiltration is simple to use and understand. The solute concentration in the retentate follows the 
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general formula in Equation 3.5 (Mulder, 1996; Sereewatthanawut et al., 2010) when rejection of 
the solute is assumed to be constant over time. For easy reference, this is rewritten below. 
               
             Equation 4.26 
Equation 4.26 suggests that an increased rejection leads to a  slower decrease in the concentration 
of the solute in the retentate over the number of diafiltration volumes. Hence a solute with a higher 
rejection will be enriched in the retentate over a solute with a lower rejection. 
Consider a case where A, a more permeable solute, and C, a more retained solute are separated 
using constant volume diafiltration. The following 4 equations can be used to quantify the 
performance of the separation in stage j. Firstly, the purity of C enriched in the retentate produced 
by the diafiltration can be  determined using  Equation 4.27. 
        
      
             
 Equation 4.27 
The yield of C obtained in the retentate is 
            
      
      
 Equation 4.28 
The purity of A produced, produced in the permeate stream, can be expressed as 
        
            
                               
 Equation 4.29 
While the yield of A in the permeate stream can be determined by 
            
             
      
 Equation 4.30 
Predictions of constant volume diafiltration performance have often been performed using Equation 
4.26 and high rejection of  the more retained solute have often been cited as a decisive factor in 
enabling a successful separation (So et al., 2010; Székely et al., 2011) while low rejections of the less 
permeable product were desired. The use of solute rejection for the prediction of diafiltration 
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performance, however, is not intuitive. When examining separation processes such as distillation 
and liquid-liquid extraction, one will notice these process’ selectivities are expressed in terms of the 
partitioning of one solute over the another into another phase. Adapting such an approach in 
constant volume diafiltration, a selectivity term can be formed using the relative permeability of 
solute A over solute C into the permeate. This term has been used by a number of groups as a 
measure of the driving force for solute fractionation through membranes (Caus et al., 2009; Ghosh, 
2003; Gunderson et al., 2007; Lightfoot et al., 2008; Mayani et al., 2010), and is termed the relative 
permeation factor in this work. The relative permeation factor of A over C in a membrane stage j is  
        
         
         
 
      
      
 Equation 4.31 
The use of this term was demonstrated by simulating the diafiltration of a solution containing A and 
C, from a C purity of 0.60 to 0.80. The rejections values for A and C were manipulated in the 
simulations. Simulations with the same relative permeation factors gave identical separation 
performance and different process productivity (see No. 1 – 4, Table 4.1). The separation 
performance was determined by the yield of A, the yield of C and the purity of A in the permeate; 
the process productivity was determined by the number of diafiltration volumes required for the 
separation. Rejection values were unsuitable for the prediction of separation performance; 
simulations with different pairs of rejection values that had the same relative rejection differences 
gave vastly different separation performances, though they had similar productivities (see No. 5 – 8, 
Table 4.1). It appears that rejection values could only predict process productivity. 
Constant volume diafiltration has 2 main challenges. Firstly, it requires the use of considerable 
amounts of fresh solvent for total purification (Sereewatthanawut et al, 2010). While a solvent 
recovery stage can significantly decrease solvent usage, energy has to be expended to implement 
this recycle. 
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Table 4.1: Summary of effects various solutes’ rejections on the separation performance of a 
constant volume diafiltration process in purifying a feed with Compound C purity of 0.60 to 0.80. 
Similar to Table 1, No. 1 – 4 had increasing difference in rejections between C and A but had the 
same relative permeation factor of A over C; No. 5 – 8 had the same difference in rejections 
between C and A but decreasing relative permeation factor of A over C. 
No.      / -      / - 
       
     / - 
       / -     / - 
      / 
- 
      / 
- 
    / - 
1 0.9999 0.9990 0.0009 10.00 1090 0.897 0.664 0.811 
2 0.9990 0.9900 0.0090 10.00 109 0.897 0.664 0.811 
3 0.9900 0.9000 0.0900 10.00 10.9 0.897 0.664 0.811 
4 0.9000 0.0000 0.9000 10.00 1.09 0.897 0.664 0.811 
5 0.9000 0.3000 0.6000 7.000 1.63 0.849 0.682 0.751 
6 0.8000 0.2000 0.6000 4.000 1.63 0.721 0.730 0.636 
7 0.7000 0.1000 0.6000 3.000 1.63 0.612 0.770 0.570 
8 0.6000 0.0000 0.6000 2.500 1.63 0.520 0.805 0.528 
 
Secondly, diafiltration is an inefficient process for the removal of trace amounts of permeable 
solutes. This inefficiency is apparent when one tries to achieve high purity separation using constant 
volume diafiltration. Suppose a purification of a binary solution containing 10g L-1 of Compound C 
(with a rejection of 0.99) and 10g L-1 of Compound A (with a rejection of 0.9) was performed. If the 
concentrations of these 2 solutes in the retentate were plotted over the number of diafiltration 
volumes (Figure 4.16), one would notice that the rate of increase in the purity of Compound C in the 
retentate would decrease over time. This decrease in diafiltration productivity as quantified using 
the marginal output of diafiltration volumes (Equation 4.32), which was defined as the  increase in 
purity of the less permeable solute (C) in the retentate per to a unit increase in diafiltration volume, 
decreases towards zero with increasing purity of C (See Figure 4.17).  
      
     
  
 Equation 4.32 
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Figure 4.16: Concentration profile of retentate when performing constant volume diafiltration to 
purify Compound C from a solution containing 10g L-1 of Compound A and 10g L-1 Compound C. The 
rejection of Compound A was defined as 0.90 and Compound C as 0.99. Note the diminishing 
effect of increasing diafiltration volumes as the number of diafiltration volumes increases. 
 
Figure 4.17: Change in the effect of increasing diafiltration volumes in purifying Compound C in the 
retentate. Note the increasing inefficiency of constant volume diafiltration at high Compound C 
purity. 
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The high solvent usage in diafiltration is partly a consequence of the decreasing diafiltration 
productivity at increasingly high purities. The concentration and amount of retained solute, 
Compound C, will constantly decay throughout the diafiltration process as long as the rejection of C 
is less than unity. Hence the decreasing productivity at high Compound C purity will contribute to an 
increased loss of C at high C purities. While hybrid processes (Pink et al., 2008; Székely et al., 2011; 
Székely et al., 2012) can decrease solvent usage and increase diafiltration productivity by 
circumventing the need to perform diafiltration to high purities, these processes involve the use of 
an irreversible adsorption step that is detrimental to the total process yield of C. 
When the rejection of the desired solute is not unity, the solute will also co-elute into the permeate 
stream, making complete separation of the less permeable and more permeable solute impossible 
with this process.  
4.2.3 Continuous solvent exchange and fractionation 
Addressing the challenges in constant volume diafiltration would require maximising depletion of 
the diafiltering fluid capacity while increasing the removal of the more permeable species. Barring 
chemical or physical transformation of the solute and the use of a different membrane, a change in 
process configuration might just be able to achieve that.  
While continuous solute fractionation processes have not been demonstrated for organic solvents, 
Lightfoot & co-workers (Gunderson et al., 2007; Lightfoot, 2006; Lightfoot et al., 2008) and Ghosh 
(2003) have been particularly prolific in the use of membrane cascades for the fractionation of 
solutes. They developed a process model for such a cascade, by approximating each membrane 
stage as a constant volume diafiltration unit.  Mayani et al. (2010) brought this idea to fruition by 
demonstrating the use of a cascade to fractionate lysozyme from other proteins. Their cascade 
design, however, involves the use of differently sized stages making modular and flexible design of 
such processes for the pharmaceutical industry challenging. Barker & Till (1992) were able to use a 
modular system for dextran fractionation, however, their system was batch operated. 
4.3 Conclusion 
The process models for commonly used membrane processes were reviewed to determine the 
operational limits of the processes. While examples for the use of single stage batch membrane 
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processes exist, meaningful deployment of such processes relies on the complete or near-complete 
retention of the desirable solute. As such these processes are not robust, with slight deviation from 
total rejection likely to cause failure in separation. Furthermore single stage diafiltration processes 
are not productive due to the high diafiltering solvent usage for high purity solute fractionation and 
solvent exchange. Continuous membrane processes developed in response to the limitations of the 
single stage batch processes have their merits in improving solute fractionation and solvent 
exchange. However, these processes either inherently do not have the capability to perform the 
required separation function, or are hard to fit into the typical multipurpose pharmaceutical 
manufacturing plant due to their non-modular design. 
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5. Membrane Cascades 
Chapter 4 lists the limitations of batch membrane processes and the attempts made to operate 
these processes continuously in response to these constraints. Many, if not most, of the membrane 
processes listed were not modular in design due to the different stage sizing. The design of 
alternative membrane processes, that are flexible and robust, is imperative for the wider adoption 
of such processes in the typical multipurpose pharmaceutical manufacturing plant. More 
importantly, there has to be a high level of confidence that the processes can be used for 
purification even when slight deviations in membrane performance occur. 
A new pure solvent recovery and solute concentration membrane process is presented in the first 
part of this Chapter in response to limited concentration capabilities and rigid design of the existing 
solvent recovery membrane processes.  
In the later part of the Chapter, a membrane cascade process for solvent switching / solute 
fractionation is presented, in response to the inherently unproductive separation capabilities of 
batch diafiltration processes.   
5.1 Solvent Recovery and Solute Concentration 
As noted in Chapter 4, batch solvent recovery membrane processes and their continuous 
counterparts in literature are unable to perform solute enrichment and pure solvent recovery 
concurrently unless the membranes used reject the solute in question close to unity. The constraint 
of high rejection limits the scope for multipurpose usage of these processes, hence impeding their 
use in pharmaceutical manufacturing. Therefore a new process which can perform solute 
enrichment and solvent recovery with a wide variety of membrane rejections, while being flexible 
and modular in nature, needs to be developed.  
5.1.1 Case study and process development 
In one of the possible routes for the production of a small developmental API molecule 
(approximately 300Da) at UCB Pharma, a continuous chiral chromatographic process is used to 
separate the API from its racemic mixture.  The chromatography employs a solvent mixture,  
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Figure 5.1: Schematic for solvent recovery of the eluent (product solution) from the continuous 
chromatography process used in the production of the API. 
containing methanol and ethyl acetate, as the mobile phase. As large amounts of mobile phase are 
utilised, they need to be recovered after the separation. The recovery process involves 2 stages. 
Firstly the product solution, containing either the API or its enantiomer at 10g L-1 in concentration, is 
pre-concentrated with an evaporator to 90g L-1. The resulting vapour stream is then be sent to a 
total condenser to recover the solvent, which is continuously recycled back into the 
chromatographic process. Secondly, the product concentrate from the evaporator is sent to a 
crystalliser where the remaining solvent is evaporated, with the vapours once again sent to a total 
condenser for solvent recovery.  The recovered solvent cannot contain more than 0.005g L-1 of 
solute to minimise impurity effects on the chromatographic separation. 
The phase changes in evaporation and condensation require the input of significant amount of 
energy, even if heat integration can be used to reduce the energy requirement. Furthermore, the 
higher volatility of methanol relative to ethyl acetate in the mobile phase means the mobile phase 
composition changes as the product solution is concentrated. The solution becomes less polar as it 
gets concentrated via evaporation. A consequence is a decrease of API solubility, which is mitigated 
by heating the concentrate to elevated temperatures to prevent premature crystallization. 
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The use of a membrane process to replace the first pre-concentration stage was an attractive 
proposition as the elimination of phase changes may lead to significant energy savings, acting as a 
hedge against the energy price volatility that has characterised the last decade (Kojima, 2009). 
Furthermore, if the membranes do not discriminate between the solvents, the API can be kept in 
solution without addition heating to maintain API solubility. 
The limited solute concentration capacity of membrane processes in literature can be addressed 
with the addition of a stripping section to provide additional solute enrichment capacity. A 
membrane cascade analog of a distillation column was designed, with a McCabe-Thiele approach 
used to formulate an easy to use process model for the cascade. The partial molar volume of the 
solute was neglected. This cascade is illustrated in Figure 5.2. At steady state, the material balance 
over such a cascade can be split into 3 parts: the part above the feed stage, where the behaviour in 
each unit is described by the top operating line(s); the part below the feed stage, where the units’ 
performances are represented with the bottom operating line(s); and the feed stage. 
The material balance in the rectifying section above the feed stage follows the general formula 
below, where i             refers to the solute and j             refers to the stage number. 
                          Equation 5.1 
While in the stripping section below the feed, the material balance follows 
                          Equation 5.2 
Solute i partitions across the membrane as a function of its rejection by the membrane. 
                   Equation 5.3 
Rearranging Equation 5.1, an equation for the operating line(s) above the feed can be obtained 
        
  
    
     
  
    
    Equation 5.4 
In a similar fashion, Equation 5.2 can be rearranged to an expression for the bottom operating line(s) 
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Figure 5.2. Schematic of a multipass membrane cascade with n stages. Cascade stages in the 
rectifying section decrease solute content in the recovered solvent while stages in the stripping 
section enrich solute content in the concentrate stream. In this cascade,                 and 
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     Equation 5.5 
 
The stage into which the feed enters is termed the feed stage. At this stage, the top and bottom 
operating lines intersect. The material balance over this stage can be expressed by both a top 
operating line equation (Equation 5.4) and a bottom operating line equation. The analysis of the 
bottom operating line for this stage requires the inclusion of the additional   and      terms. 
Rearrangement of this analysis yields Equation 5.6.  
      
    
  
       
 
  
     
  
  
     Equation 5.6 
The overall rejection in this cascade, as a measure of its performance, can be expressed as 
        
   
    
 Equation 5.7 
 
5.1.1.1 Degree-of-freedom analysis 
Degree of freedom analysis was performed around the cascade to determine potential controllable 
parameters for the cascade’s operation. For each membrane stage j, the typically known parameters 
are      (except for stage 1),    ,       ,       ,    and  . The unknown variables are   ,  ,      
and     . 
The permeate flow from each membrane stage is known to be a function of effective 
transmembrane pressure across the membrane and stage temperature.  
            Equation 5.8 
Similarly, the membrane rejection is a function of the effective transmembrane pressure and stage 
temperature. Consequentially it is a function of membrane flux. 
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            Equation 5.9 
Hence Equation 5.3 can thus be expressed as 
                      Equation 5.10 
The flow balance around each membrane stage can be expressed as 
 
                             
                       
Equation 5.11 
While the solute balance around each membrane stage follows 
 
                                                 
                                      
Equation 5.12 
Equations 5.8, 5.10 – 5.12 are 4 independent equations which can be solved to determine the 4 
unknown variables for membrane stage j. In this scenario, the steady state operation of each stage 
would rely firstly on control of temperature and secondly on control of either the transmembrane 
pressure in each stage or the permeate flux from each stage. 
Once steady state operation of every individual stage is achieved, steady state operation of the 
cascade becomes possible. The flow and composition of the feed stream are usually known during 
design of the cascade hence   and      are known parameters. The unknown variables on the other 
hand are   ,  ,  ,     and     . In this cascade design, the recycle ratio is defined by 
   
  
  
 Equation 5.13 
The cascade at steady state will run with a known permeate flow, therefore 
          Equation 5.14 
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The flow balance over the whole cascade is represented by 
         Equation 5.15 
And the solute balance by 
                    Equation 5.16 
With 4 independent equations and 5 variables, there is still one degree of freedom. Either     or      
must be specified to solve this equation set. To prevent crystallisation in the concentrate stream,      
should be fixed. From this analysis, it is apparent that the manipulation of the recycle ratio with the 
fixing of the product retentate concentration would suffice to control cascade performance. 
5.1.2 Factors affecting multipass membrane cascade performance 
The illustration of the cascade performance using a McCabe-Thiele approach gives better clarity on 
how the system will perform in response to changes in 
1. The number of stages; 
2. The partitioning of the solute across the membrane; 
3. The ratio of retentate flow fed into and permeate flow from each stage. 
Consider such a 3-stage membrane cascade where a 10g L-1 feed is fed into the 2nd stage to produce 
a concentrate stream of 20g L-1. One can produce a McCabe-Thiele diagram with a single top 
operating line intersecting a bottom operating line as shown in Figure 5.3. An examination of 5.3(a) 
reveals that an increase in the number of stages above the feed will decrease solute concentration in 
the recovered solvent stream, increasing the capacity for solvent purification. On the other hand, an 
increase in the number of stages below the feed will increase the solute concentration in the 
concentrate stream, amplifying the cascade’s solute enrichment capability. 
The effect of solute partitioning across the membrane can be seen when comparing 5.3(a), where 
the membranes had a single pass rejection of 0.55, and 5.3(b), where the same rejection was 0.80. 
The cascade depicted in 5.3(b) is able to produce a recovered solvent stream of 0.55g L-1, which is 
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more dilute than the 3.13g L-1 produced in 5.3(a). Effectively, the cascade represented by 5.3(b) has 
a higher overall rejection of 0.97 compared to 0.84 in 5.3(a). 
The consequence of increasing the recycle ratio from 1.2 in 5.3(b) to 10.0 in 5.3(c) is an increase in 
ratio of retentate fed into, and permeate from, each stage. Overall this will lead to an increase in the 
gradients for the operating lines in 5.3(c) relative to 5.3(b) and effectively lead to the production of a 
much more dilute recovered solvent stream (0.23g L-1 compared to 0.55g L-1) in 5.3(c) than in 5.3(b). 
5.1.3 Comparison of cascades 
By changing the recycle ratio in this cascade, the overall rejection can be modified. Simulations were 
performed for a 3-stage membrane cascade, with a single stage rejection of 0.55, for the 
concentration of a 10g L-1 feed to 30g L-1. An increase in recycle ratio increased the overall rejection 
in this cascade up to a theoretical maximum of 0.91 when all the permeate was recycled (total 
recycle; see Figure 5.4). While this maximum overall rejection was identical to the continuous 
solvent recovery cascades (see Section 4.1.2) and higher than the batch concentration cascade (0.85; 
see Section 4.1.1.1), this cascade also had a higher capacity for solute concentration than the 
continuous concentration cascades (maximum retentate concentration of under 23g L-1) due to the 
inclusion of the stripping section.  
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Figure 5.3. (a) Graphical representation of a 3–stage multipass membrane cascade with a recycle 
ratio of 1.2, with each stage possessing a single pass rejection of 0.55, used to concentrate a 
solution from 10g L-1 to 20g L-1. (b) Depiction of the membrane cascade, employing membranes 
with single pass rejection of 0.80 and operating at a recycle ratio of 1.2, used for the same 
application. Each step change led to a larger change in permeate concentration in that stage, 
improving recovered solvent quality. (c) Illustration of the same membrane cascade depicted in 
5(b), however with a recycle ratio of 10. Increase in recycle ratio led to increases in operating lines’ 
gradients. Consequentially, this led to an improvement in recovered solvent quality.  
 
Figure 5.4: Relationship between overall rejection in the multipass membrane cascade and the 
recycle ratio in the cascade. Note that the overall rejection increased with recycle ratio to a 
theoretical maximum of 0.91 approached at infinite recycle ratio (total recycle). 
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Figure 5.5: Process flow diagram of the 3-stage membrane cascade. M1, M2 and M3 refer to 
membrane units holding flatsheet membrane coupons. T1, T2 and T3 refer to buffer tanks on 
weighing scales connected to a computer running a LabView code for the implementation of a 
level controller. The numbers correspond to the membrane stage they fed into. The dotted lines 
denote the control loop used for control to maintain steady state operation of the cascade. LC = 
level controller, MV = metering valve, PI = pressure indicator, PCV = pressure control valve, TI = 
temperature indicator. Numbers beside the flow and concentration label in each line correspond 
to the flow and concentration of that line determined via sampling after running the cascade for 
141h (Sample 4). The units are ml min-1 for flow and g L-1 for concentration.    
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5.1.4 Results and discussions 
The favourable simulated performance of the cascade motivated the construction of a 3-stage 
membrane cascade to demonstrate its feasibility. This cascade was operated over 141h. The 
permeate and retentate from the cascade were mixed to form the feed stream and recirculated back 
into the cascade. The feed stream was fed into the 2nd stage to demonstrate operation of both the 
rectifying section and the stripping section. The schematic of the cascade is shown in Figure 5.5. 
5.1.4.1 General observations 
Initially, DuraMem® 300 membrane coupons were used in the membrane units. However, the low 
fluxes (20-23 L m-2 h-1, corresponding to permeate flows of 1.8-2.1ml min-1) through these coupons 
made flow control of the recycle difficult. At times there was not enough back pressure, causing flow 
through only one of the metering valves. Therefore PuraMem® S membrane coupons, which had 
higher fluxes (36-46 L m-2 h-1, corresponding to permeate flows of 3.2-4.2ml min-1) were used 
instead. 
Due to the large system volume relative to the flow rates in the system (leading to long residence 
times) and the number of stages, the time it took for the cascade to reach steady state was very 
long. In the case of this cascade, the flows stabilised about 20h after starting up the system. A similar 
observation was noted by Lin & Livingston (2007). This stabilisation time can be reduced by 
decreasing the ratios of system volume to flow rates. However, due to equipment constraints, this 
was not possible for this work. 
Whilst the single stage rejection of the membrane units were low and never higher than 59%, the 
overall rejection of the whole cascade was much higher, ranging from 73-83%. The consistency of 
the overall cascade performance was remarkable despite the large variation in the single stage 
rejection over time. This suggests that a cascade system is inherently more reliable than a single 
stage system in maintaining system performance. 
5.1.4.2 Solvent partitioning over the membrane 
Initial filtration of only the solvent mixture was performed to ascertain if the two different solvents 
permeated through the membrane at significantly different rates. 
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Single stage membrane filtration recirculation experiments were performed as described in Section 
3.3.1. The filtration of the solvent mixture was shown not to produce significant solvent partitioning, 
with the rejection of methanol being relatively constant at all pressures tested (See Table 5.1). A 
membrane cascade, employing PuraMem® S membranes, was designed for the concurrent 
production of a recovered solvent stream, with not more than 0.005g L-1 of solute, and a concentrate 
stream, with 90g L-1 of solute, from a feed stream containing 10g L-1 of solute. The design required 
14 stages and a methanol rejection of 8% was predicted to give a methanol concentration of 8.5wt% 
in the permeate stream and 12.1wt% in the retentate stream from a feed concentration of 8.9wt%.   
Table 5.1: Single-pass methanol rejection at various pressures over the membranes to be 
employed in the cascade  
Pressure / bar MeOH rejection  
PuraMem® S 
MeOH rejection  
DuraMem®300 
10 0.069 0.016 
20 0.076 -0.12 
30 0.051 -0.19 
 
Furthermore, initial operation of the 3-stage membrane cascade employing DuraMem® 300 
membranes at 30bar was shown to not significantly accentuate any slight solvent partitioning (see 
Table 5.2). As a result, changes in solvent composition should not be of concern during operation of 
the cascade. This is significant because the solvent composition is critical to API solvation, ensuring 
premature precipitation of the API will not be an issue when using the cascade. 
Table 5.2. Partitioning of methanol when using a 3-stage membrane cascade employing 
DuraMem® 300 membranes. Pressure in each stage maintained at 30bar. 
Sample 
Operating 
Time 
RMeOH,1 / 
- 
RMeOH,2 / 
- 
RMeOH,3 / 
- 
RMeOH,o / 
- 
zMeOH,F  / 
wt% 
xMeOH,1 / 
wt% 
yMeOH,p / 
wt% 
A 5h -0.034 -0.003 0.069 -0.120 9.09 7.41 8.27 
B 29h -0.067 -0.032 -0.028 -0.060 9.19 6.71 7.15 
5.1.4.3 Control issues 
There was an issue with the consistency of solute rejection in each unit, which seemed to be linked 
to the control of permeate flow from each stage. Pressure was controlled, instead of retentate flow 
and permeate flow, in each unit. As a result, there were runs where the retentate flow from the (j + 
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1)th unit and/or permeate flow from the (j - 1)th stage were/was too low. Consequently, the feed flow 
into the jth unit (T1 , T2 and T3; See Table 5.3) had to be lowered to maintain the setpoint level in the 
buffer tank. At a certain feed flow level, the flow was insufficient in maintaining the pressure set by 
the pressure control valve while at the same time was not low enough to cause a pressure decrease 
below the threshold pressure for the control valve to close. Hence the membrane unit was unable to 
repressurise to the set pressure and this sustained reduction in pressure led to a decrease in the 
rejection of API along with the permeate flux in that unit. To implement a more effective 
embodiment of this cascade, it might be prudent to use a flow controller to control the permeate 
fluxes in each membrane stage instead. This will allow control of fluxes in each stage directly and 
more effectively, albeit with higher equipment costs. 
5.1.4.4 Effect of solute partitioning 
When comparing the samples 1 and 2 with sample 4 (see Table 5.3), one will notice that the higher 
single pass rejection in stage 2 in samples 1 and 2 (0.56 and 0.57 compared to 0.37) resulted in a 
higher overall rejection in these samples (0.81 and 0.80 compared to 0.73). Therefore it has been 
demonstrated that a higher single pass rejection will increase the overall rejection and improve the 
separation performance of the cascade.  
5.1.4.5 Effect of increasing recycle ratio 
The increase of the recycle ratio increased the overall rejection of the cascade as shown in Figure 
5.6. In samples 1 and 2 (operating time of 20h and 43h, respectively), where the recycle ratios were 
1.3, the overall rejections were 0.81 and 0.80, respectively. An increase of recycle ratio to 4.10 in 
sample 3 (operating time 70h) increased this rejection to 0.87. This was, however, achieved at the 
expense of the capacity which the cascade could treat. Whereas in samples 1 and 2, 1.8ml min-1 and 
1.7ml min-1 of recovered solvent streams were produced, in sample 3 only 0.8ml min-1 of recovered 
solvent was produced.  
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Table 5.3: Relationship between the feed pumps’ flow rates with the permeate flux and API rejection in each stage. Note the lower single pass rejection 
of the API (    ) in some stages, which corresponded to lower fluxes (  ) from those stages and lower pump flow rates into those stage 
Sample 
Operating 
Time 
T1 / ml 
min
-1 
f1 / L m
-2
 
h
-1
 
RAPI,1 / - 
T2 / ml 
min
-1
 
f2 / L m
-2
 
h
-1
 
RAPI,2 / - 
T3 / ml 
min
-1
 
f3 / L m
-2
 
h
-1
 
RAPI,3 / - RAPI,o / - R / - 
1 20h 3.32 36 0.22 7.30 44 0.56 5.74 46 0.58 0.81 1.3 
2 43h 3.94 37 0.27 7.84 43 0.57 5.99 44 0.52 0.80 1.3 
3 70h 5.21 42 0.55 9.10 43 0.59 6.95 45 0.58 0.87 4.1 
4 141h 4.61 38 0.28 8.44 43 0.37 6.22 41 0.55 0.73 1.5 
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Figure 5.6. Dependence of overall rejection on the recycle ratio in the cascade. There was a strong 
correlation between the overall rejection and recycle ratio. An increase in recycle ratio produced 
an increase in the overall rejection in the cascade. 
   
Figure 5.7: Graphical illustration of the cascade operation on a McCabe-Thiele type graph for 
sample 4. Refer to Figure 5.5 for the corresponding flows and concentration in that sample set. 
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5.1.4.6 Process model validation 
Figure 5.7 illustrates the behaviour of the cascade in sample 4 (refer to Figure 5.5 for concentration 
and flow numbers). In general, the operating lines have a gradient of 
    
  
 while the partitioning lines 
have a gradient of         . The cascade aims to produce both a high purity solvent stream (low 
concentration in permeate, y-axis) and a high concentration retentate stream (high value on the x-
axis). Operating lines with steeper gradients will therefore perform the separation with a lower 
number of stages while partitioning lines with gentler gradients have the same effect. As a result, a 
large difference between the gradients of the operating line and the partitioning line decreases the 
effort required for the separation. On the other hand, if the operating line and the partitioning line 
intersect, that intersection is a pinch point where the solute concentration in both the retentate and 
the permeate will change no further no matter the number of stages put in place. In such a cascade, 
it is impossible for the concentrations of the retentate and the permeate at that pinch point to be 
achieved. 
The equation set for the multipass membrane cascade was solved for each sampled run by plugging 
in experimental values for pump, permeate and retentate flows (see Table 5.4); the solute 
concentration in the feed, zAPI,F, (see Table 5.5) and the rejection values in each stage (see Table 5.3). 
The model was fitted to experimental data by determining the least sum of squared residuals 
between the experimental solute concentration values and the process model predicted values. A 
more detailed description is given in Appendix 8.4. As seen in Table 5.6, the predicted 
concentrations were in agreement with the actual concentrations. The magnitudes of difference 
between the predicted concentrations and the experimentally determined concentrations were all 
either equal to or below 30%.  
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Table 5.4: Flow table showing flows sampled and recorded during cascade operation. 
Sample 
Operating 
Time 
Measured Flows / 
ml min
-1 Pump Flows / ml min
-1 
Inferred Flows / ml min
-1 
                                   
1 20h 0.1 1.8 3.32 7.30 5.74 2.50 3.2 4.0 4.2 3.3 1.6 2.4 
2 43h 0.6 1.7 3.94 7.84 5.99 2.50 3.3 3.9 4.0 3.9 2.0 2.3 
3 70h 1.5 0.8 5.21 9.10 6.95 2.50 3.7 3.9 4.1 5.2 2.9 3.3 
4 141h 1.2 1.5 4.61 8.44 6.22 2.50 3.4 3.8 3.7 4.6 2.6 2.2 
 
Table 5.5: Concentration table showing sampled concentrations of API during operation of the cascade. 
Sample 
Operating 
Time 
API concentration / g L
-1 
                                                     
1 20h 3.3 7.4 5.7 5.9 2.6 3.3 1.4 1.4 
2 43h 3.5 7.7 5.7 5.9 2.5 3.1 1.4 1.5 
3 70h 5.9 7.9 3.5 4.9 2.0 2.4 1.0 1.0 
4 141h 4.2 6.5 4.7 5.1 3.2 4.0 1.8 1.8 
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Table 5.6: Relative convergence of the calculated solute concentration values and the actual 
sample concentration values. 
Sample 
Percentage difference between predicted concentration and actual 
concentration 
                                               
1 -17 -17 -8.0 -8.0 -10 -11 -10 
2 16 16 11 11 22 30 22 
3 20 20 2.4 2.4 4.0 4.6 4.0 
4 -0.21 -0.21 1.6 1.6 -1.9 -4.6 -1.9 
 
5.1.4.7 Economic feasibility 
An evaluation of the economic feasibility of using the cascade to replace the first solvent recovery 
stage described in this case study, for the concentration of the API solution from 10g L-1 to 90g L-1 
while producing a very pure recovered solvent stream containing not more than 0.005g L-1 API, was 
performed. While optimisation techniques are known (Gassner & Marechal, 2010; Voros et al. 1997), 
they were not implemented. Given the relatively short product lifecycle in a non-generic API 
producer, focus was placed instead on designing a cascade that is highly modular and flexible for 
multipurpose usage. Hence all the stages in the cascade were sized identically and operated with the 
same permeate flow and rejection. The position of permeate recycle was fixed in the last stage for 
simplicity. The feed was located at the stage that possessed a retentate concentration which had the 
lowest difference with the feed concentration to operate close to idealised cascade conditions 
where minimum work was required for the separation (McCandless, 1994; McCandless, 1999).  
Experimental rejections of the API at the test pressures were used in the simulations. Initial 
simulations were performed for 2 variables, R = 1 and 3 and P = 10bar and 30bar. The linear 
regression of the annualised cost for these simulations suggests that the annualised cost will be 
minimised at maximum pressure where the single pass rejection was the highest at 0.71. This was in 
line with expectations given the high cost of the membranes. Note that publication of the price of 
the membranes has been restricted by the manufacturer Evonik-MET. Since it was not possible to 
obtain data for rejection at higher pressures given the capacity limitation of pumps at UCB Pharma 
SA, a sensitivity analysis was performed for various recycle ratios at 30bar. 
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Figure 5.8: Relationship between total membrane area required and utility cost (operating cost) of 
the cascade with the recycle ratio of the cascade. Simulations were performed using single pass 
rejection of API at 30bar across a PuraMem® S membrane. 
The relatively high cost of the membrane modules meant the total membrane area required 
correlated very well with the capital expenditure of such a process, and an optimal cascade design 
would require the minimisation of membrane area required. While the minimum utility cost 
occurred at around R = 0.9, the minimum for membrane area requirement occurred at R = 1.2. At R = 
1.2, total utility cost was estimated to be €170k/year for 1.5E6 kWh y-1 of electricity (Refer to Figure 
5.8). This translated to a cost increase of about €20k/year for a process that used about half the 
energy used in flash-condensation, due to the switch to electricity which is more costly than gas. The 
challenge in producing additional energy saving in the membrane cascade arose from the inability to 
perform integration of electrical energy used in the pumps. Unless there are specific needs for non-
thermal treatment when recovering the solvents, it is unlikely to be an attractive option.   
It would appear that membranes with better rejection properties are required to make such 
cascades competitive with traditional processes. To give a perspective on how membrane rejection 
will affect the design of the cascade, simulations were performed with the assumption that single 
pass solute rejection could be changed independently (for example by changing the solute used). In 
these simulations, 10g L-1 of solution was once again treated to form a concentrate stream of 90g L-1 
and recovered solvent stream of not more than 0.005g L-1. For each solute rejection, the optimal 
recycle ratio was changed to minimise utility cost. The results, as summarised in Table 5.7, show that 
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even a slight increase of single pass rejection to 0.800 brought the operating cost down to a level 
competitive with the flash-condensation process described in Section 5.1.1, which was predicted at 
UCB Pharma to have a utility cost of €150k per year. More importantly, this set of simulations shows 
that the cascade can provide significant cost savings without requiring the use of too much 
membrane area even if the rejection across the membrane is not complete. Therefore it is clear that 
the use of the cascade can be very attractive if tight membranes with high fluxes were developed. 
Table 5.7: Dependence of the multipass membrane cascade performance on solute rejection. As 
single pass rejection of the solute (    ) increases, a lower recycle ratio (R) is required for the 
permeate product stream to meet specification. In turn fewer stages will be required for the 
separation leading to a decrease in cascade sizing and utility requirement. 
     / - 
Optimal 
  / - 
No. of 
stages 
required 
/ - 
Feed 
stage / - 
Pump 
power / 
kW 
Membrane 
area 
required / 
m
2
 
Utility 
cost /  
€ y
-1
 
0.700 1.20 14 4 210 1330 180 000 
0.800 0.60 12 3 120 830 100 000 
0.900 0.40 8 2 68 480 60 000 
0.980 0.20 4 2 34 210 30 000 
0.990 0.10 4 2 30 190 26 000 
0.999 0.05 2 1 16 90 14 000 
1.000 0.00 1 1 12 40 11 000 
 
5.1.5 Conclusion on solvent recovery cascade 
The use of a membrane cascade in improving the performance of membranes in solute 
concentration and solvent recovery of a dilute API solution was demonstrated. The separation was 
particularly challenging as it was done on a small API (molecular weight under 300Da). The 
separation capability of this membrane cascade is not  limited by the separation performance of the 
membrane used. Competent engineering, with the aid of easily available equipment, can be used to 
augment the separation capacity of otherwise loose membranes. The system is controllable through 
the manipulation of the recycle ratio, and is flexible, robust and reliable in the event of changing 
feed conditions. On the other hand, the difficulty in energy integration on such a cascade, due to the 
dominant use of electricity in this operation, and the high cost of the membrane relative to its 
performance, make such a cascade economically uncompetitive at the moment. However, with the 
emergence of better membranes, such cascades might become attractive as the lower energy 
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requirements provide a good hedge against energy price volatility that has characterised the last 
decade (Kojima, 2009). 
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5.2 Solute Fractionation and Solvent Exchange 
The state-of-the-art single-stage diafiltration processes used for solute fractionation / solvent 
recovery are not robust due to the sensitivity of their performance to slight deviations in membrane 
rejection.  Furthermore, full solute fractionation on a single membrane stage requires total 
membrane rejection of the desired compound and such a rejection is not always possible.  The 
requirement for process flexibility in the pharmaceutical industry also demands that any membrane 
process should function without stringent need for total rejection of any solute. 
A + B C + A (excess) C (crude)
A (crude)
PurificationReaction
C (pure)
(MW ~ 200) (MW ~ 300) (MW ~ 500)
Polishing
 
Scheme 5.1: Scheme for the production of a developmental API (Compound C) at UCB Pharma S.A. 
Compounds A and B were reacted in a coupling reaction, with the less costly Compound A added 
in excess to increase conversion of the more costly Compound B. A purification step was needed 
to purify Compound C first before a crystallisation step could be used to obtain a pure Compound 
C. 
5.2.1 Case study and process development 
In the synthesis of a developmental API at UCB Pharma S.A., a final coupling process between 2 
reagents A and B was used to form the API, Compound C (see Scheme 5.1). Reagent A has a 
molecular weight of about 200Da; B has a molecular weight of about 300Da; and C has a molecular 
weight of about 500Da. The addition of excess A, which was less costly than B, was desired because 
it increased the in-situ yield of Compound C from 70%, when equimolar amounts of A and B was 
used, to 100%, when a much higher ratio of A to B was used. The corresponding cycle time for the 
reaction was also reduced from 3 days to 1 day. However, this addition of excess A was constrained 
by traditional separation techniques at UCB Pharma. These compounds (A, B and C) were all neutral 
and hence typical acid/base treatment and water wash of the organic phase were unable to remove 
excess A from C. Furthermore the crystallisation processes developed were unable to purify C when 
too much A was present. Since conventional purification processes at UCB Pharma were ineffective, 
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an OSN process was the only possible purification method that could remove most of reagent A from 
Compound C, after reagent B was completely consumed, before a final crystallisation step could be 
used to polish Compound C (see Scheme 5.1). At the end of the reaction step in Scheme 5.1, the 
binary weight purity of C was 0.60 and 0.40 for A. The target for OSN purification was to increase the 
purity of C to 0.80, while reducing the purity of A to 0.20, to enable the polishing step of the crude 
mixture.   
  
 
Figure 5.9: Diafiltration of a solution, containing 2 solutes of 10g L-1 each, across an 8-stage 
cascade. The rejection of the more permeable solute was 0.80 and its elution from the cascade 
was more apparent at first. The rejection of the less permeable solute was 0.97 and it eluted only 
after further diafiltration volumes were delivered. In contrast to chromatography, the less 
permeable solute can be collected from the retentate rather than through elution from the 
cascade.   
As the rejection of C by the membrane was not absolute, a new process had to be determined for 
the successful fractionation of A from C. While in theory, a series of membrane stages be used as the 
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stationary phase for chromatography (see Figure 5.9), the increase in the number of stages is not as 
trivial as traditional chromatography and a simpler process had to be developed. 
A new membrane process should address 2 challenges faced in constant volume diafiltration to be 
economically competitive. Firstly, the consumption of diafiltering solvent for solute fractionation 
needs to be reduced. Secondly, the loss of the less permeable solute needs to be minimised even as 
increasingly high purities of the separated solutes are achieved, if total rejection of the solute is 
impossible. The desired outcome might be realised with the appropriate stream recycles. Work on 
solute fractionation via liquid-liquid extraction has been published (Brian, 1972; Robbins & Cusack, 
1998). This was adapted to design 2 types of membrane cascades, with the relative permeability of 
one solute over the other through a membrane driving the separation. A McCabe-Thiele approach 
was used to develop the process models for the membrane cascades. To simplify the process 
models, the partial molar volumes of the solutes were ignored i.e. the volume of the solution was 
assumed to remain unchanged with solute solvation. 
A solute fractionating cascade would take the form illustrated in Figure 5.10. A feed solution 
containing the solutes to be separated is fed into the feed stage. It is then channelled progressively 
through the retentate chambers of a series of membrane units below the feed, termed the stripping 
section of the cascade, where it is stripped of the more permeable solute with a countercurrent flow 
of solvent media (stripping fluid). The staged process in the stripping section encourages maximal 
depletion of the stripping solvent stream as it is reused over a number of stages. Eventually, a 
stream enriched with the less permeable solute exits as the retentate of the 1st stage. 
Simultaneously, the increasingly depleted stripping solvent is sent upwards of the stripping section 
into the feed stage, where it strips the feed solution for one final stage. This depleted solvent stream 
exiting as the permeate of the feed stage is then sent up through a purifying section which attempts 
to further retain the less permeable species relative to the more permeable solute. This is achieved 
through a series of membrane stages and appropriate recycling of the permeate stream from the 
final stage back into the purifying section.   
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Figure 5.10. Schematic of a continuous solute-fractionating membrane cascade. The solution to be 
fractionated is fed into the feed stage F. A countercurrent flow of stripping (diafiltering) fluid is 
channelled into the retentate chamber of stage 1 via P0. The permeate stream from stage n is 
partially recycled back into the purifying section to recover the less permeable solute. The 
retentate from stage 1 is the stripped product stream enriched in the less permeable solute. The 
net permeate from the cascade in stream Pp is the purified product stream enriched in the more 
permeable solute. 
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To develop a process model, the material balance over the stripping section was analysed first 
                         . 
                                 Equation 5.17 
By rearranging the material balance, the stripping section can be described by the operating line 
equation 
      
    
  
       
  
  
     
  
  
     Equation 5.18 
If the feed stage is included in the material balance analysis with the stripping section, Equation 5.19 
will adequately describe the material balance of the streams around the feed stage 
                                       Equation 5.19 
This can be rearranged to 
      
    
  
       
 
  
     
  
  
     
  
  
     Equation 5.20 
On the other hand, the general material balance equation of the purifying section can be expressed 
as 
                         Equation 5.21 
Hence, the operating line for the purifying section on a McCabe-Thiele plot is 
      
    
  
       
  
  
    Equation 5.22 
If the permeate flux in all stages were assumed to be constant for initial design, Equation 5.22 can be 
expressed as 
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    Equation 5.23 
Where 
   
  
  
 Equation 5.24 
In each stage the partitioning lines, which dictate how the solutes partition across the membrane, 
can be expressed as  
                   Equation 5.25 
 
Figure 5.11. Schematic of a staged membrane cascade for permeable stripping. The solution to be 
purified is fed into the feed stage F. A countercurrent flow of stripping (diafiltering) fluid is fed into 
the retentate chamber of stage 1 via P0. The retentate from stage 1 is the stripped product stream 
enriched in the less permeable solute. The permeate from the feed stage, enriched in the more 
permeable solute, is the waste stream from the cascade.  
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This fractionating cascade can be simplified when the rejection of one species approaches unity. In 
such a scenario, the use of a purifying section becomes redundant as very little of the less permeable 
species will be lost from of the stripping section. On the other hand, the stripping section will still be 
utilised to maximise depletion of the stripping solvent. Such a cascade was first proposed by Lin and 
Livingston (2007) for solvent exchange and is shown in Figure 5.11. This is termed a permeable 
stripping cascade in this work. 
In this case, the material balance over the whole cascade                          . is 
                                 Equation 5.26 
The operating line for the whole cascade is thus simply  
      
    
  
       
  
  
     
  
  
     Equation 5.27 
If the solvent used for stripping is pure, the final term can be removed for increased simplicity. 
The partitioning line in this cascade can be expressed with Equation 5.25. 
5.2.1.1 Degree of freedom analysis 
Solute fractionating cascade (Figure 5.10) 
Assuming that a pure solvent is used for the stripping process, the parameters of the cascade will be 
the flows and recycle ratio (  ,   ,  ,   ,  ) and the solute concentrations for each solute i (    , 
    ,    ).  
Efficient use of the cascade requires a constant stripping flow throughout the whole cascade. This 
aims to avoid dilution or concentration of the less permeable solute in the retentate of the first 
stage. 
                    Equation 5.28 
The flow balance around the cascade is 
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            Equation 5.29 
For every solute species i in the cascade, there is a solute balance equation over the whole cascade  
                    Equation 5.30 
Note that Equation 5.24 is still valid. Hence for each solute, there are 8 variables in the whole 
cascade and 4 independent equations giving 4 degrees of freedom. For initial process design, the 
flow and composition of the stream to be treated will be known ( ,     ). Therefore 2 more 
parameters have to be set for the equation set to be solved. 
Permeable stripping cascade (Figure 5.11) 
It was assumed that a pure solvent is used for the stripping process. The parameters of the cascade 
will be the flows and recycle ratio (    ,   ,  ,   ) and the solute concentrations for each solute i 
(    ,     ,    ).  
Efficient use of the cascade also requires a constant stripping fluid flow throughout the whole 
cascade, hence Equation 5.31 should be obeyed. 
                    Equation 5.31 
The flow balance about the cascade is 
               Equation 5.32 
For every solute species i in the cascade, there is a solute balance equation over the whole cascade  
 
                   
Equation 5.33 
For each solute, there are 7 variables for in the whole cascade and 3 independent equations giving 4 
degrees of freedom. For initial process design, the flow and composition of the stream to be treated 
will be known (    ,       ). Therefore 2 more parameters have to be set for the equation set to be 
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solved.    and      were specified for the target solute and    and   for the other solutes in this 
thesis. 
5.2.2 Factors affecting permeable stripping cascade 
The simplicity of the permeable stripping cascade made it an attractive process to evaluate further. 
Simulations were performed for the sensitivity analysis of the performance of the permeable 
stripping cascade in stripping Compound A from Compound C. The separation problem involved 
purification of a binary solute solution containing Compound C, with purity of 0.60, and Compound A 
to a target Compound C purity of 0.80 in the retentate stream from stage 1. The cascade was 
assumed to operate such that Equation 5.31 was fulfilled and that the solutes’ rejections were 
constant in all stages. 
In this section, it was assumed that A had a single pass rejection of 0.90 while C had a single pass 
rejection of 0.99, unless otherwise stated. Simulations were performed for different cascades, each 
with a different number of stages. The descriptors for the permeable stripping cascade process were 
defined using equations from Equation 5.34 to Equation 5.37. 
The purity of Compound C produced by the cascade was expressed by 
      
    
         
 Equation 5.34 
The yield of C by 
        
      
          
 Equation 5.35 
The purity of A in the eluent was represented by 
      
    
         
 Equation 5.36 
While the yield of A in the cascade by 
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 Equation 5.37 
5.2.2.1 Effect of the number of membrane stages 
The simulations showed that an increase in the number of stages decreased the amount of stripping 
solvent required for the purification. For example, with a single stage the ratio of 
  
    
 required was 
23.0. The addition of a 2nd stage decreased the ratio to 9.90. If the permeate flux through the 
membrane was directly proportional to membrane area, the change in configuration would result in 
a 57% reduction of solvent consumption while requiring 90% of the area of membrane used. Further 
increases in the number of stages reduced the consumption of stripping solvent further. However, 
the improvement became marginal beyond 4 stages (see Figure 5.12). The decrease in solvent 
consumption due to the additional number of stages was also more pronounced when a more 
stringent purification target was required. When using a single stage to purify the solution from a C 
purity of 0.60 to 0.80 and 0.90, the ratio of 
  
    
 required was 23.0 and 125.0, respectively, while 
purification to 0.95 was impossible. Using 2 stages, the purification to 0.80, 0.90 and 0.95 required a 
  
    
  ratio of 9.9, 21.1 and 38.2, respectively. 
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Figure 5.12. Effect of increasing the number of stages on the stripping solvent flow to solution feed 
flow ratio. An increase in the number of stages decreased the stripping solvent consumption but 
the rate of decrease became marginal beyond 4 stages. 
The decrease in solvent consumption was a result of the cascade design, which enabled the reuse of 
permeate from stage j to strip the solute in stage j + 1. There were 2 consequences to this feature; 
firstly, an enrichment of the more permeable species into higher stage numbers occurred; secondly, 
the spare stripping capacity of the permeate stream from the (j -1)th stage could be used in the jth 
stage. 
An increase in the number of stages also resulted in an increase in C yield and A purity along with a 
decrease in A yield. Similarly, the increase in C yield and A purity became marginal beyond 4 
membrane stages and plateaued at around 0.93 and 0.87, respectively. There was also no further fall 
in the yield of A when more than 4 stages were used (see Figure 5.13). 
 
 
Figure 5.13. Effect of increasing the number of stages on the yield of C in the retentate from stage 
1 and the yield and purity of A obtained in the permeate stream from stage F. 
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Evidently, there was a limit to the use of only the stripper section in augmenting the separation 
performance of a membrane. However, it was encouraging because the use of minimal number of 
stages was predicted to produce a significant productivity boost for the cascade. 
5.2.2.2 Relative permeation factor 
The relative permeation factor (Equation 4.31) determined separation performance in solute 
fractionation. Simulations were performed for a 3-stage permeable stripping cascade, but with 
variations to the rejection values of A and C. The separation performance of this cascade is 
summarised in Table 5.8. 
The relative permeation factor for A over C was shown to determine the yields of both A and C from 
the cascade and purity of A in the permeate. Total rejection of the less permeable compound (which 
will translate to a separation factor of infinity), C, was desirable. However, it was not necessarily 
essential for an adequate separation, as a sufficiently high separation factor between the target 
solutes would suffice.  This can be inferred from the identical separation quality for No. 1 – 4 in Table 
5.8. 
Table 5.8. Summary of the effect of varying solute rejections on the separation performance of a 
3-stage membrane cascade in purifying a binary feed solution containing Compounds A and C from 
C purity of 0.60 to 0.80. No. 1 – 4 had increasing difference in rejections between C and A but had 
the same relative permeation factor of A over C; these entries had the same separation 
performance but increasing separation productivity, as determined by the flow ratio of stripping 
fluid to feed solution to be treated. No. 5 – 8 had the same difference in rejections between C and 
A but had decreasing relative permeation factor of A over C; these entries had worsening 
separation performances but very similar separation productivity. 
No.      / -      / - 
       
     / - 
 
         
 
/ - 
       / - 
  
  
 / - 
       
/ - 
       
/ - 
     
/ - 
1 0.9999 0.9990 0.0009 1 110 10.00 787 0.921 0.654 0.847 
2 0.9990 0.9900 0.0090 111 10.00 78.7 0.921 0.654 0.847 
3 0.9900 0.9000 0.0900 11.1 10.00 7.87 0.921 0.654 0.847 
4 0.9000 0.0000 0.9000 1.11 10.00 0.787 0.921 0.654 0.847 
5 0.9000 0.3000 0.6000 1.67 7.000 1.17 0.883 0.671 0.793 
6 0.8000 0.2000 0.6000 1.67 4.000 1.13 0.776 0.711 0.679 
7 0.7000 0.1000 0.6000 1.67 3.000 1.10 0.678 0.746 0.607 
8 0.6000 0.0000 0.6000 1.67 2.500 1.09 0.585 0.781 0.557 
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The relative difference between solute rejections did not correlate well with the performance of the 
cascade. This was evident from the differing separation performances in No. 5 – 8 in Table 5.8.  
Therefore the use of rejection values, which is commonly used in membrane characterisation, to 
predict the success of solute fractionating is not effective. 
5.2.2.3 Rejection effects 
While the individual rejection values of the solutes and their relative differences did not seem to 
have any correlation with the overall separation performance of the cascade, it was a good gauge of 
the productivity of the cascade. A large difference in the rejections of A and C led to a smaller 
  
  
 
ratio required. In fact, the inverse of the relative difference in rejection was in the same order of 
magnitude as the ratio of the flow of stripping solvent to the flow of solution to be treated in almost 
all the entries in Table 5.8.  
A high rejection for the less permeable solute had the tendency to lead to good fractionation 
performance because the cascade will more likely operate close to a pinch point for the solute. 
Operation close to the pinch point will result in little change in solute concentration per cascade 
stage (See Figure 5.14). A pinch occurs when the operating line and the partitioning line intersect in 
the x > 0 region. Since the partitioning lines always intersect at the origin and the operating lines 
always intersect y = 0 in the x > 0 region, the condition in Equation 5.38 must be fulfilled for the 
partitioning line and the operating line to intersect. 
 
  
    
 
 
      
 Equation 5.38 
One can see that with a higher rejection, the boundary space to fulfil the inequality becomes larger. 
Furthermore, a higher rejection allows for the use of a much higher stripping solvent to feed solution 
ratio (See Table 5.9). 
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Figure 5.14. McCabe-Thiele type representation of a 3-stage permeable stripping cascade 
operating at 
  
  
      used to purify a binary solution containing Compounds A and C, with C 
purity of 0.60, to C purity of 0.80 with C concentration of 100g L-1 in the product stream. The 
conditions here correspond to           and         . (a) shows the stripping of the less 
permeable C while (b) shows the stripping of the more permeable A. In (a), operation close to the 
pinch point ensures a smaller change in concentration per stage than in (b), where the cascade 
operates away from the pinch point. Consequently, there is little stripping of C relative to A, giving 
rise to a purification of C in the retentate stream of the cascade. 
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Table 5.9. Dependence of ease of operating cascade close to pinch point on the rejection of solute 
across the membrane. A high rejection allows a much higher stripping solvent to feed solution 
flow ratio and still allows the intersection of the operating and partitioning lines which is a 
prerequisite for pinch condition  
No.      / - 
 
      
 / - 
1 0.9999 10 000 
2 0.9990 1 000 
3 0.9900 100 
4 0.9000 10 
5 0.8000 5.0 
6 0.7000 3.3 
7 0.6000 2.5 
 
5.2.3 Comparison with constant volume diafiltration 
The most apparent effect of using the cascade instead of diafiltration was the considerable decrease 
(about 30% decrease in solvent use comparing all entries in Table 5.8 with Table 4.1) in the amount 
of solvent required for the purification. Take for example the purification of 1L day-1 of a solution 
with Compound C purity of 0.60 to a purity of 0.80. A comparison of No. 1 in both Table 5.8 and 
Table 4.1 revealed that for every 1L day-1 of solution treated using constant volume diafiltration, 
1090L of stripping solvent was needed per day; this was much higher than the 787L day-1 required 
for the 3-stage cascade process under the same conditions. If the diafiltration process was assumed 
to require 2 trains of equipment to keep up with the cascade’s capacity (See Figure 5.15 for 
schematic representation), and if the membrane flux was identical in both processes, the 
diafiltration setup would use only 8% less membrane area than the 3-stage cascade and yet incur a 
30% increase in solvent consumption. 
Less obvious is the increase in yield of the less permeable solute. Simulations showed a modest 
increase in C yield (2 – 7 percentage point increase) when using the cascade process as an 
alternative to constant volume diafiltration. This along with the decrease in solvent use will certainly 
contribute to a lower operating cost compared to diafiltration. 
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Figure 5.15. Schematics of the membrane processes used to purify 1L day-1 of a solution containing 
Compound C with purity of 0.60 to purity of 0.80. The membranes used in both processes reject 
0.9990 of Compound A and 0.9999 of Compound C. (a) shows a single train of the diafiltration 
process where the 1L solution was diafiltered over a single day and equipment rinsed over the 
next day. (b) represents the 3-stage cascade process where 1L day-1 of solution was continuously 
purified. 
The cascade’s advantage over constant volume diafiltration was more apparent when higher levels 
of purification were needed. Comparisons between simulations of constant volume diafiltration and 
a 3-stage cascade were made for the purification of increasing C purity (see Table 5.10). The amount 
of solvent savings a 3-stage cascade could realise, over constant volume diafiltration, was higher 
when purifying from 0.60 to 0.95 (saving of 7.7L diafiltering solvent per L solution) than to 0.80 
(saving of 3.0L diafiltering solvent per L solution). The yield improvement of C when using the 
cascade, which was critical to the economic feasibility of the process, was also more apparent when 
purifying to 0.95 (4.1 percentage points) than to 0.80 (2.4 percentage points).   
While the simulations have shown the potential of this membrane cascade, it was more interesting 
to provide an operating example of it to demonstrate its feasibility. Therefore this cascade was 
constructed to demonstrate its capability to separating Compound C from Reagent A.  
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Table 5.10: Comparison of single stage constant volume diafiltration and a 3-stage permeable 
stripping cascade in the purification of a solution with a Compound C purity of 0.60 to various 
purity levels. Entries 1a – 1c were simulations for a single stage constant volume diafiltration. 
Entries 2a – 2c were simulations for a 3-stage permeable stripping cascade. A purification to higher 
purities accentuated the advantages in solvent requirements of the cascade. Furthermore, there 
was a much better Compound C yield.  
No.      / -      / - C Purity
a / - Ratiob / - 
      
c/ 
- 
      
d/ 
- 
A Puritye/ - 
1a 0.9900 0.9000 0.80 10.9 0.897 0.664 0.811 
1b 0.9900 0.9000 0.90 19.9 0.819 0.863 0.761 
1c 0.9900 0.9000 0.95 28.3 0.754 0.940 0.718 
2a 0.9900 0.9000 0.80 7.9 0.921 0.656 0.847 
2b 0.9900 0.9000 0.90 13.9 0.861 0.857 0.805 
2c 0.9900 0.9000 0.95 20.6 0.795 0.938 0.753 
a Target purity of Compound C in the retentate, of the single stage diafiltration or from stage 1 of the 
3-stage cascade, at the end of the purification. 
b Volume of stripping solvent required to purify per unit volume of a binary solution containing A and 
C, with a C purity of 0.60. 
c Yield of Compound C in the retentate, of the single stage diafiltration or from stage 1 of the 3-stage 
cascade, at the end of the purification. 
d Yield of Compound A in the permeate, of the single stage diafiltration or from stage 3 of the 3-
stage cascade, at the end of the purification. 
e Purity of Compound A in the permeate, of the single stage diafiltration or from stage 3 of the 3-
stage cascade, at the end of the purification. 
 
5.2.4 Results and discussion 
Initial recirculation experiments were first performed to determine a suitable membrane-solvent 
combination and operating pressure. After which, a 3-stage permeable stripping cascade was 
constructed as shown in Figure 5.16 and operated over 56h to purify a stream of reagent A and 
Compound C. 
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Figure 5.16. Schematic of the 3-stage solute fractionating membrane cascade. M1, M2 and M3 are 
membrane units holding flatsheet membrane coupons. T1, T2 and T3 are buffer tanks on weighing 
scales connected to a computer running a LabView code for the implementation of a level 
controller. The numbers correspond to the membrane stage they feed into. The dotted lines 
denote the control loop used for control to maintain steady state operation of the cascade. LC = 
level controller, PI = pressure indicator, BPR = back pressure regulator, TI = temperature indicator. 
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5.2.4.1 Recirculation experiments 
In the original process, the post-reaction mixture containing Reagent A and Compound C was in a 
methyl tertiary butyl ether (MTBE) solution. Initial screening of the PuraMem® series membranes 
was performed to determine the partitioning of the solutes in an MTBE solution. However, none of 
the membranes tested were able to partition either A or C close to unity, although the membranes 
were able to reject C more readily. This resulted in a very low relative permeation factor of A 
compared to C. 
A decision was made to perform a solvent switch to methanol (MeOH) so that hydrophilic 
DuraMem® series membranes could be screened for solute partitioning. MeOH had the advantages 
of being unreactive and cost-effective while being compatible with the downstream crystallisation 
process. As it turned out, C was almost totally rejected by the DuraMem® series membranes when 
the methanolic solution was filtered across it, resulting in a much higher relative permeation factor 
of A compared to C. 
Solutions of A and C in MTBE were initially filtered across PuraMem® 280 and PuraMem® S 
membranes. Despite the high fluxes (see Figure 5.17) and significant differences in the rejection of A 
and C (see Figure 5.18 and Figure 5.19) on PuraMem® S and PuraMem® 280, the relative permeation 
factor of A over C was low (see Figure 5.20). With such selectivities, the predicted yields of C from 
either constant volume diafiltration or the 3-stage permeable stripping cascade were low. Do note 
that pressure was the independent variable in these tests; the rejections and relative permeation 
factors were plotted against flux to facilitate the choice of membranes because a high flux and high 
relative permeation factor were needed for a suitable membrane. The pressure used was not critical 
as long it was within the design range of the equipment. 
152 
 
 
Figure 5.17. Relationship between fluxes across the 5 membranes tested and the pressure in the 
retentate tank. Recirculation experiments for the PuraMem® S and PuraMem® 280 membranes 
were performed using a solution of A and C in MTBE. The filtration experiments for the DuraMem® 
series membranes were performed using a solution in MeOH. The solutions were maintained at 
30˚C. 
 
Figure 5.18. Relationship between the rejection of A across the 5 membranes tested and the flux 
across the membrane. Recirculation experiments for the PuraMem® S and PuraMem® 280 
membranes were performed using a solution of A and C in MTBE. The filtration experiments for 
the DuraMem® series membranes were performed using a solution in MeOH. The solutions were 
maintained at 30˚C. 
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Figure 5.19. Relationship between the rejection of C across the 5 membranes tested and the flux 
across the membrane. Recirculation experiments for the PuraMem® S and PuraMem® 280 
membranes were performed using a solution of A and C in MTBE. The filtration experiments for 
the DuraMem® series membranes were performed using a solution in MeOH. The solutions were 
maintained at 30˚C.  
The concurrent solvent switch to MeOH and use of DuraMem® series membranes gave significantly 
higher selectivities (see Figure 5.20) despite somewhat lower rejection differences. In a sense this is 
very similar to the process of changing the mobile phase and stationary phase in chromatography. 
Different solvent (mobile phase) and membrane (stationary phase) combinations can produce a 
variety of results. DuraMem® 300 gave a combination of high flux and moderately high relative 
permeation of A over C (see Figure 5.20) at 10bar and 30°C. Hence it was used, at this pressure and 
temperature, in the cascade demonstration. The pressure was not increased further as there was no 
discernible improvement to membrane selectivity and also because further increases in permeate 
flux would make control of the cascade difficult due to the low capacity of the HPLC pumps.  
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Figure 5.20. Relationship between the relative permeation factor of A over C across the 5 
membranes tested and the flux across the membrane. Recirculation experiments for the 
PuraMem® S and PuraMem® 280 membranes were performed using a solution of A and C in MTBE. 
The filtration experiments for the DuraMem® series membranes were performed using a solution 
in MeOH. The solutions were maintained at 30˚C. Note the much higher permeation factors for the 
DuraMem® series membranes, which are essential for a successful fractionation. The combination 
of high flux values and relative permeation factor for DuraMem® 300 made it a desirable 
membrane for the separation. 
5.2.4.2 Cascade operation 
The cascade was first operated with a countercurrent flow of pure MeOH with a pressure of 10bar 
and 30°C in each cascade stage. Setting              
   and adjusting the countercurrent 
flow, we realised that the condition              
   must be fulfilled for the steady flow to be 
achieved. Lowering the countercurrent flow any further caused a depressurising of the final stage. 
The cascade was used for solute fractionation continuously for 56h. However, the cascade was 
stopped for 1h to replace the pump seal in P3 at 27h. The flow rate ratio was also changed at 32h. 
A solution containing 0.57-0.60 C was eventually purified to 0.78-0.79 C with a 
  
  
 ratio of 3.5. A 
solution containing 0.57 C was purified to 0.83 with a 
  
  
 ratio of 5.0. 
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5.2.4.3 Long stabililisation time 
Due to the large cascade dead volume (c.a. 2.5L) relative to the flow rates into the cascade (0.80-
4.00ml min-1), the time for steady state to be reached was substantial. The first appearance of 
detectable amounts of C occurred 3h after the start of the separation, while the cascade approached 
steady state between 7 – 27h from the start of the stripping process; sampling 23h after the start of 
the stripping process revealed that the solute balances were at or below 5% (see Figure 5.21) though 
it increased again at 27h possibly due to difficulties for the cascade to approach steady state. 
Disturbance of the cascade by stopping the cascade or changing the flow ratio were disruptive as 
seen from solute balances from operating times 27h to 36h in Figure 5.21. Stopping the cascade for 
1h to replace the pump seal at 73h increased the net balance of C in the cascade to 27.3% from 
13.5%. The change of the flow ratio at 32h similarly caused an increase in C balance to 54.3% 
(sample at 36h) from 27.3% (sample at 30h). Further operation of the cascade for more than 20h 
stabilised operation of the cascade once again, as seen in solutes balances at operating time 56h 
when the balances for C and A were brought to -5.6% and 4.6% respectively.  
The balance of the solute in Figure 5.21 was defined as 
          
                                  
                
      Equation 5.39 
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Figure 5.21. Solute balance of A and C over the cascade during cascade operation. Note that the 
cascade was disturbed first at 27h to replace the pump seal in pump T3 and at 32h when the flow 
rate ratio of stripping solvent to solution to be treated was changed 
5.2.4.4 Effect of stripping solvent to solution flow ratio 
An increase in the flow ratio from 3.5 to 5.0 caused the purity of C produced to increase (see 
Samples 4 and 7 in Table 5.11) from 0.78 to 0.83. This was in line with expectations as an increased 
ratio increased the stripping of A from the solution due to the higher availability of stripping solvent. 
The yield of A also increased from 0.47 to 0.69 as more of A was flushed out with the countercurrent 
stripping flow. The increase in the yield of C from 0.68 to 1.01 and purity of A from 0.88 to 0.93 were 
due to factors other than the change in flow ratio and cannot be explain by the simplified model 
described in Section 5.2.1. A more rigorous use of the model, which is shown in Section 5.2.4.5, was 
needed for the explanation. 
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Table 5.11: Table summarising the performance of the cascade during operation, with comparison with the model-predicted performance shown on the 
right side of the table. The cascade was operated continuously for 56h, only stopping at Time = 27h to replace the pump seal in one of the pumps. The 
flow ratio of the stripping solvent and the solution to be treated was changed at Time = 32h. The model was in agreement with what was observed, as 
long as sufficient time was provided for the cascade to approach steady state. 
Sample Time / h 
  
  
 / - 
Determined from experiment Determined from model 
     / -        / -      / -        / -      / -        / -      / -        / - 
1 7 3.5 0.71 0.17 0.93 0.42 0.60 0.96 0.59 0.05 
2 23 3.5 0.79 0.84 0.76 0.61 0.66 0.88 0.63 0.31 
3 27 3.5 0.79 0.73 0.72 0.45 0.66 0.80 0.64 0.39 
4 30 3.5 0.78 0.68 0.88 0.47 0.68 0.96 0.88 0.32 
5 36 5.0 0.81 0.39 0.91 0.82 0.96 0.88 0.86 0.95 
6 52 5.0 0.83 1.26 0.92 0.57 0.79 0.96 0.93 0.66 
7 56 5.0 0.83 1.01 0.93 0.69 0.73 0.96 0.90 0.54 
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Table 5.12: Flow table showing recorded flow rates of flows sampled during cascade operation. 
Sample 
Time / 
h 
Measured flows / 
ml min-1 
Pumps' flows /  
ml min-1 
Inferred flows /  
ml min-1 
                                 
1 7 2.00 2.30 3.50 6.12 6.05 4.04 1.00 4.12 2.62 3.04 1.74 
2 23 1.95 2.30 3.50 5.20 4.55 3.80 1.00 3.25 1.70 2.80 1.50 
3 27 1.70 2.70 3.50 5.20 4.50 4.00 1.00 3.50 1.70 3.00 1.30 
4 30 1.55 2.90 3.50 5.20 5.36 4.70 1.00 3.65 1.70 3.70 1.80 
5 36 0.70 4.00 4.00 4.10 4.50 4.79 0.80 3.40 0.10 3.99 0.79 
6 52 1.50 3.00 4.00 4.70 5.09 4.87 0.80 3.20 0.70 4.07 1.87 
7 56 1.35 3.50 4.00 5.38 5.93 5.37 0.80 4.03 1.38 4.57 1.87 
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Table 5.13: Concentration table showing sampled concentrations of A and C during operation of cascade. 
Sample 
Time 
/ h 
Concentration of solutes in various streams / g l-1 
Stripped 
solution 
Stage 1 Stage 2 Stage 3 
Stripped 
waste 
Feed Solution 
                                                                      
1 7 1.75 0.73 0.04 0.19 3.77 1.68 0.12 0.58 10.46 5.21 0.17 2.47 20.49 13.58 
2 23 8.77 2.38 0.03 0.62 8.17 3.15 0.17 1.31 13.42 6.34 1.14 3.59 20.49 13.58 
3 27 10.00 2.68 0.04 0.70 10.31 3.94 0.19 1.52 9.70 5.24 1.15 2.98 23.24 17.76 
4 30 10.19 2.85 0.03 0.74 11.81 4.95 0.12 1.64 13.38 7.71 0.38 2.86 23.24 17.76 
5 36 10.44 2.49 0.03 0.65 15.15 5.67 0.10 1.89 13.89 8.17 0.30 2.92 23.24 17.76 
6 52 15.65 3.19 0.04 0.74 13.95 4.94 0.05 1.61 8.94 5.50 0.22 2.70 23.24 17.76 
7 56 13.97 2.82 0.03 0.70 13.21 4.76 0.05 1.44 9.03 5.57 0.22 2.78 23.24 17.76 
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Table 5.14: Relationship between the flux from each membrane stage and the solute rejection in the corresponding stage. Note the lower single pass 
solute rejections correspond to the lower fluxes in that stage. Direct control of permeate flux in each stage might be a better strategy for flow control 
compared to pressure control in each stage. 
Sample 
Time / 
h 
Stage 1 Stage 2 Stage 3 
  
          
    / -     / - 
  
          
    / -     / - 
  
          
     / -     / - 
1 7 46 1.00 0.75 34 0.97 0.65 26 0.98 0.53 
2 23 36 1.00 0.74 31 0.98 0.58 26 0.92 0.43 
3 27 39 1.00 0.74 33 0.98 0.61 30 0.88 0.43 
4 30 41 1.00 0.74 41 0.99 0.67 32 0.97 0.63 
5 36 38 1.00 0.74 44 0.99 0.67 44 0.98 0.64 
6 52 36 1.00 0.77 45 1.00 0.67 33 0.98 0.51 
7 56 45 1.00 0.75 51 1.00 0.70 39 0.98 0.50 
161 
 
5.2.4.5 Process model validation 
The derived process model was put to the test. Experimentally determined flows (see Table 5.12), 
feed solution composition (see Table 5.13) and rejections (see Table 5.14) were used in the process 
model to determine the performance of the cascade relative to the actual performance of the 
cascade (see Table 5.11). More details on the use of the model are located in Appendix 8.5. 
There was a convergence in the predicted cascade performance and actual cascade performance, 
especially for samples 3, 6 and 7 (see shaded cells in Table 5.11), where steady state behaviour was 
approached. In these samples, the magnitudes of difference were all below 25%. 
Do note that the divergence between the experimental results and model values in sample 1 – 2 and 
4 – 5 was due to the long stabilisation time, as a result of the high residence time in the cascade, 
required for the cascade to reach steady state. The large difference between experimental 
performance in samples 1 and 2 and the performance predicted by the model was because the 
cascade did not reach steady state. Steady state was approached only at 27h (sample 3). Since the 
cascade was stopped at 27h to replace a pump seal, the cascade once again required approximately 
another 27h to reach steady state. Hence samples 4 and 5, taken 3h and 9h after replacement of the 
pump seal respectively, showed cascade performances that diverged from the performance 
predicted by the model. It took another 25h for the cascade to equilibrate back to steady state, 
when experimental cascade performance started to converge with the model predicted 
performance.  
5.2.4.6 Comparison with constant volume diafiltration 
A constant volume diafiltration using DuraMem® 300 membranes was performed at 10bar and 30°C. 
The same purification produced a Compound C yield of 0.88 due to the non unity rejection of C 
across the membrane. 2.58L of diafiltering fluid was required per 1.00L of solution purified, making 
diafiltration more productive than the cascade (5.00L diafiltering fluid per L solution) in terms of 
solvent consumption. However the decrease in process yield, from quantitative recovery in the 
cascade process after 52h, meant that the diafiltration process was not economically feasible due to 
the high cost of the lost API (Compound C). There was also no scope for process enhancement, 
making diafiltration a more rigid process. 
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The successful use of diafiltration required the use of the tightest DuraMem® 150 membrane at 
40bar and 30°C to decrease Compound C loss into the permeate stream.  In doing so the same 
separation increased the yield of Compound C to 0.95 while requiring 5.60L of diafiltering volume 
per 1L of solution treated. This translated to an increase in solvent consumption (0.60L increase per 
L solution purified) over the cascade for a comparable separation performance. Importantly, 
constant volume diafiltration required a specific membrane while the cascade was able to utilise a 
looser membrane. This is a testament to the flexibility of the cascade process. 
While the long residence time with the current set of equipment and flow rates means that the 
cascade process will only be more productive than the constant volume diafiltration process if more 
than 13.5L of solution was treated, the time to reach steady state can be reduced by decreasing the 
size of the stage relative to the flow rate of the pump.   
5.2.4.7 Economic feasibility  
Due to confidentiality reasons, costing information cannot be revealed in this work. However, 
evaluation of the use of this cascade revealed that the raw material cost savings from the increased 
in-situ yield of the API (Compound C), enabled by the purification using a 3-stage permeable 
stripping cascade, was 2 orders of magnitude higher than the annualised cost of the cascade. 
Therefore an implementation of the cascade process was expected to decrease the cost for the 
production of the API. 
5.2.4.8 Challenges 
The process is currently compromised by insufficient control over the flow rates in the cascade. This 
led to each membrane stages having varying degrees of  
  
    
 ratios (see Table 5.12). This resulted in 
cascade inefficiencies as some stages did not perform to the designed stripping capacity. A better 
implementation of the process would involve control of permeate flux from each membrane stage 
directly with a flow controller. Such a controller would regulate the retentate flow from each stage 
with feedback response from the permeate flow rate from the same stage. Additionally this control 
might potentially regulate the solute rejection in each stage as the solute rejection seems to be 
correlated with the flux from the membrane in each stage (see Table 5.14). Furthermore such a 
control strategy would be able to regulate the cascade independently of the differing osmotic 
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pressures in each stage. This is advantageous over regulation of pressure in each stage where 
pressure offset might be necessary to compensate for the higher osmotic pressures in some stages.  
The process, in its current form, is relatively inflexible.  In an idealised process, the flow of the 
stripping solvent will be a function of membrane area at constant temperature, constant effective 
transmembrane pressure and constant rejection. Therefore this flow will be fixed at the design 
phase of the process. Hence it is likely the only way to change the stripping solvent to solution flow 
ratio will be through the manipulation of the flow rate of the feed solution to be purified. On the 
other hand, the maximum solute purification capacity of the cascade will be proportional to the 
maximum concentration of solution which it can treat. The higher the solution concentration this 
cascade can take, the higher the capacity of the cascade. In view of these limitations, the strategy for 
designing such a cascade will involve determining the maximum solution concentration which the 
cascade can handle and oversizing the cascade stages to ensure leeway in varying operational 
parameters. 
5.2.5 Conclusion on permeable stripping cascade 
As a result of the constraints in manufacturing and process development in the pharmaceutical 
industry, a solute fractionating cascade that can be modified rapidly has been proposed. This 
cascade was able to reduce solvent usage significantly and increase separation yield with minimal 
added stages. Furthermore the cascade was predicted to be more productive and effective in solute 
fractionation than constant volume diafiltration, which is the state of the art in membrane-driven 
solute fractionation.  
The purification of a developmental API from an excess reagent was demonstrated using this 
cascade. Firstly suitable solvent and membrane switches improved the single stage membrane 
separation. With this improved combination of solvent and membrane, the API purification was 
demonstrated using the 3-stage permeable stripping cascade. The feasibility of the cascade was 
confirmed experimentally, in line with predictions by the developed process model. The cascade was 
able to purify a solution with API (Compound C) purity of 0.6 to 0.8 to enable further polishing with a 
crystallisation step. While a higher degree of purification beyond a Compound C purity of 0.8 was 
theoretically possible, constraints in flow control made necessary increases in the stripping fluid to 
solution feed flow ratio difficult. Additional equipment is required for a better implementation of the 
process.  
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5.3 Materials and methods 
5.3.1 Membrane cascade 
The cascade was a staged membrane process. Each stage was composed of a membrane cell, a 
pump and a weight (level) controller. The solution to be concentrated was fed in the centre of the 
cascade to demonstrate how both the stripping and rectifying sections of the cascade worked. 
5.3.2 Membrane cell 
The membrane cells were designed based on Evonik-MET (UK) deadend filtration cells. Each cell 
could hold an estimated 500ml of fluid to be filtered across a membrane coupon with an active 
filtration area of 54cm2 at the bottom of the cell. A magnetic stirrer above the membrane provided 
the turbulence to mitigate concentration polarization. The cell had 3 ports at the bottom, one port 
on top and 2 ports on the cap of the cell. A pressure gauge was connected at the bottom for 
pressure monitoring close to the membrane coupon. A proportional relief valve was also connected 
at the bottom and used to regulate the pressure above the membrane coupon. A resistive 
thermometer was inserted into a port at the cap and connected to a stirrer hotplate on which the 
cell was placed. This provided real time temperature regulation in the cell and magnetic stirring at 
the same time. The inlet flow from the pump was connected to the top port of the cell. The other 
port on the cap was left opened until the cell was fully filled with liquid, and then plugged with a 
swage cap to ensure no gas remained in the membrane unit. 
5.3.3 Membranes 
PuraMem® 280, PuraMem® S, DuraMem® 150, DuraMem® 200 and DuraMem®300 flatsheet 
membranes purchased from Evonik-MET (UK) were used in the experiments. PuraMem® 280 and 
PuraMem® S were used for solutions in methyl tertiary butyl ether (MTBE). The more hydrophilic 
DuraMem® 150, DuraMem® 200 and DuraMem® 300 membranes were used for the solution in 
methanol (MeOH). Flatsheet DuraMem® 300 membranes were used in the cascade. 
5.3.4 Chemicals 
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In Section 5.1, the API was available at UCB Pharma S.A. The solvent mixture recovery was a mixture 
of 90% ethyl acetate and 10% methanol by volume. HPLC grade solvents purchase from Merck were 
used.  
In Section 5.2, Reagent A and Compound C were available at UCB Pharma. The HPLC grade solvents 
(acetonitrile, MeOH and MTBE) were purchased from Merck KGaA and used without further 
processing. The rest of the reagents were purchased from Sigma Aldrich. 
5.3.5 Analytical methods 
In Section 5.1, the composition of the solvent mixture was determined using gas chromatography 
and flame ionisation detection (GC-FID). An Agilent 6890 series GC system was used. 
In both Sections 5.1 and 5.2, the concentrations of the API, reagent A and Compound C were 
determined using HPLC with a Xbridge C18 50 x 4.6mm column from Waters, maintained at 35°C, 
employing a gradient method. The HPLC system used was a Waters 2695 series HPLC system. Three 
solvents lines were used: Deionised water (solvent A); acetonitrile (solvent B); and 7.9g L-1 
ammonium hydrogen carbonate solution with 1vol% ammonia solution (28%) added (solvent C). The 
eluent flow was kept constant at 3ml min-1 for the 5min required for complete elution. For the first 
0.33min, the eluent was, by volume, 80% solvent A, 10% solvent B and 10% solvent C. The 
composition was changed to 90% solvent B and 10% solvent C for the rest of the elution.  
5.3.6 Solvent recovery cascade operation (Section 5.1) 
The cascade was constructed as shown in Figure 5.5. The cascade employed 3 membrane units (M1, 
M2 and M3) connected in series, such that the permeate stream from the jth unit was fed into the (j - 
1)th unit while the retentate from the (j + 1)th unit was fed into the jth unit. A pair of metering valves, 
MV-Wp and MV-Pp were used to split the permeate stream from the final unit such that some of the 
permeate was recycled back into the cascade. This acted as a means to control permeate flow out of 
the cascade without changing the sizing of the final unit or the operating pressure in that stage. 
During operation, the membrane units were pressurised with fluid fed in using Merck-Hitachi syringe 
pumps (model L-6200A). Between each unit, a buffer tank (T1, T2 and T3) collected the permeate 
from the (j +1)th unit and the retentate from the (j – 1)th unit (with the exception of the first stage) to 
be fed into the jth unit. 
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During startup, the buffer tanks (T1, T2, and T3) were first filled up to the setpoint level through the 
addition of solvent or solution. Next the membrane units (M1, M2, and M3) were pressurized by 
feeding fluids into the units. The pressure in each unit was regulated around the set pressure using a 
pressure control valve. During startup, feed flow was prescribed at a fixed rate into T2. Pump T2 was 
then set to maximal flow to pressurize M2. As fluid flow started in P2 and W2, pumps T3 and T1 were 
started respectively at maximal flow. When each membrane unit was pressurized to the prescribed 
pressure, the controllers of the corresponding feed pumps were switched on to regulate the level of 
the buffer tanks from which the membrane units gained their feed.  
During operation, the cascade was run continuously by recirculating about 5L of a 5g L-1 API solution 
in the methanol/ethyl acetate solvent mixture. The extents of opening of the pair metering valves, 
which controlled the recycle ratio back into the cascade, were the main parameters that were 
changed. At certain periods of time, where pump flows and scale readings were constant for at least 
15min, samples were taken to determine flows Pp and W1, and concentration of API in all the 
streams labelled. 
When shutting down the cascade, all pumps were switched off and fluids were allowed to exit from 
the membrane units over an hour so that they could depressurise. 
5.3.7 Permeable stripping cascade operation (Section 5.2) 
The cascade was deployed as illustrated in Figure 5.16. The cascade employed 3 membrane units 
(M1, M2 and M3) connected in series. The permeate stream from the jth unit was fed into the (j + 1)th 
unit (with the exception of the 1st unit) while the retentate stream from the (j + 1)th unit was fed into 
the jth unit (with the exception of the final unit). HPLC grade solvent used for stripping the more 
permeable solute was fed into the 1st unit while the solution containing the solutes to be 
fractionated was fed into the last (3rd) unit. The permeate stream from the final (3rd) unit, which was 
essentially a dilute solution enriched in the more permeable solute, was collected and analysed over 
time. The retentate stream from the 1st unit, being enriched in the less permeable solute, was also 
collected and analysed over time.  
During operation, the membrane units were pressurised with fluid fed in using HPLC pumps (Merck-
Hitachi L-6200). The pressure in each membrane unit was regulated with a back pressure regulator. 
The temperature of the fluid in each unit was regulated with a hotplate receiving feedback from  a 
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resistance thermometer inserted into the unit. Before each membrane unit, a buffer tank (T1, T2 
and T3) collected the fluids to be fed into the unit. 
Before start-up, the buffer tanks (T1, T2 and T3) were filled above the setpoint level by adding fresh 
stripping solvent. The tanks which provide the feed for Pump P0 and Pump W4 were filled with large 
volumes of HPLC grade MeOH. The membrane units were then pressurised by feeding the fluid into 
the units. Once the set pressures were reached in all the units, countercurrent feed flows were 
prescribed by Pump P0 and Pump W4 into T1 and T3, respectively. Simultaneously, the controllers for 
Pumps T1, T2 and T3 were switched on to regulate the liquid levels in the buffer tanks. The feed rates 
for Pump P0 and Pump W4 were varied to determine the lowest 
  
  
 ratio achievable on this cascade.  
Two batches of solution were made up by mixing a weighted amount of A and C in HPLC grade 
MeOH. The concentrations of these batches were verified with HPLC analysis after solution 
preparation. The feed tube for Pump W4 was inserted into one of these batches after determination 
of the limits of the cascade. When the first batch was exhausted, the tube was inserted into the next 
batch. The cascade was then left to run continuously over 56h with the controllers adjusting the 
pump flow rates until steady state was reached. The flow rates of the controlled pumps and weight 
of each buffer tank were monitored during operation and samples were taken from the cascade at 
time intervals where pump flows and scale reading were constant for at least 15 minutes. Flow 
samples for W1 and P3 were taken over a measured time interval to determine their flow rates.  The 
rest of the flow rates were determined from the reading on the pumps or inferred using the flow 
balance around each membrane unit.  For the other labelled streams, only sufficient volumes for 
HPLC analysis were taken over short periods of time to avoid excessive perturbations in the system.  
When shutting down the cascade, all pumps were switched off and fluids allowed to exit from the 
membrane units over an hour to ensure full depressurisation.  
5.3.8 Control 
Regulation of the levels in the buffer tanks between each membrane unit was done through the 
control of pumps that drew their feed from the tanks. The pumps were controlled with the aid of a 
LabView procedure. The permeate from unit (j – 1) and retentate from unit (j + 1) flowed into the 
buffer tank (denoted by Tj) between units j and (j – 1), while the pump (Pump Tj) drew from the 
buffer tank to feed into unit j. The level in each buffer tank was monitored through its weight. This 
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weight was kept constant by a PI controller algorithm that changed the pump flow based on 
feedback from the weighing scale, sampling every 100ms. 
Each controller was first tuned employing the Ziegler-Nichols closed-loop tuning method (Ziegler & 
Nichols, 1993) (refer to Figure 5.5 and Figure 5.16 for control loop denoted by dotted lines). The 
controllers were then further fine-tuned to obtain minimal drift from the average feed flow while 
making sure controller gain was sufficient to keep the weight reading of each tank within ±1g of the 
setpoint. 
5.4 Conclusion 
The use of process engineering to develop new membrane process configurations have been shown 
to increase the range of scope for commercial membranes. Through various process modifications 
such as solvent changes and stage configurations, membranes can be made versatile for a variety of 
processes.  
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6. Conclusions and Further Work 
6.1 Conclusions 
The achievement of the key scientific deliverables listed in Chapter 1 is a testament to the success of 
this work. The following were covered in various Chapters of this thesis. 
1. Review of various membrane transport models (Chapter 2). 
2. Case study on the use of process modifications on solutes to improve OSN separation, 
including their relevance in improving solute rejection and their use for membrane 
performance predictions (Chapter 3). 
3. Review of common OSN processes and their inherent limitations (Chapter 4). 
4. Case study for the use of process engineering to address the limitation of the state of the art 
OSN processes (Chapter 5). 
The development of tools and methods to enable the use of organic solvent nanofiltration in the 
chemical synthesis of APIs, from the perspective of a pharmaceutical company, is the central theme 
of this work. Identification of membrane screening as one of the most time-consuming steps in 
membrane process development led to evaluation of membrane transport models for the prediction 
of membrane performance in lieu of membrane screening. In the hope of circumventing the need 
for the use of a ‘perfect’ membrane, further attempts were made to develop a structured approach 
to process modification to enable the use of commercial membranes without the requirement for 
total rejection of the target compound.   
The Donnan Steric Pore Model can be used to predict membrane performance from independently 
determined membrane physical properties. Its ability to correlate membrane performance with 
membrane physical characteristics was the reason for the evaluation of DSPM as a predictive tool for 
membrane transport. However, the Hagen-Poiseuille equation in the DSPM was unable to accurately 
predict solvent permeation through nanofiltration membranes. This led to attempts to improve the 
prediction of the DSPM by replacing the Hagen-Poiseuille equation with a predictive molecular 
dynamics tool. Unfortunately, molecular dynamics simulations were computationally tedious. 
Coupled with the inability of current methods to independently determine membrane properties 
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such as pore size and membrane tortuosity accurately and quickly, the DSPM is unable to provide a 
competitive advantage over conventional experimentation.        
Process chemistry can selectively manipulate solute rejection and in turn can be used to increase the 
applicability of the limited range of membranes on the market. Both the selective addition of charge 
to solutes and increase in molecular size of solutes were able to enhance the membrane rejection of 
the targeted solutes. The use of pH control for targeted manipulation of the membrane permeation 
selectivity of various solutes was presented. After which, the polyalkylation approach was used to 
augment the size of an organocatalyst, enabling the successful recycling of an organocatalyst on a 
single membrane stage. These 2 case studies demonstrated the role process chemistry plays in 
improving the versatility of OSN processes. 
However, process chemistry was not always able to address the issues facing conventional 
membrane processes. The processes were reviewed and the common problems they face are non-
robustness and inflexibility, often due to the sensitivity of the processes to single pass rejection. 
Thus, cascade processes were designed, with the aim to provide an alternative process for use in the 
pharmaceutical industry, by addressing these problems. 
A membrane cascade was first designed to enable the use of membranes with incomplete solute 
retention in pure solvent recovery. The consistency of the cascade performance despite 
discrepancies in the single pass rejection proved the improved reliability of the cascade over a single 
stage process. Following which, another cascade was designed and demonstrated for the separation 
of 2 solutes, despite being unable to reject the target solute completely. These cascade designs 
provided the means for more extensive and flexible use of commercial membranes than 
conventional membrane processes. Furthermore, the modular designs of the cascades meant that 
the processes could be repurposed for other separation problem through simple reconfiguration of 
the stages, facilitating their deployment in the typical multipurpose API production plant. The 
flexibility of these cascades is the main advantage cascades developed in this work have over other 
cascades mentioned in literature. 
All together, the work in this thesis presents ways to improve the ease of membrane process 
development in the pharmaceutical industry and provides a reference for common separation 
problems in the industry which can be resolved with OSN.   
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6.2 Recommendations for Further Work 
While this work has opened up greater possibilities for application of membrane processes in the 
pharmaceutical industry, a few things still need to be resolved and improved upon. The following 
should be done, in the listed order, to improve upon the work in this thesis. 
The design of the membrane stages for the cascades in this work was not perfect. On hindsight, 
undue consideration for high residence times in each membrane unit resulted in retentate volumes 
that were excessively large relative to the pump’ flow capacities. The rejection across each 
membrane unit should stay constant when the whole cascade reaches steady state, hence having a 
large residence time in each unit is not paramount to operation of the cascade. In fact, it 
unnecessarily prolonged the duration required for experimentation. Further work on the membrane 
cascades should utilise smaller membrane units, which cost less to build, to facilitate 
experimentation.     
While membrane cascades have been demonstrated, the process control over them has not been 
perfect leading to inconsistent stage performance. The performance of the cascades can be further 
improved, and made more robust, by controlling the pressure control valve in each stage with 
deviation of permeate flow in each stage from the setpoint providing feedback to the control valve. 
This can be done easily, albeit with significant investment, using flow controllers that are already on 
the market. 
It will be a challenge for multistage membrane processes to compete with thermal processes due to 
the use of costlier electricity for pump operation. Furthermore while heat can be integrated in 
thermal processes, it is much harder to integrate electrical power used for the pumps in the 
multistage membrane processes. Energy recovery solutions on the market can recover energy from 
the pressurised retentate stream to pressurise the feed stream to each cascade stage (Flowserve, 
2012), however these need to be evaluate in the context of OSN.   
In the case when cascade flexibility is not paramount, various established optimisation techniques 
(Gassner & Marechal, 2010; Voros et al. 1997) can be used to optimise cascade design, bringing 
down capital and operating cost. This can be further explored when processes are run continuously 
for large production volumes, especially in the realms of fine and bulk chemicals. 
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Though an elevation in the molecular weight of a solute is known to increase its membrane 
rejection, certain side groups have been shown to provoke a higher membrane rejection. This 
relationship needs to be elucidated and perhaps quantified meaningfully, perhaps not unlike a group 
contribution method, before a structured method of polyalkylation can be used. Further 
experimentation on various solutes would be needed to do this. 
On a similar note, polyalkylation was used to anchor catalytic sites to a relatively small 1,3,5-
tris(bromomethyl)benzene anchor molecule in this work. A much larger anchor molecule can be 
synthesised by attaching ethylene glycol subunits to 1,3,5-tris(bromomethyl)benzene. The synthesis 
process, however, is tedious and expensive, hence it was not pursued in this work. It would be good 
to synthesise this to elucidate the effect of size on the solute rejection across the membrane. 
Furthermore, it would help to understand if there is a hard limit on the number of subunits that can 
be added before the increased solution viscosity would impede solvent permeation. The hypothesis 
of whether such spacer molecules can increase catalytic activity by reducing steric hindrance to the 
entrance of substrate, while still retaining the selectivity of the catalyst also should be tested. 
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Figure 6.1: Structure of enlarged anchor molecule with ethylene glycol subunits added as spacer 
molecules. 
Finally, the use of the DSPM is hindered by the uncertainty in the structures and characterisation of 
OSN membranes. Further refinement of methods currently in development is needed so that precise 
and direct determination of an OSN membrane’s structural characteristics such as membrane pore 
size, tortuosity and separation layer thickness can be performed to facilitate the use of the DSPM. 
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This is the hardest amongst the suggestions listed, in no small part due to the difficulty in 
characterising the structure of OSN membranes (Stawikowska & Livingston, 2012).  
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8. Appendices 
8.1 Derivation for Solvent Transport Equation in the DSPM 
Membrane pores are assumed to be circular and straight in the DSPM. No slip condition is assumed 
between the fluid in the pore and the pore walls. Furthermore, the fluid is assumed to be Newtonian 
in behavious i.e.    
  
  
. 
 
Figure 8.1. Schematic representing solvent flow in a straight and circular membrane pore. Note the 
control volume with length of Δx used for momentum balance analysis. 
The y-coordinates are defined by       . Hence 
        
  
  
  
  
  
 Equation 8.1 
As a Newtonian fluid, the dynamic viscosity of it can be expressed with 
    
  
  
   
  
  
 Equation 8.2 
The shear stress on the fluid due to the wall is 
y = 0 
rp 
x = 0    Δl 
Δ  
p1 p2 
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       Equation 8.3 
Taking a momentum balance across the control volume yields 
                
  
  
       Equation 8.4 
By rearranging and integrating on both sides, taking into account the no slip conditions at the pore 
wall, the following equation can be obtained 
            
 
  
              
 
 
 Equation 8.5 
Rearranging, a general solution for fluid velocity in the x-direction can be obtained 
   
          
    
      
   Equation 8.6 
Since the linear velocity follows a parabolic profile, the maximum velocity occurs in the centreline of 
the pore where     
      
         
    
  
  Equation 8.7 
Therefore the average fluid velocity in the pore, which is equivalent to the superficial velocity across 
the membrane, can be expressed in terms of the pressure drop across the control volume by 
    
          
    
  
  Equation 8.8 
If the pores in the membrane represent a membrane porosity of ε, conservation of fluid volume 
across the pore will yield 
          Equation 8.9 
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Hence, by expressing Equation 8.8 in terms of the pressure drop across the membrane pore and 
rearranging the resulting equation after substituting Equation 8.9, solvent transport across the 
membrane pore can be related to membrane flux with 
    
   
    
   
  
  
 Equation 8.10 
 
8.2 Synthesis Steps for Compounds in Chapter 3 
Preparation of 5 
To a solution of quinidine (4.0g) in dried DMF (30ml) under nitrogen pressure, NaH (1.36g, 60wt% 
suspension in mineral oil) was added in small portions. The mixture was stirred at room temperature 
for 2h. A solution of 1,3,5-tris(bromomethyl)benzene (1.1g, 97wt%) in dried DMF (10ml) was then 
slowly added to the mixture using a syringe under stirring. The reaction was quenched with 
deionized water after 5h.  
The pH of the mixture was adjusted to 1 by adding HCl (0.1M) and washed with n-hexane (300ml). 
The pH of the aqueous phase was then adjusted to 14 by adding solid NaOH. Ethyl acetate (1L) was 
added to dissolve all particulates in the mixture and the aqueous phase removed. The organic phase 
was washed with 2.5L deionized water and then concentrated to dryness. 
Normal phase preparative chromatography then used to purify the residue on a Kromasil column 
using a mobile phase containing dichloromethane:methanol (89:11 v/v 1.1% ammonium hydroxide). 
Isolated yield 42%. 
1H NMR (400MHz, (CD3)2SO) δ 8.69 (d, J = 4.1Hz, 1H), 7.96 (d, J = 7.9, 1H), 7.50 (br, 1H), 7.44 (d, J = 
2.6Hz, 6.9Hz, 1H), 7.40 (dd, J = 2.6Hz, 6.9Hz, 1H), 7.15 (s, 1H), 5.88-6.00 (m, 1H), 5.17 (br, 1H),  4.95 
(d, J = 17.4Hz, 1H), 4.86 (d, J = 10.4Hz, 1H), 4.32 (dd, J = 12.7Hz, 23.2Hz, 2H), 3.79-3.85 (m, 3H), 3.03-
3.14 (m, 1H), 2.83-2.93 (m, 1H), 2.60-2.70 (m, 1H), 2.41-2.50 (m, 1H), 2.10-2.20 (m, 1H), 2.08(br, 1H), 
1.79-1.89 (m, 1H), 1.64 (br, 1H), 1.35-1.59 (m, 3H); HRMS m/z for (M + H+) = 1087.6 
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Preparation of 6 
To a solution of quinidine (10g) in dried DMF (70ml) under nitrogen pressure, NaH (3.4g, 60wt% 
suspension in mineral oil) was added in small portions. The resulting mixture was stirred at room 
temperature for 2h. A solution of 1,3,5-tris(bromomethyl)benzene (2.75g, 97wt%) in dried DMF 
(10ml) was slowly added to the mixture using a syringe under stirring. The reaction was quenched 
with deionized water (200ml) after 19h. Dichloromethane (400ml) was added to the mixture and 
then washed with deionized water (2 x 200ml). The organic phase was then removed and dried in 
vacuo yielding 16.6g of a brown oil. 
Sodium ethanethiolate (18g, 90wt%) was added to this oil along with dried  DMF (180ml) and the 
mixture was stirred under nitrogen pressure and under reflux (110°C). The reaction was left to cool 
to room temperature after 24h and then quenched with deionized water (180ml). The pH of the 
mixture was adjusted to 1 using HCl (1M) and washed with ethyl acetate (2 x 250ml + 100ml). The 
aqueous layer pH was then adjusted to 8 using ammonium hydroxide and washed with 
dichloromethane (3 x 250ml). The organic layers were collected and washed with deionized water (2 
x 500ml) before drying in vacuo. 4.1g of a dry brown solid was obtained. Isolated yield = 53%. 
1H NMR (400MHz, (CD3)2SO) δ 10.20 (br, 1H), 8.62 (d, J = 4.3Hz, 1H), 7.92 (dd, J = 3.4Hz, 8.9Hz, 1H), 
7.50 (br, 1H), 7.39 (s, 1H), 7.32 (d, J = 9.0Hz, 1H), 7.20 (d, J = 14.5Hz, 1H), 5.79-6.00 (m, 1H), 5.12 (br, 
1H),  4.95 (d, J = 17.0Hz, 1H), 4.85 (d, J = 10.3Hz, 1H), 4.33 (dd, J = 6.4Hz, 11.8Hz, 2H), 3.16 (br, 1H), 
2.99 (br, 1H), 2.73 (br, 2H), 2.60 (br, 1H), 2.11-2.27 (m, 1H), 1.78-2.00 (m, 1H), 1.67 (br, 1H), 1.40-
1.56 (m, 2H), 1.03-1.38 (m, 1H); HRMS m/z for (M+3H+) = 349.2, (M + 2H+) = 523.8, (M + H+) = 
1045.7. 
Preparation of 7 
To a mixture of quinidine (3.3g) and 1,3,5-tris(bromomethyl)benzene (1.2g, 97wt%), a solvent 
mixture of ethanol/DMF/chloroform (30ml 5:6:2 by volume) was added. The mixture was stirred 
under reflux (100°C) for 18h. The mixture was then cooled to room temperature and ether added to 
it until the solution turned colourless. A precipitate was filtered off and washed with a solvent 
mixture of ether/acetone (750ml 1:2 vol/vol). The precipitate was then dried in vacuo to afford a dry 
brown powder (2.8g). Isolated yield = 63% 
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1H NMR (MHz, (CD3)2SO) δ 8.85 (d, J = 4.6Hz, 1H), 8.26 (br, 1H), 8.06 (d, J = 9.7Hz, 1H), 7.80-7.84 (m, 
1H), 7.55 (dd, J = 2.1Hz, 9.7Hz, 1H), 7.45-7.50 (m, 1H), 6.75-6.87 (m, 1H), 6.62 (s, 1H), 5.97-6.10 (m, 
1H), 5.10-5.19 (m, 2H), 4.81-4.95 (m,, 1H), 3.69-3.81 (m, 2H), 3.44 (s, 3H), 3.15-3.26 (m, 1H), 2.89 (s, 
2H), 2.31-2.47 (m, 1H), 2.08 (br, 2H), 1.93 (br, 1H), 1.65-1.80 (m, 2H), 1.10-1.24 (m, 1H); HRMS m/z 
for (M3+) = 363.  
Preparation of 8 
O-desmethylquinidine (2g) was mixed with deionized water (40g). Solid NaOH (0.24g) was added to 
this mixture and stirred at room temperature until a clear yellow solution was formed. The aqueous 
solution was washed with dichloromethane (2 x 12ml). The aqueous phase was mixed with 
isopropanol (50ml) and dried in vacuo. A dry yellow solid was produced (1.9g) and mixed with dried 
DMF (10ml). A solution of 1,3,5-tris(bromomethyl)benzene (0.63g) in dried DMF (10ml) was slowly 
added to this mixture using a syringe. The whole reaction mixture was stirred at room temperature 
for 4 days. Ethyl acetate (20ml) was then added into the mixture over 5min using a dropping funnel 
followed by aqueous ammonium chloride (70ml, 14wt%) also using a dropping funnel. The mixture 
was left to stir for 19h, after which the crystals were filtered off and washed with NaOH (2 x 25ml, 
0.1M) and deionized water (3 x 25ml). The residue was then dried in vacuo. 1.2g of a brown solid 
produced. Isolated yield = 68% 
Procedure for Michael addition reaction in Table 3.2 
Trans-β-nitrostyrene (60mg, 0.4mmol), dimethyl malonate (158mg, 1.2mmol), naphthalene (30mg) 
and the catalysts were placed in cylindrical tubes. THF (0.4ml) was then added to each tube and the 
resulting mixture stirred at -20°C using a Teflon-coated stir bar. The mixtures were sampled every 
24h for HPLC analysis at 230nm. The reaction solutions were purified using preparative thin layer 
chromatography to produce a purified product for chiral analysis. 
(-)-Methyl 2-carbomethoxy-4-nitro-3-phenyl-butyrate, Entries in Table 3.2. This product was 
obtained as a light yellow oil after flash chromatography (elution gradient: Ethyl acetate/isohexane = 
¼ by volume). %ee determined by HPLC analysis [Daicel Chiralcel OD-H, isohexane:IPA, 70:30, 
0.9ml/min, column temperature = 24°C, λ = 220nm, t (minor) = 11.7min, t (major) = 13.1min] 
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Entry 1. This product was obtained with 52% yield and 19% ee from a reaction catalysed with 
catalyst 3 (10mol%) at -20°C for 12 days.  
Entry 2. This product was obtained with 82% yield and 86% ee from a reaction catalysed with 
catalyst 4 (10mol%) at -20°C for 1 days. 
Entry 3. This product was obtained with 44% yield and 7% ee from a reaction catalysed with catalyst 
5 (3.3mol%) at -20°C for 18 days. 
Entry 4. This product was obtained with 62% yield and 94% ee from a reaction catalysed with 
catalyst 6 (10mol%) at -20°C for 3 days. 
Procedure for Michael addition reaction in Table 3.3 
Trans-β-nitrostyrene (60mg, 0.4mmol), dimethyl malonate (158mg, 1.2mmol except for Entry 3 
where 53mg, 0.4mmol was used), naphthalene (30mg) and the catalysts were placed in cylindrical 
tubes (see Table 3.3). THF (0.4ml) was then added to each tube and the resulting mixture stirred at -
20°C using a Teflon-coated stir bar. The mixtures were sampled every 24h for HPLC analysis at 
230nm. The reaction solutions were purified using preparative thin layer chromatography to 
produce a purified product for chiral analysis. 
(-)-Methyl 2-carbomethoxy-4-nitro-3-phenyl-butyrate, Entries in Table 3.3. This product was 
obtained as a light yellow oil after flash chromatography (elution gradient: Ethyl acetate/isohexane = 
¼ by volume). %ee determined by HPLC analysis [Daicel Chiralcel OD-H, isohexane:IPA, 70:30, 
0.9ml/min, column temperature = 24°C, λ = 220nm, t (minor) = 11.7min, t (major) = 13.1min] 
Entry 1. This product was obtained with 62% yield and 94% ee from a reaction catalysed with 6 
(3.3mol%) at -20°C for 3 days. 
Entry 2. This product was obtained with 89% yield and 94% ee from a reaction catalysed with 6 
(10mol%) at -20°C for 1 days 
Entry 3. This product was obtained with 89% yield and 94% ee from a reaction catalysed with 6 
(10mol%)  at -20°C for 4 days 
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Procedure for Michael addition reaction in Table 3.4 
The nitrostyrene (0.4mmol), dimethyl malonate (158mg, 1.2mmol), naphthalene (30mg) and catalyst 
6 were placed in cylindrical tubes. THF (0.4ml) was then added to each tube and the resulting 
mixture stirred at -20°C using a Teflon-coated stir bar. The mixtures were sampled every 24h for 
HPLC analysis at 230nm. The reaction solutions were purified using preparative thin layer 
chromatography to produce a purified product for chiral analysis. 
(-)-Methyl 2-carbomethoxy-4-nitro-3-phenyl-butyrate, Entry 1. This product was obtained as a light 
yellow oil with 62% yield after flash chromatography (elution gradient: Ethyl acetate / isohexane = ¼ 
by volume) and 94% ee determined by HPLC analysis [Daicel Chiralcel OD-H, isohexane:IPA, 70:30, 
0.9ml/min, column temperature = 24°C, λ = 220nm, t (minor) = 11.7min, t (major) = 13.1min] 
(-)-Methyl 2-carbomethoxy-4-nitro-3-(4-methylphenyl)-butyrate, Entry 2. This product was 
obtained as an off-white solid in 62% yield after preparative thin layer chromatography (elution 
gradient: Ethyl acetate / iso-hexane = ¼ by volume, Rf = 0.14) and 93% ee determined by HPLC 
analysis [Daicel chiralcel OD-H, isohexane:IPA, 85:15, 1.0ml/min, column temperature = 18°C, λ = 
220nm, t (minor) = 20.0min, t (major) = 22.4min] from a reaction catalysed with catalyst 6 (3.3mol%) 
at -20°C for 5 days. 
(-)-Methyl 2-carbomethoxy-4-nitro-3-(4-fluoro-phenyl)-butyrate, Entry 3. This product was 
obtained as a colourless oil in 81% yield after flash chromatography (elution gradient: Ethyl 
acetate/isohexane = ¼ by volume) and 94% ee determined by HPLC analysis [Daicel Chiralcel AD-H, 
isohexane:IPA, 70:30, 1.0ml/min, column temperature = 22°C, λ = 220nm, t (minor) = 12.2min, t 
(major) = 7.4min] from a reaction catalysed with catalyst 6 (3.3mol%) at -20°C for 3 days. 
(-)-Methyl 2-carbomethoxy-4-nitro-3-(4-nitro-phenyl)-butyrate, Entry 4. This product was obtained 
as a yellow solid in 88% yield after preparative thin layer chromatography (elution gradient: Ethyl 
acetate/isohexane = ¼ by volume, Rf = 0.17) and 95% ee determined by HPLC analysis [Daicel 
Chiralcel OD-H, isohexane:IPA, 50:50, 0.9ml/min, column temperature = 28°C, λ = 220nm, t (minor) = 
10.3min, t (major) = 15.6min] from a reaction catalysed with catalyst 6 (3.3mol%) at -20°C for 1 day; 
1H NMR (400 MHz, CDCl3) δ 8.23 (dt, J = 2.8Hz, 8.8Hz, 2H), 7.48 (dt, J = 2.7Hz, 8.6Hz, 2H), 4.91-5.02 
(m, 2H), 4.35-4.44 (m, 1H), 3.90 (d, J = 8.8Hz, 1H), 3.81 (s, 3H), 3.64 (s, 3H); 13C NMR (400MHz, CDCl3) 
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δ 167.5, 166.7, 147.8, 143.6, 133.3, 132.5, 129.2, 124.2, 77.0, 54.1, 53.4, 53.1, 42.7; HRMS m/z (M + 
NH4+) = 344 
(-)-Methyl 2-carbomethoxy-4-nitro-3-(2-furyl)-butyrate, Entry 5. This product was obtained as a 
light yellow in 92% yield after preparative thin layer chromatography (elution gradient: Ethyl 
acetate/isohexane = ¼ by volume, Rf = 0.20) and 96% ee determined by HPLC analysis [Daicel 
Chiralcel OD-H, isohexane:IPA, 60:40, 1.0ml/min, column temperature = 22°C, λ = 220nm, t (minor) = 
6.4min, t (major) = 15.0min] from a reaction catalysed with catalyst 6 (3.3mol%) at -20°C for 3 days. 
Compound 2, Entry 6. This product was obtained as an off-white solid with 67% yield after 
preparative thin layer chromatography (elution gradient: Ethyl acetate/isohexane = ¼ by volume, Rf 
= 0.14) and 92% ee determined by HPLC analysis [Daicel Chiralcel OD-H, isohexane:IPA, 85:15, 
1.0ml/min, column temperature = 18°C, λ = 220nm, t (minor) = 20.0min, t (major) = 22.4min]  
8.3 Derivation For Chromatography Analog 
Assume a constant sieving constant, where the sieving constant can be defined as 
    
    
    
 Equation 8.11 
The mass balance over stage j can be expressed as 
                           Equation 8.12 
Rearranging and substituting the sieving coefficient, one gets 
   
     
  
                 Equation 8.13 
In stage 1, since the incoming feed is pure solvent, the mass balance changes to 
   
     
  
         Equation 8.14 
Rearranging and integrating on both sides 
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 Equation 8.15 
Solving and rearranging the integral,  
                 
   
  
  Equation 8.16 
In stage 2, mass balance after substituting equation 8.6 and assuming that the retentate volume in 
all stages are equal to that in stage 1. 
   
     
  
              
   
  
         Equation 8.17 
Multiply by     
   
  
  and rearrange,  
     
   
  
 
     
  
     
   
  
 
  
  
     
  
  
       Equation 8.18 
One would notice that the terms on the left hand side can be expressed as the differentiation of a 
product, hence  
 
 
  
     
   
  
       
  
  
       Equation 8.19 
Integrating on both sides and rearranging 
            
   
  
     
   
  
  Equation 8.20 
In stage 3 and 4, perform the same treatment as shown in equations 8.17-8.20. 
            
  
   
     
      
   
  
  Equation 8.21 
For stage 4, it is  
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  Equation 8.22 
The pattern is apparent that at stage n 
     
      
  
 
   
  
 
   
     
   
  
  Equation 8.23 
The permeate from stage n hence can be expressed as  
             Equation 8.24 
 
8.4 Model Validation Multipass Permeate Cascade 
 
Figure 8.2. Simplified schematic of a 3-stage membrane cascade used in material balance analysis. 
In the top most envelop (enclosed in a dotted-line box), 2 unknowns,      and     , were identified 
given that a guess was provided for the value of        . The top operating line equation, 
Envelops to determine 
unknowns in stage 
2            
 
P2, yi,2Pn-1, 
yi,n-1 
W3, xi,3Wn, 
xi,n 
Wp, 
xi,pN2 
gas 
P3, yi,3RT Pp, yi,p 
P1, yi,1Pn-2, 
yi,n-2 
W2, xi,2Wn-
1, xi,n-1 
F, zi,FF, 
zi,F 
  
  
Stage 2 
Stage 3 
  
W
1
, x
i,1
 
Stage 1 
Envelop to 
determine 
unknowns in 
stage 3 
 
  
Envelop to determine 
unknowns in stage 3 
  
197 
 
Equation 8.25 and the partitioning line equation, Equation 8.26 were sufficient to solve for these 2 
unknowns.  
 
     
  
  
    
  
  
    Equation 8.25 
 
      
    
        
 Equation 8.26 
In the square-dotted envelop above the feed, the remaining unknown was     , With a single 
equation, Equation 8.27, this unknown could be determined 
 
     
  
  
     
  
  
    Equation 8.27 
An analysis of the square-dotted envelop below the feed revealed that the remaining unknowns was 
    . Equation 8.28 sufficed for solving it. 
      
    
        
 Equation 8.28 
The material balance in the bottom operating line equation (Equation 8.29) for the feed stage, stage 
2, can be rearranged to obtain Equation 8.30. This can be used to solve for unknown      
      
  
  
     
 
  
     
  
  
     Equation 8.29 
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 Equation 8.30 
The remaining unknowns in the bottom envelop was     . This can be solved by Equation 8.31 
                   Equation 8.31 
Equation 8.32 was not used as this would overspecify the problem. 
 
     
  
  
     
  
  
     Equation 8.32 
The difference between the solute concentration determined experimentally and the expected 
solute concentration as determined by the model were squared and summed up to determine the 
sum of squared residuals.      was reiterated until the sum of squared residuals could not be 
reduced any further.  
8.5 Model Validation For Permeable Stripping Cascade 
The process model described above was validated by using sampled flow rates and rejections to 
determine the concentration of A and C in each stream. 
Since pure methanol was used as the stripping solvent, Equation 5.27 was simplified to 
      
    
  
       
  
  
     Equation 8.33 
We first solved the variables for Compound C. To start off, a guess was provided for     . This was 
used to solve Equation 8.34. 
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     Equation 8.34 
Next 
      
    
      
 Equation 8.35 
In the next step 
      
  
  
     
  
  
     Equation 8.36 
Next 
      
    
      
 Equation 8.37 
Then 
      
  
  
     
  
  
     Equation 8.38 
Next 
      
    
      
 Equation 8.39 
Equations from Equation 8.33 to Equation 8.38 were solved simultaneously and      was reiterated 
until it converged with the value determined by Equation 8.39. This was repeated with Compound A. 
 
